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Résumé
Le foie est très sensible à l’apoptose. De nombreuses études ont rapporté une induction
marquée de l’apoptose des hépatocytes au cours des infections virales (hépatites B, C et
fulminante) et dans les hépatopathies alcooliques. Étant donné que les hépatocytes
expriment le récepteur Fas de façon constitutive, ceci soulève son implication fas dans le
développement des pathologies hépatiques. Ainsi, le but de cette thèse est d’étudier les
mécanismes de protection activés par le facteur de croissance épidermique (EGF) contre
l’apoptose induite par le Fas chez les hépatocytes de souris en culture primaire. En
particulier, ces études ont concentré sur l’implication de l’état rédox et de l’activité tyrosine
kinase (TK) du récepteur EGf. Il est à noter que l’injection du Fas in vivo résulte en
apoptose massive du foie (—100%) alors que seulement 5-10% de hépatocytes en culture
meurent par apoptose suite à leur traitement avec le Fas. Nos résultats démontrent ici que la
résistance relative des hépatocytes en culture à l’apoptose est due à la perte importante du
contenu cellulaire en glutathion (GSH) durant l’isolation et la culture des cellules (totalisant
—75% de perte après seulement 2h en culture). L’augmentation des niveaux de GSH
intracellulaire et surtout du ratio de glutathion réduit (GSH)/total (GSx), en enrichissant le
milieu avec la cysteine et méthionine (deux acides aminés précurseurs de GSH) a amené
une sensibilité accrue à l’apoptose induite par le Fas. En plus, l’EGF, qui est comni pour
son effet anti-apoptotique, a significativement diminué les niveaux de GSH intracellulaires,
le ratio GSH/GSx ainsi que l’activité de GSSG réductase. Ces changements se sont produits
i\,
en parallèle à l’effet protecteur de l’EGF contre l’apoptose et ils étaient contrecarrés par
PD168393, un inhibiteur de l’activité TK du récepteur EGf. La réplétion de la cellule en
GSH a diminué l’effet protecteur de l’EGF contre l’apoptose induite par le Fas. Cette
modulation de l’apoptose par l’état rédox semble être due à la régulation de l’activité des
caspases. Il est à noter cependant, que malgré le fait que PDI6$393 a aboli
l’autophosphorylation du R-EGF, l’activation des voies de MAPK et PI3K ainsi que
l’augmentation de l’expression de l’ARNm et de la protéine de BCL-xL, il n’a pas
complètement inhibé l’effet anti-apoptotique de l’EGF. Ceci suggère que des mécanismes
indépendants de l’activité TK du récepteur EGF participe aussi dans la protéger contre
l’apoptose. En conclusion, un état rédox oxydative semble protéger contre l’apoptose
induite par le Fas dans les cultures primaires d’hépatocytes de souris. Ce processus est
même utilisé par les facteurs de croissance, tel que l’EGF, et il est dépendant sur l’activité
TK du récepteur.
Mots-clés apoptose, hepatocytes, Fas, EGF, BCL-x1, caspases, glutathion, état rédox,
protection, activité tyrosine kinase
VAbstract
The liver is highly sensitive towards apoptosis. Numerous injurious events resuit in the loss
of hepatocytes by apoptosis, including hepatitis C, B and alcoholic liver disease. Since
hepatocytes constitutively expless fas-R, the fas system lias been involved in the
development of liver pathologies. Therefore, the aim of these studies was to investigate the
rnechanisms of protection afforded by epidermal growth factor (EGf) against Fas-induced
apoptosis in primary mouse hepatocyte cultures. In particular, these studies focused on the
involvement of the intracellular redox state and of the tyrosine kinase (TK) activity of the
EGf receptor. 0f note, in vivo injection of anti-fas resuits in massive apoptosis of the liver
(--100 %) while exposure of primary hepatocytes cultures to Fas causes 5-10 % apoptotic
bodies only. Here, our findings indicate that the relative resistance of mouse hepatocytes in
culture toward fas-induced apoptosis is due to the loss of the important stocks oC
glutathione (GSH) during the isolation procedure and culture (totaïling 75% loss afier 2h
culture). The increase ofintracellular GSH levels and especially ofthe reduced (GSH)/ total
(GSx) glutathione ratio, by supplementing the media with cysteine and methionine
(precursor amino acids of GSH), enhanced ceil sensitivity toward fas-induced apoptosis.
furthermore, EGf, a known anti-apoptotic agent, significantly lowered GSH levels and
GSHIGSx ratio in a time- and dose-dependent manner. In fact, EGF treatment decreased
GSSG reductase activity, which may account for the decline in GSH/GSx ratio. These
changes occurred in parallel to the anti-apoptotic effect of EGf on mouse hepatocytes in
culture and were inhibited by PD168393, a specific inhibitor ofthe TK activity ofthe EGF
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receptor. Ceil replenishment with GSH diminished the protective effect of EGf against
Fas-induced apoptosis. This redox modulation of apoptosis seerns to occur through
regulation ofthe activity ofcaspases. 0f note, and in spite ofthe fact that PD16$393 has
effectively abolished the autophosphorylation of the EGF-R, the activation of MAPK and
PI3K pathways as well as the induction of BCL-xL mRNA and protein expressions, it did
not completely inhibit the anti-apoptotic effect of EGF. This indicated that some TK
independent pathways are involved in the anti-apoptotic signal of EGf against Fas-induced
apoptosis. In conclusion, an intracellular oxidative state seems to protect against fas
induced apoptosis in primary mouse hepatocyte cultures. This mechanisrn is used bv
growth factors such as EGF to protect against apoptosis and it is dependent on the TK
activity of the receptor.
Keywords apoptosis, fas, EGf, BCL-xL, caspases, glutathione, redox state, protection,
tyrosine kinase activity.
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CHAPTER 1
GENERAL INTRODUCTION
A. CELL DEATH BY APOPTOSIS
1. CELL DEATH: A POINT 0F NO RETURN
Ceil structure and function are maintained in dynamic stability by cell’s genetic program.
Preserving this intracellular dynamic equilibrium in spite of the normal physiological
demands, the constrains of neighbouring ceils and the availability of metabolic substrates is
called homeostasis. Disturbance of this equilibrium by more excessive physiological
stresses or pathological stimuli may bring about a number of physiological and
morphological cellular adaptations, in which a new but altered steady state is achieved to
preserve the viability of the ccli and to modulate its fiinction as a response to such stimuli.
If the limits of adaptive response to a stimulus are exceeded, or in certain instances when
adaptation is not possible, a sequence of events follows, loosely terrned ceil injury. Celi
injury is reversible up to a certain point, but if the stimulus persists, or if the stimulus is
severe enough from the beginning, the ccli reaches the point of no return and suffers
irreversible ccii injury and ceil death.(1)
Ccli death, the ultimate resuit of celi injury, is one of the most crucial events in pathology.
affecting every celi type and being the major consequence of ischemia, infection, toxins
and immune reaction. In addition, it is criticai during embryogenesis, lymphoid tissue
development and hormonaily induced involution. Finaily, it is the aim of cancer
radiotherapy and chemotherapy.( 1)
n2. TYPES 0F CELL DEATH: NECROSIS VS APOPTOSIS
The causes of ccli injury and ccli death range from externai stimuli (such as physical,
chemicai, and infectious agents,) to internai causes (such as hypoxia, immunoiogical
reactions and genetic alterations). There are two major morphoiogicai types of ccii dcath,
necrosis and apoptosis. Ceil death by necrosis is norrnally observed aCter a pathologicai or
injurious event. Apoptosis is a programmed type of ceii death which necessitates the active
participation of the celi and one which, in contrast to necrosis, is associated with normal
physioiogy in addition to pathoiogicai conditions (2-4).
2.1. Necrosis
Morphoiogicaily, necrosis is characterized by organeiie and generai ceiiular sweiling, ioss
of membrane integrity (organeiles and plasmatic) and rupture of lyzosomes ieading to
membrane breakdown and ccii iysis (sec figure 1) (2;3;5). These morphologicai phenomena
are the resuit of important biochemical disturbances of intracelluiar homeostasis including
depletion of adenosine tris-phosphate (ATP), loss of seiective membrane permeabiiity and
impairment of ionic pumps function. These cause the ioss of ionic horneostasis (calcium,
potassium and sodium) and the ieak of cytoplasmic enzymes (e.g. alaninc aminotransferase
(ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH)). Necrosis induces
a local inflammatory reaction aimed at eiiminating the necrotic ceiis. However, this
induction ends up aggravating the tissue damages triggered by the initial insult (3;5).
42.2. Apoptosis
The second form of ccli death is apoptosis. The term apoptosis was first used by Keru,
Wyliie and Currie in 1972 (6), to distinguish a forrn of ccli death morphologicaily distinct
from necrosis. Apoptosis is characterized by cytoplasmic shrinldng, membrane blebbing,
dilated endoplasmic reticulum, and nuclear chromatin condensation and fragmentation (sec
Figure 1)(7). Mitochondria remain unchanged morphoÏogicaÏly, but its energetic ftrnction is
severely compromised since mitochondriai potentiai dissipates. Activation of caspases
(Cysteinyl aspartate-specific protease; (8)), endonucleases (9; 10) and transgiutarninases
(11) are responsible for these morphoiogical changes (3;12;13). In final stages ofapoptosis,
the ccii separates into intact, membrane-bound apoptotic boches (14) (sec figure 1). This
type of ccii death is ofien hard to observe in vivo under physiologicai conditions. Indeed,
apoptosis does flot norrnaiiy induce an inflammatory reaction and the dying celis are
rapidiy phagocytosed by non-activated tissue macrophages. (3 ;6; 15)
Table 1 Comparative table behveen the morphotogical and biochemicat properties of
apoptosis (md necrosis
Necrosis Apoptosis
Inducers Pathological Physiological orpathological
Regulation No Yes
Morphological criteria
Celi volume Oedema Retraction
Nucleus Chromatin precipitation Chromatin condensation
and fragmentation
Plasmatic membrane Loss ofimpermeability/
Ruptured Imperrneability preserved/
Inflammatory reaction Present Intact but with blebbs
Physiologically
- absent
Pathologically -present
Biochemical criteria
Nuclear DNA Random digestion Internucleosomal
fragmentation
Mitochondrial anomalies Present Present
Intracellular Ca2 Present Present
anomalies
Proteases activation Non specffic proteases Specific proteases
(caspases)
6Figure 1 Morphology ofdying celis by necrosis rnd apoptosis
Morphology of normal (A), necrotic (B) and apoptotic (C) mouse hepatocytes, where
arrows indicate apoptotic bodies. Hepatocyte nuclei can be visualized under a microscope
equipped with ultraviolet epifluorescence following staining with Hoechst 33258, a specific
DNA fluorochome. Normal nuclei appear homogenous and intact (D), as opposed to
apoptotic nuclei which are condensed (E), fragmented and very bright (F). In panel (G), a
T-ce!! undergoing apoptosis show the characteristic blebbing of the cytoplasmic membrane
(photo from Zimmermann, KC. et al. Pharmacology & Therapeutics (2001) 92: 57-70).
Non-activated tissue macrophages (panel H), stained with fluorescein, ingest apoptotic
bodies (stained with rodamine) to prevent inflammation (photo from $avill J et aï. Nature
(200Q) 407: 784-788).
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$3. ROLE 0F APOPTOSIS IN HEALTH AND DISEASE
3.1. Apoptosis in physiotogy
The concept of spontaneous ce!! death as a physiologica! event was first reported by
Walther f!emming in 1885 who noticed that many of the epithelial cel!s !ining the
regressing ovarian follicu!es showed fragmented nuc!ei typica! of what is now known as
apoptosis that he termed “chromatolysis”. (2) Later on, embryologists also understood the
importance of “chromato!ysis” as a morphogenetic mechanism during embryogenesis.
Indeed, the formation of digits, the deve!opment of the immune (through the elimination of
seif-reactive lymphocytes) and of the nervous systems were ai! shown to necessitate this
specia! kind of ceil death. However, these finding were thought to be limited to embryonic
tissue. (2)
WIty tue explosion in stttdies ht articles related to apoptosis? In 1972, Kerr et a!. (6) have
documented the diversity of the occurrence of apoptosis in different tissues and in a wide
range of physiologica! and patho!ogica! conditions. Later, Wyllie (10) has demonstrated
that nuclear apoptotic events inc!uded the activation of an endonuclease that resu!ted in the
degradation of chromatin into nuc!eosome-sized DNA !adders that have becorne a
biochemica! hal!mark of apoptosis. However, these findings remained without significant
recognition for a!most a decade. The discovery that the adult hermaphrodite
Caenorhabditis etegans forms 1090 somatic cel!s, of which precisely 131 cells die by
9apoptosis, hurtied apoptosis into hot topic status in the 1990s. (16) The study of mutants of
C. eÏegans in the apoptotic processes identified 3 genes which are involved in the
regulation of apoptosis in ail somatic ceils (ced-3, ced-4 and ced-9). In addition, these
genes have been shown to have marnrnaiian homologues (caspases (17), apoptosis
protease-activating factor-1 tApaf-l] (1$) and B-cell iyrnphoma [BCL-2] (19) famiiies of
genes respectiveiy)(20). With this regain of interest in apoptosis, researchers have focused
on the physiological aspects of apoptosis as a widespread phenomena. Indeed, apoptosis
has been shown to be involved in severai physioiogical processes, such as:
• Acquisition of immunologicai self tolerance in T celis (21),
• Elimination of viraiiy-infected ceils by cytotoxic T cells (21),
• Down-reguiation of the immune reaction afler inflammatory reaction (Activated
induced ceii death) (21;22),
• Organ atrophy foiiowing hormonal retrievai (23),
• Establishment of the immune priviieged sites (such as testes, ovaries, uterus and
retina) (22;24)
• Maintenance of tissue homeostasis (i.e. appropriate number of ceils) and is therefore
considered as the counterpart of mitosis (25).
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3.2. Apoptosis in pathotogy
Given the widespread and critical role of apoptosis in biology, it is not surprising that
deregulation of apoptosis occurs frequently during pathological conditions. Indeed, the
aberrant activation of apoptosis may contribute to a number of diseases such as
neurodegenerative disorders (e.g. Alzheimer and Parkinson) (26) and viral infection.
Several viruses were shown capable of inducing (27-29) or inhibiting (30-32) apoptosis
directly in infected ceils or to induce their elimination by cytotoxic T cells through
activation of the fas receptor (fas-R) and/or Granzyme B systems (33-35). In contrast,
impaired apoptosis may be a significant factor in the etiology of diseases such as cancer
(36;37) and autoimmune disorders (systemic lupus erythematosis (34) ancl
lymphoproliferative disorders (38; 39 ;40)).
4. APOPTOSIS AND THE LIVER
4.1. TIte tiver
The liver, which constitutes approximately 2% of body weight in adult humans, resides at
the crossroads between the digestive tract and the rest of the body. Hence, it plays a major
role in maintaining the body’s metabolic homeostasis. This includes 1) the uptake of
dietary amino acids, carbohydrates, lipids and vitamins, their subsequent storage.
rnetabolism and release into the blood and the bile; 2) the biotransformation of hydrophobic
substances (circulating metabolites, endogenous waste products and xenobiotics (1)) into
11
water-soluble derivatives that can be excreted into the bile or the urine; 3) the synthesis of
semm proteins such as albumin, vitamin transporters and blood clofting factors. In addition.
the liver is integrated into the reticuloendothelial system of defence of the body against
foreign macromolecules and microorganisms. (41)
Hepatic disorders therefore have severe consequences on overali health. The liver is
vuinerable to a wide variety of metabolic, toxic, microbial, circulatory and neoplastic
insults that cause liver injury both by necrosis and apoptosis (1;41;42).
4.2. Physiotogicat andpatltotogicat retevance of tiver ceit apoptosis
In normal liver, apoptosis is a rare event. Indeed, only about 1-5 apoptotic celis are found
out of 10 000 hepatocytes in the rodent liver. (43) This very low rate could be explained by
the low rate of turnover of hepatocytes under physiological conditions. However, this rate
is increased during liver involution to remove excessive hepatocytes. This can occu
following withdrawal of hypertrophic or hyperpiasic stimuli (e.g. increased functional
demand, over feeding, pregnancy or during severe protein loss) (42) or during liver atrophy
following left portal vein ligation (14;44). furthermore, aberrant activation of apoptosis has
been noted in metabolic liver diseases such as alcoholic liver disease (where high levels of
Fas ligand were detected, see below). (45) In addition, several studies have reported a
marked increase in the levels of apoptosis in fulminant hepatitis (46) and viral infections
such as hepatitis B(42;47) and hepatitis C(4$), as well as in immune-mediated liver
diseases, such as host-versus-grafi reaction and allografi rejection (42). On the other hand.
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failure of apoptosis to delete genetically altered celis appears to contribute to the
development ofhepatocellular cancer and cholangiocarcinorna. (37)
Based on this evidence, new therapeutic approaches could be developed to treat theses
diseases. Indeed, pharmacological inhibition of apoptosis may arneliorate liver injury
and/or promote liver regeneration. On the other hand, purposeftil induction of apoptosis in
malignant ceils may be usefiul in treating hepatobiliary cancers. Thus, understanding the
mechanisms of apoptotic induction and inhibition is highly relevant for the cÏinical
diagnosis and treatment of liver diseases. (49)
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B. APOPTOSIS : CELLULAR MECHANISMS
The apoptotic process is divided into three phases: induction, execution, and finaily
degradation and elimination. During the induction phase, celis receive signais to initiate the
apoptotic process, decode and interpret them. When the ceii takes the decision to commit
suicide, it activates the executioner caspases: this is the point of no return. These caspases
then cleave multiple intraceliuiar targets (such as endonucieases, transglutaminases, other
caspases) to produce the biochemical (DNA iadder, protein precipitation and degradation of
cytoskeieton components) and morphoiogicai (chromatin fragmentation, membrane
blebbing, cytoplasm disintegration) aiterations characteristic of apoptosis. Finally.
apoptotic bodies are phagocytosed by macrophages and neighbouring ceiis. (7;15) (see
f igure 1)
1. INDUCTION 0F APOPTOSIS
Apoptosis can be initiated by different signais from outside as weil as inside the ceil
1. Ceil-surface death receptors of the Tumour Necrosis factor Œ (TNfa) family, such
as fas and TNf receptors, are among the best characterized extracelluiar inducers
of apoptosis. Binding of iigands to their receptors initiates a fairiy weii-defined
caspase signaliing cascade that activates, in an amplification ioop, other executioner
caspases directly (type I ceils) or through cieavage of pro-apoptotic proteins of the
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BCL-2 family. The latter then transmit the signal through activation of die
mitochondrial apoptotic pathway (type II cells, see below). (50-53)
2. Granule-mediated apoptosis: granules released by cytotoxic T celis contain perforin
ta pore-forming protein which facilitates the entry of granules components into the
target cell) and Granzyme B (a serine protease which cleaves afier an aspartate
residue) (54). It has been suggested that Granzyme B can directly cleave anci
therefore activate caspase-3, which then activates caspase-7. (55)
3. Genotoxic agents, such as topoisomerase inhibitors (e.g. etoposide), anti
metabolites (e.g. 5-fluorouracil), DNA damaging agents (like cisplatin) and
y—irradiation, are among the best-studied initiators of apoptosis. Damage to DNA is
sensed by p53, which upregulates Bax and therefore activates the mitochondriaÏ
apoptotic cascade. (53;56-5$)
4. Loss of survival signais, such as growth factors (e.g. epidermal growth factor
[EGF], hepatocyte growth factor [HGF], nerve growth factor [NGF], etc) and
contact with the extraceilular matrix, which are normally perceived by cells.
activates the apoptotic program by default. (59-6 1) This has been shown to occur
through the association of Bad with Bax, two pro-apoptotic proteins of the BCL-2
famiiy (see below), in the cytoplasm thus favouring the oligornerization and the
transiocation of the complex to the mitochondria. The sequence culminates with the
initiation ofthe downstream caspases. (62-66)
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5. Mitochondrial-elicited death pathway: numerous pro-apoptotic pathways converge
on the mitochondria to induce mitochondrial permeability transition (MPT): the
outer membrane becomes protein-permeable while the iimer membrane continues to
retain matrix proteins but dissipates the mitochondrial transmembrane permeability
(A’J’). MPT triggers the activation of caspases and nucleases through the release of
pro-apoptotic proteins normally confined to the mitochondrial interniembrane
space, such as cytochrome e and Apoptosis Inducing Factor-Ï (AIF-1). (13). The
release of cytochrome e stimulates the assernbly of the apoptosome (procaspase-9,
cytochrome e and Apaf- 1) in the cytoplasrn and therefore the activation of the
downstream caspase-3. On the other hand, AIF-1 transiocates to the nucleus and
activates a nuclear DNase (reviewed in (67;68)).
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Figure 2 Mech anisms of iudttction and inhibitioit of apoptosis
Pro-apoptotic rncchanisrns: (1) Ceil surface death receptors (e.g. Fas, TNFŒ) activate
initiator caspases (e.g. caspas-$) to cleave Bid and generate tBid. (2) Growth factors (GF)
deprivation induces the dephosphorylation of Bad and its dissociation of 14-3-3 proteins.
(3) Genotoxic agents increase the expression of Bax in a p53-dependent manner. Ail these
apoptotic stimuli induce the transiocation of Bax from the cytosol to the mitochondria. This
culminates in the release of cytochrome e and Diablo/Smac. Diablo/Smac relieves the
inhibitory effect of IAP. Cytochrome c forms the apoptosome with Apaf- 1, procaspase-9
and ATP. This activates caspase-9, which then activates caspase-3. The latter caspase is
responsible for the degradation of cytoskeleton components (e.g. fodrin, gelsolin) as well as
ICAD (inhibitor of CAD), thus releasing CAD (Caspase Activated DNase). CAD is the
DNase responsible for the fragmentation of DNA into 180-200 bp, which are the haflmark
of apoptosis.
Anti-apoptotic rnechanisrns (in Black boxes). There are several checkpoints for where
apoptotic signal can be inhibited. (4) fLIP is a natural inhibitor of the formation of the
DISC complex. (5) lAPs (Inhibitors of apoptosis proteins) are natural inhibitors of active
caspases. (6) Anti-apoptotic members of the BCL-2 (e.g. BCL-2) act directly on Bax
activity in the mitochondria. (7) Akt, a serine/threonine kinase, phosphorylates Bad on
serÏ36, thus favouring its sequestration with 14-3-3 proteins, and procaspase-9, thus
preventing its activation.
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2. EXECUTION 0F APOPTOSIS
During this phase, the fate of the celi is set. Indeed, the celiular response to the above
rnentioned apoptotic signais is reversible and depends on the intraceilular context.
Irreversible activation of the apoptotic process can 5e faciiitated (pro-apoptotic) or
abrogated (anti-apoptotic) by specific proteins whose expression and activity are under
tight control. In this section, the pro-apoptotic proteins wiil be discussed. The anti
apoptotic proteins will be detailed in section D.
There are three key pro-apoptotic families of genes:
1. ICE (interleukin-1 converting enzyme) farniiy, which are now best known as
caspases;
2. Pro-apoptotic members ofthe BCL-2 family (e.g. Bid, Bax);
3. Inhibitors oflnhibitor Apoptosis Proteins (e.g. DiabÏo/Smac)
2.1. THE FAMIL Y 0F ICE-PROTEASES (CASPASES)
Proteases: Proteases participate in protein destruction and in the reguiation of protein
activities in different contexts. They are involved in protein maturation (e.g. caspase-1 in
the context of pro-IL-1 processing), regulate and arnplify specific reactions (e.g. the
ciotting and complement cascades) and allow celis to migrate (e.g. proteases of the
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extracellular matrix). In addition, they are responsible for the degradation of proteins
outside the celi (digestive proteases) and in a similar aibeit more controlÏed and
discriminating manner inside the ceil (jroteosome). Finally, in the context of celi death,
they act as triggers ofthe apoptotic process, as regulatory elements within it, and ultimately
as a subset ofthe effector elements ofthe machinery itseif. (54)
Caspases: Ced-3 encodes a protein which resemblcs the mammalian interleukin 1 1-
converting enzyme (ICE), commonly called caspase-1.(69) They are proteases with a
reduced cysteine residue in their active site (QAÇXG) which confers them the specificity
of cleavage afier an aspartate residue.(70) This specificity of cleavage is shared with
another protease, Granzyme B (see section B.1).
To date, 14 caspases have been identifled in mammals. Caspases are constitutively
expressed and are norrnally present as inactive precursors in celis. Caspases have a ver)’
conserved structure composed of a N-terminal prodomain of varying length, and a domain
that, afier processing, will give rise to two subunits: a large subunit (17-21 KDa) which
contains the active site, and a smali subunit (10-14 KDa). (70-72)
Upon receiving an apoptotic signal, the pro-forms (zymogens) of caspases undergo
sequential proteolytic processing at internai aspartate residues (releasing the srnall subunit
then the prodornain) to generate the active enzyme. Caspases then assemble into two large
subunits and two small subunits thus forming the active caspases.(12;73;74) In addition, the
cysteine in the active site must be reduced in order for the caspases to function. Indeed,
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several in vitro as well as in vivo studies have reported that oxidants inhibit the proteolytic
activity of caspases while anti-oxidants restore or maintain their activity. (75-77)
Based on the length of their prodomain, caspases can be divided into two groups: class 1.
which contains a relatively long prodomain (e.g. caspases 1, 2, 4, 5, 8, 9, 10, 12, and 13)
and ctass II containing a short prodomain (e.g. caspases 3, 6, 7).(54;70) The long
prodomains in many class I caspases contain protein-protein interaction domains that play a
crucial rote in the recruitment of caspases to specific death complexes. This triggers
oligomerization of procaspase molecules, thus facilitating their activation by autocleavage.
For example, the prodomain of caspases-8 and -10 contain a Death Effector Domain
(DED), which mediates their binding to adaptor molecules FADD (Fas Associated protein
with Death Domain) (7$;79) or TRADD (TNF Receptor Associated protein with Death
Domain) (80). Other caspases (such as 1, 2, 4, and 9) contain a Caspase Recruitment
Domain (CARD, (81), which plays an important role in the interaction between different
caspases as well as with various adaptor proteins. Class II caspases, which lack a long
prodomain, also lack the ability to auto-activate and require cleavage by class I caspases to
get activated.(54;70;74) For this reason, class I caspases are referred to as initiators
caspases whule class II as executioner ones. The fact that caspases can auto-activate and/or
activate others constitutes a caspase cascade that not only amplifies the process but also
transmits the signal from one compartment to another within the cett. Caspases are
activated or inactivated through a series of intracellular steps, or pathways, in response to
death or survival signals, which are subject to multiple regulations (see Section D).
21
2.2. THE PRO-APOPTOTIC PROTEINS 0f THE BCL-2 FAMIL V
As mentioned above, mitochondria play an important role in apoptosis. In particular, they
release AIF-1 and cytochrome c (64;6$;$2), which are responsible for the mediation ofthe
apoptotic signal to downstream effectors. BCL-2 farnily members (mammalian homologue
ofced-9) have been identified as key regulators of cytochrome e release.(13;6$;83;84)
The BCL-2 famiiy is characterized by conserved motifs known as the BCL-2 homology
domain (3H). Members of this family have at least one of the four 11H identified.
According to their fiinction and structure, these proteins have been subdivided into three
subfamilies (68;$5):
1. Anti-apoptotic proteins, such as BCL-2, BCL-x1, BCL-w and MCL-1. BCL-2 and
BCL-xL contain ail four BH (BH1-BH4), but other members contain at least BHI
and BH2. (discussed in detail in Section D.2)
2. BH3-only containing pro-apoptotic proteins which include Bid, Bad, Blk.
3. Classical pro-apoptotic proteins such as Bax and Bak, which share sequence
homology in ail BH domains except BH4.
These proteins can form homo- and heterodimers that invoives the 3H dornains (84;$6;87).
The BH3 domain of pro-apoptotic proteins appears to be required for the interaction
between anti- and pro-apoptotic proteins ($8).
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BH3-onty coittaining pro-apoptotic proteins: Members of the BH3-only subset of the
BCL-2 family coimect proximal signais to the core apoptotic machinery. These proteins, of
which Bid is a prototype, are capable of heterodimerizing with members of other subsets of
the BCL-2 family.(73) They are found in the cytosol under non-apoptotic conditions. Upon
receiving the apoptotic signai, they become activated. For example, Bid activation by
cleavage (following Fas-R stimulation) favours the interaction of truncated Bid with Bax.
This interaction induces a conformational change of Bax leading to its oligornerization and
insertion into the outer mitochondriai membrane (65;89;90) and finally culminating in the
activation ofthe downstream caspase cascade.
Classicaipro-apoptotic proteins: The expression of Bax and Bak has been associated with
high sensitivity toward apoptosis. In fact, genotoxic agents induce apoptosis by increasing
the expression Ïevels of Bax. Bax has been shown to form pores in synthetic lipid bilayers
that resemble the channel-forming properties of the bacterial toxins coÏicins and
dtphteria.(91) 0f note, the channel forming activity of Bax (and Bak) has not been yet
dernonstrated in vivo. Bax transiocation to the mitochondria has been shown to cause
cytochrome c release and activation ofcaspases, leading to celi death by apoptosis. (64-66)
However, the exact mechanism responsible for these proteins’ function are flot yet
elucidated.(64-66;89;90)
, -,
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2.3. Diabto/Srnac proteins
Diablo (direct IAP binding protein with low pI) /Smac (second mitochondrial activator of
caspases) is a mammalian protein analogous to the pro-apoptotic Drosophila molecules.
Grim, Reaper, and HID. (92;93) It is released from the mitochondria following apoptotic
stimulation in a Bid-dependent manner to relieve inhibition of caspases by the inhibitor of
apoptosis proteins (lAPs; see section D.5; (94)). Once released from the mitochondria.
Diablo/$mac binds to lAPs and antagonizes their anti-apoptotic effect. It therefore assists
the initiator caspase-9 and effector caspases (caspase-3, caspase-6, and caspase-7) in
becoming active, ultirnately leading to celi death (95;96). Extra-mitochondrial transiocation
of Diablo/Smac along with cytochrome c and other pro-apoptotic proteins represent
important regulatory checkpoints for mitochondria-mediated apoptosis.
3. DEGRADATION AND ELIMINATION 0F APOPTOTIC CELLS
When the full complement of caspases that are necessary for the proper execution of the
cell death program have become activated, the final disintegration phase begins. In this
phase, the biochemical bases for the morphological changes take place.
Nuctetts: Active caspase-3 is responsible for the cleavage of the Inhibitor of Caspase
Dependant DNase (CAD), an inhibitory protein which retains Caspase Dependent DNase
(CAD) in the cytoplasm (97). This degradation releases CAD, which transiocates to the
nucleus. This nuclease cuts the DNA between the nucleosomes thus producing 180-200 bp
DNA fragments. The activity of CAD is responsible for the DNA laddering that is a
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hallmark of apoptosis.(98) Lamin A (99), Lamin B (100) and NuMA (101) are also
degraded by caspases which transiocates to the nucleus (e.g. caspase-6). This leads to the
disassembly and the destruction of the nuclear cytoskeleton thus further contributing to
nuclear fragmentation. In order to ensure that the damage done by the apoptotic process is
flot repaired, PARP (poly (ADP-ribose) polyrnerase), which is involved in the repair of
damaged DNA, is also degraded by caspase-3. (102) The mitochondrial protein AIF
released in parallel to cytochrome c following apoptotic stimulation induces high molecular
weight DNA fragments in a caspase-independent manner. (103)
Ptasnta membrane: Structural breakdown of the celi includes cleavage of fodrin (104).
membrane-associated cytoskeletal protein, as well as direct cleavage of gelsolin (105), an
actin regulatory protein, resulting the disruption of actin filaments. Taken together these
two events can be held responsible for dissociation of the submembrane cytoskeleton and
the destabilization of the plasma membrane (membrane blebbing). In addition, the
asymmetrical distribution of phosphatidylserine (PS) is lost resulting in the presentation of
PS on the external surface of apoptotic cells. This has been shown to facilitate the
phagocytosis of apoptotic cells by macrophages and neighbouring ceils thus reducing the
possibility of an inflarnmatory response (106;107).
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C. FAS RECEPTOR / FAS LIGAND SYSTEM
1. FAS SYSTEM AND ITS ROLE IN DISEASE
In 1989, two groups independently isolated mouse-derived antibodies that were cytotoxic
for various human ceil unes (108). The celi surface proteins recognized by these antibodies
were named fas and APO- 1. The fas system is composed of Fas receptor (Fas-R) and Fas
ligand (Fas-L) (109). Fas-R is highly expressed in activated mature lymphocytes (110) and
human lymphocytes transfected with Epstein-Ban virus or human immunodeficiency virus
(108;1 11). In addition, many nonlymphoid tissues express high levels of Fas-R, including
liver, heart, lung, kidney and ovary (112). Fas-L is primarily expressed by activated T celis
and plays a role in peripheral T- and B-cell homeostasis. (14;34;47; 113)
The apoptotic potential of Fas-R / Fas-L system has been mostly studied in the immune
system. Indeed, it was observed the Ïpr (lymphoproliferative) and gld (generalized
lymphoproliferative disorder) phenotypes (39) were associated with progressive
lymphadenopathy and immune complex syndrome that resemble the human autoimmune
disease systemic lupus erythematosus (38;40). A major role of Fas system in lymphoid
ceils lies in the control the immune response. It acts as a seif-limiting feedback in activated
lymphocytes through a process called activation-induced celi death. Indeed, afier antigen
driven expansion of lymphocytes, there is upregulation of fas-L on activated T celis that is
required for subsequent death and removal of activated lymphocytes. (20;114) In parallel.
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cytotoxic T ceils eliminate virally infected and genetically altered celis by activating the
fas apoptotic death signal. (33;34)
One of the early indications that the fas system plays an important role in hepatic
homeostasis and therefore in the development of hepatic disorders is the observation that
injection of anti-fas antibody to mice caused massive hepatic apoptosis and animal demise
shortly thereafier (115). Hepatocytes constitutively express Fas-R and may upregulate its
expression in a variety of liver diseases (14;42;47). Numerous studies have iinplicated fas-
R and Fas-L in both hepatitis B (42;47) and C (4$), where infected celis appear to be
extremely sensitive to fas-mediated apoptosis (52). In alcoholic liver disease (116) as weB
as Wilson’s disease (117), Fas-L mRNA was found to be expressed in hepatocytes. This
expression is hypothesized to mediate hepatocyte loss observed in these disorders.
Therefore, the mechanisms of apoptotic induction of the Fas system as well as protection
against it in the liver should be of great therapeutic interest.
2. FAS RECEPTOR SIGNAL TRANSDUCTION
The structure of fas-R indicated that it is a type I transmembrane protein (46 KDa), which
belongs to the TNf and NGF receptor family. It possesses 3 cysteine-rich extracellular
domains involved in the recognition and binding of the fas-L. The cytoplasmic domain
contains a conserved region (about 70 amino acids) that is necessary and sufficient to
transduce the apoptotic signai (11$). This domain is called the Death Domain (DD). It is
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involved in the recniitment of and the protein-protein interaction with FADD (20; 10$; 113).
an adaptor protein that also contains a DD region.
It is weIl documented that ceil death induced by Fas-R stimulation is dependent on caspase
activation.(20;51;1 19) However, there some reports describing a caspase-independent
killing.(5 1 ;120-122) This led to the hypothesis of two independent signal transduction
pathways activated at the level of Fas-R: one is mediated by the adaptor protein DAXX
(death associated protein; (123)) which can enhance fas-induced apoptosis through the
activation of jun-amino terminal kinase (JNK) cascade; the other involves the adaptor
protein FADD and the subsequent recruitrnent of caspases to the Death Inducing Signalling
Complex (DISC) and therefore the activation ofthe caspase cascade (51;78;79;124).
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Figure 5 fas receptor signattiitgpathways
Binding of Fas ligand (Fas-L) to Fas receptor (Fas-R) induces the trimerization of the latter.
This activates Daxx- and FADD- dependent signalling pathways. (1) In the former, Daxx
associates with the death domain (DD) of the Fas-R. This activates Apoptosis Signal
regulating Kinase-1 (ASK-Ï), which resuits in the activation of the jun-arnino terminal
kinase (JNK) pathway leading to ceil death by apoptosis. (2) The fADD pathway is
initiated by its recruitment to the Fas-R. Procaspase-8 molecules are then recruited to form
the Death Inducing Signalling Complex (DI$C) and therefore get activated. (2a) In type II
ceils (e.g. hepatocytes), caspase-$ cleaves Bid to generate tnincated Bid (tBid). tBid
associates with Bax protein in the cytoplasm and induce its transiocation to the
mitochondria resulting in the release of cytochrome e and Diablo/Smac proteins into the
cytoplasm. Diablo/Smac relieve the inhibitory effect of IAP (Inhibitors of Apoptosis
Proteins) thus facilitating the activation of caspases. Cytochrome c along with Apaf- I
(apoptosis protease activating factor- 1), procaspase-9 and ATP form the apoptosome,
which culminate in the activation of caspase-9. Caspase-9 then cleaves and activates
caspase-3. (2b) In type I cells (e.g. lymphocytes), caspase-8 directly cleaves and activates
caspase-3. Active caspase-3 degrades several cellular components leading to celi death by
apoptosis.
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2.1. fADD patit way:
fas-induced activation of the caspase signalling cascade also involves two major pathways
termed type I and type II. Basically, they differ in the involvement of the mitochondria in
fas signal transduction. In type I ceÏÏs, such as lymphocytes, there ïs activation of a
sufficient amount of initiator caspases at the receptor level to directly transmit the signal to
effector caspases. (20;125) Hepatocytes are type II celis, where the signal generated at the
receptor ïs not strong enough to transduce the signal and needs to be amplified. Therefore,
the weak apoptotic signal is transmitted to the mitochondria where it induces MPT and
activates downstream caspases (see Section 3.1 and beÏow).(5 1 ;1 19)
2.2. fas sigitatting in hepatocytes (type II ce!ts):
Binding of the fas-L or of anti-Fas antibodies to fas-R in hepatocytes resuits in receptor
trimerization. The clustering of the DD in the intracellular portion of the receptors recruits
the adapter molecule called FADD via the DD ofthe latter (50;79). Procaspase-8 molecules
(fLICE) are recruited to the Fas-RJFADD complex through an interaction mediated by the
DED present on FADD along with the prodornain of caspase-2, thus forming the DISC
complex. The close proximity of procaspase molecules favours their oligomerization, and
stirnulates their autocleavage resulting in their activation.(79; 119) Active caspase-$ then
cleaves Bid, a 3H3 only pro-apoptotic protein of the BCL-2 family. This generates a p15-
Bid fragment (tBid) which transiocates to the outer membrane of the mitochondria.(73)
tBid can interact, through its BH3 domain, with the anti-apoptotic BCL-xL which
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destabilizes the BCL-xL/BAX heterodimers.(126) This favours the homo-oligomerization
of BAX. In addition, this association prevents the formation of the anti-apoptotic complex
between BCL-XL and Apaf-1/procaspase-9, leading to the release of the latter. (73;127)
Consequently, cytochrorne c ($2)as well as Diablo/Srnac (92;93) are released from the
mitochondria, although the mechanisms of this liberation are flot yet ftilly elucidated.
(51;82;1 19;128)
Once released from the mitochondria, cytochrome e interacts with Apaf- 1 and procaspase-9
(in an ATP-dependent manner) to form a complex known as the apoptosorne ($3;127).
Formation of the apoptosorne resuits in the cleavage and activation of caspase-9, which in
turn leads to the cleavage and activation of caspase-3, a central executioner caspase.(73)
Caspase-3 then cleaves and activates downstream caspases and other important proteins.
which are directly or indirectly responsible for the systernatic dismantiing of the apoptotic
cell and finally culminating in ceil death by apoptosis. (see Section B.3)
2.3. fADD-independent signatting:
Several pieces of evidence demonstrated the involvement of caspase-independent pathways
in the modulation of the apoptotic signal.(120;122;124) One of these pathways is the JNK
pathway.(129) The involvement of this pathway in apoptosis was initially characterized in
UV irradiation and TNf-Œ treatment. (129-131) Fas-mediated apoptosis was shown to
require JNK activation in 293 and L920, but not in HeLa cells (123). On the other hand, a
$EK- 1 (upstream activator kinase of JNK) mutant was found to sensitize thyrnocytes to
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fas-induced apoptosis (132). This suggested that the involvement of the JNK pathway in
Fas-induced apoptosis was celi specific, which signifies that the biological relevance of its
implication requires further investigation.
The JNK pathway was linked to the Fas-R through the discovery of the DAXX protein in
1997 using an interaction trap system in yeast (123). DAXX associates with the DD offas
R, although it lacks a DD of its own. In addition, Yang et al. have shown that the
simultaneous overexpression of fas-R and DA)O( activated the INK pathway and
enhanced Fas-induced ceil death by apoptosis. This effect of DAXX was shown to be
mediated by the MAP kinase kinase kinase ASK- 1 (poptosis Signal regulating Kinase-l)
(121;133).
2)
D. ANTI-APOPTOTIC MECHANISMS
1. GROWTH FACTORS AND PROTECTION AGAINST APOPTOSIS
Not ail fas-bearing ceils are susceptible to fas-induced apoptosis. Indeed, depending on the
extracellular environment and the intracellular context in which the apoptotic signal is
received, the celi may or may flot undergo apoptosis. Growth factors are known for their
ability to antagonize apoptosis. Growth factors such as NGf, HGf, EGf, and IL-3 have
been shown to protect various types of celis (e.g. astiocytes, PC 12, hepatocytes, HepG2,
lymphocytes, fibroblasts, etc.) against a variety of apoptotic inducers including physical
(UV, y-radiations), chemical ones (cisplatinum, 5-fluoracil), and ceil-surface death
receptors (fas, TNf) (46;134-136). This protection has been mainly associated with the
increase in the expression of the anti-apoptotic members of the BCL-2 family (e.g. BCL-2
and BCL-xL) (137;13$), as well as the inactivation of pro-apoptotic proteins (e.g. Bad,
caspase-9), the latter foÏÏowing their phosphorylation by the serine/threonine kinase Akt
(see below). (62;139;140)
Celis possess anti-apoptotic mechanisms to prevent the unintentional activation of the
apoptotic program. Several of these mechanisms were discovered due to their abnormal
expression (lack of or over expression) in diseases such as cancers and viral infections.
Many types of cancer have developed mechanisms to avoid apoptosis. These include
overexpression of anti-apoptotic proteins of the BCL-2 family, downregulation and
jprevention of the recruitment of initiator caspases, overexpression of IAP or expression of
decoy receptors (intact extracellular domain but truncated intracellular domain) (36).
In parallel, several viruses have adapted anti-apoptotic mechanisms to delay and even
prevent the onset of the apoptotic program in infected ceils in order to give them the time to
replicate. Herpes virus (141), Baculovirus (30;142), and Polyomavirus Middle T antigen
(143) are some examples ofthese viruses.
Here will be discussed some of the key inhibitory factors of apoptotic signalling, including
the BCL-2 family, IAP, FLIP and Akt. (see Figure 2)
2. ANTI-APOPTOTIC PROTEINS 0F THE BCL-2 FAMILY
The original protein BCL-2 was discovered in 1985 by Tsujimoto et al. (144) in follicular B
ceYl lymphoma, hence its name B-cell lymphoma-2 (BCL-2). In this type of cancer, the
BCL-2 gene is translocated from chromosome 1$ (where it normally resides) to
chromosome 14 where it becomes juxtaposed with the immunoglobulin heavy-chain (IgH)
locus. Such transiocation brings this anti-apoptotic gene under the influence of a strong
promoter whose normal job is to drive high levels of 1g gene expression in B-cells. This
results in the loss of normal regulation of the BCL-2 gene, and in the production of
inappropriately high levels of B CL-2 protein in germinal center B-cells. This contributes to
the neoplastic B-cell expansion by preventing celi turnover (by inhibiting apoptosis) rather
than accelerating rates of cell division. BCL-2 is thus the first example of a hurnan proto
oncogen that functions through effects on celi death rather than celi cycle mechanisrns (85).
Furtherrnore, its expression increases the survival of celis deprived of trophic factors such
as growth factors (GF) and cytokines. In addition, the anti-apoptotic effect of several GF
has been associated with the increase in the expression levels of B CL-2 or BCL-xL proteins
($6;137).
These proteins have been localized in the membranes of mitochondria, nucleus and
endoplasmic reticulum. (67) BCL-xL was the first member of this family to be crystallized.
This revealed a structure similar to the pore-forming bacterial toxins (colicins and
diphteria) (91;145). As mentioned above, proteins of the BCL-2 family can forrn homo
and heterodimers.($5;146;147) The balance between cell survival and death seems to be
regulated by the proportion of anti- or pro-apoptotic dimers formed (146;147) where by
overexpression of BCL-2 would favours the formation of BCL-2/BCL-2 dimers. The high
proportion of anti-apoptotic dimers prevents the release of cytochrome c and the
subsequent transmission of the apoptotic signal (7 ;68 ; 85; 86).
Several hypotheses regarding the anti-apoptotic action of BCL-2 and BCL-xL proteins have
been put forth, including regulation of the mitochondrial megachannel (148;149)and anti
oxidant function (67;86;150;151). However, their exact mechanism of action is flot yet
known.
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3. PHOSPHATIDYLINOSITOL 3-OH KINASE! Akt PATHWAY
The PI 3-K is one of the phosphorylation pathways activated by GF (see Section E.3.2).
Several studies have recently irnplicated this pathway, and especially the downstream
serine/threonine kinase Akt, in the protection against apoptosis. Indeed, inhibition of the PI
3-K pathway by wortmannin or LY294002 sensitizes ceils to apoptosis (152). In parallel.
wortmannin treatment was found to enhance fas- and TNf-a-induced caspase-3
activation.(153) This effect was shown to resuit from two phosphorylation events upstream
of casapse-3 activation: 1) phosphorylation of the pro-apoptotic protein Bad (62;1 54-1 56)
and 2) phosphorylation ofprocaspase-9.
As mentioned above, Bad can heterodimerize with BCL-2 and BCL-xL to antagonize their
anti-apoptotic effect. Gf, such as IL-3 and NGf, specifically induce the phosphorylation of
Bad on serine 136 (pBad-136) through Akt (62;156;157). This favours the association of
pBad-136 with 14-3-3 proteins instead of BCL-2 or BCL-xL therefore sequestering Bad in
the cytoplasm and preventing it from transiocating to the rnitochondria.(139) Thereby, this
phosphorylation promotes cell survival by allowing the unhindered action of anti-apoptotic
proteins ofthe BCL-2 family (139;155;156).
In parallel, it was demonstrated that serine phosphorylation of pro-caspase-9 (sen 96)
prevents its autocleavage and therefore its activation (15$). In fact, cytochrome c-induced
proteolytic processing of procaspase-9 was defective in cytosolic extracts from ceils
expressing constitutively active Akt (140;15$;159). Therefore, the activation of the
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PI 3-KJAkt-dependent phosphorylation inactivates the important apoptotic mitochondrial
pathway. These two combined phosphorylation events contribute to the protective effect of
PI 3-K/Akt activation against apoptosis.
4. FLICE-INHIBITORY PROTEIN (FLIP)
The formation of the DISC complex in ceil-surface death receptor signalling, such as Fas
and TNF-a, can be regulated by a family of proteins called FLIP (fLICE-inhibitory
protein). This family of inhibitors was originally identified in oncogenic viruses, including
Kaposi’s sarcoma-associated human Herpes virus-8 (HHV-$) (160) and molluscipox virus
(141;161). Furthermore, high levels of FLIP were detected in melanomas where it promotes
escape from T-cell induced apoptosis (160). In parallel, some studies have suggested that
T-cell sensitivity toward Fas-induced apoptosis was conelated with the decrease in FLIP
rnRNA expression levels (162). Therefore, FLIP seems to inhibit apoptosis, and especially
the activation of procaspase-8. FLIP contains two DED that mediate FLIP binding to the
prodomain of caspase-8 and -10. This prevents the recruitment of procaspase molecules to
these receptors and their subsequent activation(162;163). There are different forms of FLIP.
The longest form (FLIPL) bas, in addition to the two DED, the equivalent of an inactive
caspase domain.
n
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5. INHIBITOR 0F APOPTOSIS PROTEINS (IAP)
Recently, key intrinsic inhibitors of caspases called IAP have been identified and they
represent important regulatory factors in apoptotic signalling. They were originally
identified as viral products that can inhibit the defensive apoptotic response of the host celi
to allow more time for the virus to replicate (164). Proteins in this family (such as XIAP.
HIAP1, cIAP2, NIAP and survivin) possess one or more baculovirus repeats (BIR), a
characteristic cysteine-rich domain of about 70 amino acids. They also contain a carboxy
terminal RING zinc-fingerthat can act as ubiquitin ligase (165;166).
In general, lAPs are thought to function at the caspase activation step in the ceil death
pathway. They bind to the inactive, prodomain-containing caspase (zymogen) and prevent
it from being processed into the active enzyme.(1 67; 168) The BIR domains of XIAP and
HIAPI have been shown to bind and inhibit caspase-3, -7, and -9 (167;169;170). Even the
smallest member of the IAP family, survivin, which contains only a single BIR, is also
capable of inhibiting caspase-3 (171). Despite the sequence similarities between the BIR
dornains of XIAP, they exhibit different affinities in term of binding and inhibiting
caspases. Indeed, BIR2 specifically inhibits caspase-3 and -7 while 31R3 inhibits caspase-9
only (170;172-174). Furthermore, it has been shown that XIAP can be cleaved into BIR1-2
and BIR3-RING zinc-finger fragments by activated caspases in vitro and in Fas-treated
celis (172). Exogenous expression of a BIR3-RTNG fragment potently suppresses Bax
induced apoptosis. This pathway, which proceeds through the release of cytochrome c from
jthe mitochondria, and the formation of the apoptosome complex, culminates in the
recruitment and activation of caspase-9 (172).
As for the ubiquitin ligase ability of XIAP and clAPi, it appears to be responsible for auto
ubiquitination and self-degradation of these lAPs through the proteosome, in response to
certain apoptotic stimuli (166). The RING finger may also function as a negative regulator
ofother apoptotic components, since the RING finger of clAPi mediates the ubiquitination
of caspase-3 and -7 (165). This suggests that lAPs initially bind and inhibit caspases, then
subsequently ubiquitinate and trigger the degradation of the IAP-caspase complex.
Mammalian lAPs could be important in diseases since the cIAP2 gene is ofien translocated
in mucosa-associated lymphoid tissue lymphomas (175) and ML-IAP/Livin is ofien
abnormally expressed in melanoma ceil unes. (176). In addition, elevated expression of
survivin lias been observed in some cancers (177).
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E. EPIDERMAL GROWTH FACTOR (EGF)
1. STRUCTURE 0F THE EGF RECEPTOR
The EGF receptor (EGF-R) is a 170 kDa transmembrane glycoprotein with intrinsic
enzymatic activity. It is constituted of three distinct structural elements (178-183):
a) Extracethdar N-terminus domabt: It possess two cysteine-rich regions that form
the binding site for specific ligands such as EGf and Tumour growth factor-Œ
(TGfa);
b) Transinembrane domain: it is responsible for anchoring the receptor in the
membrane;
c) Cytoptasmic C-terminus doniain: it is comprised of three regions
i) Juxtamembrane region. It contains negative-feedback phosphorylation sites
for Protein Kinase C (PKC; Thr 654) and Mitogen activated Protein Kinases
(MAPK; Thr 669).
ii) Tyrosine kinase region (TK). This region, which contains the ATP binding
site (Lysine 721), catalyses the transfer of the y-phosphate of ATP to a
tyrosine residue of the receptor and also to that of some other intracellular
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proteins. The TK region is highly conserved between the different receptors
Tyrosine Kinase (RTK).
iii) Carboxy-terminat region: it comprises 5 tyrosine residues (Tyr 1173, 1 148,
1086, 1068, 992) that are the autophosphorylation sites of the EGF-R. These
phosphorylated residues serve as docking sites for Src-homolgy-2 (SH2)- anci
phosphotyrosine homology (PTH)- containing proteins (see below) (181; 184).
2. ACTIVATION 0F EGF-R:
The monomeric EGF-R is inactive: it lias a weak affinity toward its ligand and a low rate of
TK activity. The binding of EGF to EGF-R induces a conformational change of the
extracellular domain of EGF-R, which favours the dimerization of two ligand-monomers
complexes. This dimerization stabilizes the interactions between the cytoplasmic domains.
increases EGf-R affinity toward the ligand and amplifies its TK activity. (185) The exact
mechanism by which EGf-R dimerization induces the activation of the TK activity is not
yet elucidated. However, the current conceptual model postulates that the carboxy-terminal
region of the receptor, in the basal non-phosphorylated state, functions as an auto-inhibitory
substrate of the TK activity of the EGF-R. The conformational change induced by EGF
binding places the C-terminus in proximity of the TK domain of the other monomer,
leading to its phosphoiylation on specific tyrosine residues (Tyr 1173, 1148, 1086, 1068.
992). This, in tum. relieves the inhibitory effect that the C-terminus exerts on the TK
activity of the EGF-R. Various intracellular substrates can then access their binding sites
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either in the catalytic domain (to be phosphorylated) or in the C-terminus (to interact with
the phosphorylated tyrosine residues) to activate different downstream signalling pathways
(179-181).
3. EGF-R SIGNAL TRANSDUCTION PATHWAYS
Signal transduction from the TKR is based on protein-protein interactions. The
phosphorylation of the EGf-R on specific tyrosine residues creates binding sites for
proteins with SH2 and PTH domains. These are non-enzymatic protein-protein binding
dornains with very high affinity to specific sequences determined by the context of amino
acids surrounding the phosphorylated tyrosine (186). They are found in several intracellular
proteins of different structure and function. Some of them are enzymes (like phospholipace
C-y [PLCy] (1$6;1$7) and PI 3-K(18$)) which are phosphorylated by the catalytic activity
of the receptor and therefore activated, while others are adaptor proteins (ex. Grb2 et Shc)
that recruits cytoplasmic molecules to the plasma membrane, thus connecting the RTK to
the intracellular signalling pathways (181).(see Figure 4)
3.1. liitogen-Activated Protein Kinases Pathway (MAPK):
This pathway is composed of a cascade of serine/threonine protein kinases, which once
activated by phosphorylation, phosphorylate other proteins to modulate their activity (189).
The activation ofthis pathway starts by the recruitment ofGrb2, a SH2-containing protein,
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to the region of phosphorylated Tyr 1068 on the EGF-R. With it, Grb2 transiocates $05
(Son of $evenless), a guanyl nucleotide exchanger responsible for the activation of Ras by
replacing its guanyl dis-phosphate (GDP) by guanyl tris-phosphate (GTP). GTP-bound Ras
recruits the serine/threonine kinase Raf-1 to the membrane and activates it. The latter, in
tum, phosphorylate MAPK kinase 1 (MEK1) on serine 218 and 222, which activates it.
MEK1 is a double specificity protein kinase that phosphorylates p42 and p44, two isoforms
of the ERK family (Extracellular signal Regulated Kinase), on Thr 183 and Tyr 185 in
order to activate them.
p42/p44 are serine/threonine kinases responsible for the phosphorylation of a wide array of
cytoplasmic substrates like p9ORSK kinase, cytoskeleton components and even the EGF-R
itself (Thr 669 retro-negative control). Some of the activated ERK are translocated to the
nucleus where they phosphorylate transcription factors, such as c-Myc and Elk (189), to
stimulate their transcriptional activity. These transcription factors induce the expression of
genes controlÏing DNA synthesis as weIl as ceil cycle re-entry (ex. Cyclin Dl and
Dihydrofolate reductase) thus culminating in cellular proliferation. (61)
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Figure 6 EGf receptor sigizatting path ways
Ligation of EGF to its receptor induces the dimerization, activation of the intrinsic tyrosine
kinase activity of the receptor and the autophosphorylation of the receptor. This creates
docking site for different proteins. Grb2 binds to the phosphoiylated tyrosine residues and
recruits SOS to the membrane in order to activate Ras. This activates the Mitogen
associated protein kinase (MAPK) pathway starting with Raf-1, MEK then ERK.
Phospholipase C y (PLCy) is recruited as well to phosphorylated EGF-R where it becornes
activated. It hydrolyzes phosphatidylinositol 4,5 bis-phosphoate (PIP2) into di-acyl glycerol
(DAG; which activates PKC) and Inositol 1,4,5 tris-phosphate (1P3, which releases Ca2
from the endoplasmic reticulum). Phosphatidylinositol 3-kinase (PI 3-K) is a tyrosine
kinase recruited to dimerized and phosphorylated EGF-R to get phosphorylated and
activated. This resuits in the activation of the serine/threonine kinase Akt, a known anti
apoptotic pathway. A recent new pathway is ernerging invoïving reactive oxygen species
(ROS). However, the mechanisms responsible for their production as welI as the
mechanisms of their action are not yet elucidated.
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3.2. Phosphatidyt Inositot 3-OH Kinase Pathway (PI 3-K):
The PI 3-K is a family of enzymes responsible for the phosphorylation of phosphoinosides
(PI) on their D-3 position (188). The products generated can then modulate the activity of
multiple cellular effectors, such as PKC, PKB/Akt and PI 3-K itself thus mediating the
pleiotrophic effects of this pathway (159;190;191). PI 3-K is composed of two subunits
designated according to their respective molecular weight: z) p85 : is the regulatory subunit.
It contains several protein-protein interaction domains such as SH2, $H3 and PH, which
play a very important role in the assimilation of different signalling pathways; ii) pi 10: is
the catalytic subunit.
When EGF-R is phosphorylated, PI 3-K is rapidly recruited to the plasma membrane hy the
SH2 dornains contained in the p85 subunit where it becomes phosphorylated on tyrosine
residues by the TK of the EGF-R. The activated kinase then phosphorylates PI 3,4-di-
phosphate (PIP2) to generate PI-3,4,5-tri-phosphate (PIP3), which recruits Akt to the
membrane. This interaction induces a conformational change ofAkt thus exposing Thr 30$
and Ser 473 and rendering them accessible to be phosphorylated by 3-phosphoinosides-
dependent protein kinase-1. These phosphorylations activate Akt (192).
3.3. Phospliolipase Cy Pathway (PLCy):
Phospholipases are enzymes (e.g. PLA1 ,2, PLC et PLD) involved in the rnetabolisrn of
phospholipids and the generation of lipid second messengers (181;1$6). PLC specifically
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hydrolyze the glycerophosphate bond of phosphatidylinositol 4,5- bis-phosphate (PIP2).
The resuit of this hydrolysis is the formation of two second messengers, but with very short
lifespan z) 1,2 di-acyl glycerol (DAG) that activates protein kinase C (PKC), a
serine/threonine kinase protein, which phosphorylates various proteins to modulate their
activity (e.g. NaiH exchanger, Raf-1, EGF-R); iz) Inositol 1,4,5, tris-phosphate (1P3),
which induces the release of Ca2 from endoplasmic reticulum into the cytoplasm through
its interaction with the 1P3 channel-receptor. Ca2 is one of most important second
messengers used by ceil-surface receptors, which stimulates the activity of Ca2-
calmodulin kinase and therefore regulates the activity of several enzymes (e.g. PLC).
Several isoforms of PLC exist (ail Ca2-dependant), grouped into three families (f3,)’, ).
Only members of the y family have SH2 domains that allow them to bind to TKR and
therefore to be phosphorylated and activated by them (186).
3.4. Reactive oxygen species (ROS):
Recently, ROS have ernerged as potential messengers of Gf signalling. However the
targets as well as the enzymes that generate them are flot yet known (detailed in section
f 4.4).
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F. INTRACELLULAR REDOX STATE
Reactive oxygen species (ROS) have been of interest for many years in ail areas of bioiogy.
Originally, ROS were recognized as being instrumentai for rnammaiian host defence.
Indeed, Baldrige and Gerard found in 1933 (193) that ROS are generated by the NADPH
(nicotaminde adenine dinucleotide phosphate, reduced form) oxidase compiex of
speciaiized phagocytic celis (neutrophils and macrophages) as cytotoxic agents to fight
invading pathogenic agents, a process known as the oxidative burst (194). However, over
the past severai decades, studies have clearly invoived ROS, and the resulting state calied
oxidative stress, in the deveiopment of severai pathologies such as atherosclerosis.
neurodegenerative diseases (Parkinson and amyotrophic laterai scierosis), stroke, diabetes.
cancer, ischemialreperfusion, aicoholic liver disease, hepatocellular carcinorna as weii as
acute and chronic inflammatory diseases (arthritis, colitis, pancreatitis, chronic hepatitis)
(195-197). Moreover, ROS have been involved in the reguiation of apoptosis, aithough
their exact role is stili controversial.(196;19$;199)
On the other hand, recent work has uncovered an exciting role for ROS: that of key
signaliing moiecules. Indeed, severai mammaiians celi types have been shown to produce
smail amounts ofROS.(194) This weak generation ofROS was shown to be important for a
variety of ceiiuiar fiinctions, including ceil growth, protein synthesis, neuromodulation and
ion transport. (194;198) In addition, accumuiating evidence indicates a vital roie for ROS
in mediating ceiiular responses by various extracellular ligands.(168;194;200;201)
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Therefore, understanding the nature, source and targets of ROS as well as the stimuli that
trigger their production is of important benefit for the developrnent of new therapeutic
strategies.
1. REACTIVE OXYGEN SPECIES (ROS)
for organisms living in an aerobic environment, exposure to R0$ is continuous and
unavoidable. Indeed, molecular oxygen (02) is essentiai for the survival of ail aerobic
organisms. Aerobic energy metabolism is dependent on oxidative phosphorylation, a
process by which the oxido-reductive energy of the mitochondriai electron transport (a
multicomponent NADH dehydrogenase enzymatic complex) is converted to the high
energy phosphate bond of ATP. Cytochrome e oxidase, the terminal enzymatic component
of this mitochondrial enzymatic compiex, catalyzes the reduction of 02 to H20. Partially
reduced and highiy reactive forms of 02 (free radicals with oxygen-based unpaired electron
collectively called ROS) may be formed during these electron transfer reactions, as shown
in Figure 5.(194;195;202) They include superoxide anion (0{) and hydrogen peroxide
(H202) formed by one- or two- electron reductions of 02, respectively. In the presence of
transition metal ions (e.g. Fe, Cu, Co), the even more reactive hydroxyl radical (0W) can
be formed by Fenton or Haber-Weiss reactions (194;203). There are other types of free
radicals called reactive nitrogen species (RNS) : nitrogen-based metabolites with unpaired
electron such as nitric oxide (N0).(204)
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Figure 7 Sources of reactive oxygen species fR05) and their mechanisms ofetiinination
The most commonly formed ROS formed by NADPH oxidase, xanthine oxidase,
cytochrome P450 as well as mitochondrial electron transport pathway is superoxide anion
(02). UV and y-inaddiation can produced 02 in addition to hydrogen peroxide (F1202)
and hydroxyl radical (0H). Several enzymes act on ROS in order to neutralize them.
Superoxide dismutase convert 02 into H202 where catalases and peroxidases (glutahione
[GSH] and thioredoxin {TRX] peroxidase) then reduce it to water. In that process, reduced
glutathione (GSH) and TRX(red) are oxidized into oxidized glutathione (GSSG) and
TRX(0). Nicotimide adenine denucleotide phosphate ÇNADPH) is used by GSSG and TRX
reductases (not shown) to replenish the reduced forms ofthese scavenger molecules.
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ROS and RNS can be generated in almost ail celi type by multiple sources including
mitochondrial electron transport system, NAD(P)H oxidase, xanthine oxidase, microsornal
cytochrome P450 (e.g. CYP 2E1;(Ï96)), nitric oxide synthase (type I, I and III) and
cyclooxygenase (196;204). Mitochondria are a major source of ROS under physiological
conditions, because 2-3% of the 02 consumed is converted to 02 (Figure 5).(196) This
production is increased in ischemialreperfusion injury and in TNf-Œ—treated celis, which
resuits in R0$ accumulation if the anti-oxidant system is impaired or overwhelmed
Ç196)(see section F.3).
2. CYTOTOXIC EFFECTS 0F ROS
ROS can cause severe cellular damages since they are highly reactive toward intracellular
macromolecules (i.e. protein, lipid and DNA), as summarized in figure 6. Indeed, high
concentrations of F1202 and 02 cause DNA damage such as base damage (depurination or
depyrirnidination), single-brand breaks, double-strand breaks, cross-linking between DNA
and chromosomal aberrations (194;205;206). These damages may lead to increased risk of
mutagenesis if flot repaired. Furthermore, extensive oxidative modification of proteins
cause a permanent loss of ftmction from irreversible oxidation of functionally important
amino-acids, the formation of protein-protein cross-linkages, fragmentation of the
polypeptide chain and finally proteolytic degradation of the damaged protein (205). ROS
have indeed been shown to inactivate vital proteins such as adenyl cyclase, glutathione
(GSH) peroxidase, aldehyde dehydrogenase, glutamine synthase, catalase and creatine
n
j-,
phosphokinase (194;207;208). In addition, ROS can cause an alteration of microfilarnents
via depolymerization of the actin network resulting in morphological changes of the plasma
membrane (blebbing) (209). This occurs through irreversible oxidation of thiol-containing
amino acids such as methionine (for example oxidation of methionine into methionine
sulfones) and cysteine (210). Membrane lipid peroxidation is another cellular damage
caused by ROS exposure. Indeed, reaction of polyunsaturated fatty acids, especially C20:4
and 22:6, with ROS resuits in the formation of peroxy radicals, hydroperoxides, aldehydes
and malonaldehydes, which impair membrane integrity and produce a wide range of
biological effects leading to celi injury (194;21 1). As a resuit, cytosolic Ca2 is increased
(thus altering the activity of Ca2-depending enzymes), ATP is depleted, NADPH and GSN
are oxidized.(l 94;205;212)
These lesions are severe and can lead to celi death mainly by necrosis if flot prevented or
repaired. Hence, it is necessary for ceils to tightly control their content in ROS. In order to
do so, ceif s have developed several anti-oxidant (or reductant) mechanisms that maintain
the intracellular redox environment in a highly reduced state.
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Figure $ ROS cytotoxic effects
ROS are highly reactive to intracellular macromolecules. They can induce DNA base
damage, DNA strand breaks and cross linking between chromosomes. In addition ROS
induce lipid peroxidation, which impairs Iipid signalling and compromises membrane
integrity. Proteins are also severely affected by oxidation (degradation, inactivation and
alteration of structure). Consequently, intracellular homeostasis is altered (e.g. increase in
Ca2 cytoplasmic concentrations, thiol and ATP depletion).
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3. INTRACELLULAR ANTI-OXIDANT MECHANISMS AND REDOX
STATE
The anti-oxidant system consists of scavengers (such as glutathione, vitarnins C and E.
thioredoxin) and enzymes (e.g. superoxide dismutase [SOD], GSH peroxidase, catalase) to
neutralize ROS before they can exert damage. (see figure 5)
3.1. Scavengers
Scavengers are reductant substances that get oxidized in order to reduce ROS and oxidized
macromolecules. They include Œ-tocopherol (vitamin E), Ascorbate (vitamin C). uric acid
and thiols (such as glutathione and thioredoxin [TRX]). Œ-tocopherol is a membrane anti
oxidant due to its liposolubiÏity. It is capable of preventing the formation of lipid peroxides
in cellular membranes. Ascorbate plays an important role in restoring the Œ-tocopherol
reduced form. In addition, ascorbate is capable of scavenging O{. (196)
Thiols are sulfhydryl (SH) containing molecules that can readily give their proton (Hj to
reduce ROS or ROS-attacked molecules while they become oxidized thernselves. TRX is a
small multifunctional protein that has a redox-sensitive dithiol. TRX reduce critical protein
sulfhydryl residues to regulate protein folding, receptor assembly, transcription factor
activity as well as reducing some ROS, such as H202. (19$;202) However, the most
important intracellular anti-oxidants is the thiol-containing peptide glutathione. It plays
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several important functions including detoxification of xenobiotics, reduction of ROS and
ofoxidized proteins (see Section F.3.3).
3.2. Enzymes
In general, the most efficient way to eliminate undesirable toxic species, is by means of
degradation. Therefore, cclIs possess anti-oxidant enzymes including SOD, catalases and
GSH peroxides to annihilate ROS.
SODs are a family of metalloenzymes that converts 0{ to H202 and 02. It is an important
ubiquitous enzyme localized in the cytoplasm, the mitochondria, the peroxisomes as well as
the extracellular space. (194;196;207). Interestingly, overexpression of SOD bas been
shown to sensitize ceils to oxidative stress. This can be overcome by increasing the
expression of catalases or peroxidases suggesting that this higher sensitivity is due to H202
accumulation. (213)
Catalases and peroxidases (GSH or TRX -dependent) decompose H202 to H20 and 02.
They are heme-containing proteins that use NADPH as the reducing factor. Catalases are
mainly localized in peroxisomes whiÏe peroxidases are found in the cytosol, mitochondria
and extracellular space. However, both types of enzyme have identical rnechanism of
action. for example, GSH peroxidase oxidizes reduced GSH to form oxidized glutathione
(GSSG) to reduce H202 as well as lipid peroxides. Therefore, these enzymes play an
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important role in maintaining the structure and the function of biological membranes
(196;198).
3.3. GSHsystern
The tripeptide GSH (L-y-glutamyi-L-cysteinyl-glycine) is ubiquitous in animais, plants,
and microorganisms. G$H ofien reaches millimolar levels inside ceils, which makes it one
ofthe most highly concentrated intracellular anti-oxidants (214-216). This is especially true
in the liver where its concentration reaches 10 mM (214). GSH is synthesized from
precursor amino acids (L-glutamine, L-cysteine and L-glycine) in the cytosol of virtually
ail ceils by the sequentiai action oftwo enzymes (197;215;217;218). f irst, the binding of
cysteine and glutamate is catalyzed by y-glutamylcysteine synthetase (GCS) to forrn y
glutamylcysteine. This reaction is the rate limiting step of GSH synthesis and it depends on
the availability of L-cysteine (215 ;21 7;2 18). In addition, the activity of GCS is regulated by
the gene expression of its subunits, by S-nitrosylation, phosphorylation and oxidation (219-
221). On the other hand, GSH acts by feedback competitive inhibition on GCS to regulate
its own synthesis (222;223). Noteworthy, the liver is distinctive from other ceils in regard
to G$H biosynthesis in the unique abifity of hepatocytes to convert methionine to cysteine
(through the transsulfuration pathway) (216). The second step in GSH synthesis, catalyzecL
by GSH synthetase (GS), adds glycine to y-glutamylcysteine to form GSH in an ATP
dependent manner (215;217).
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The y bond between the first two amino acids (instead of the typical alpha bond) renders
GSH resistant to the degradation by standard intracellular proteases. The onfy enzyme
capable of degrading GSH is y-glutamyl transpeptidase, an enzyme located at the outer
surface ofthe ccli (215;217;224). This means that GSH can not be lost by catalysis inside
the celi. 0f note, the preformed GSH cannot enter the celi per se: it must be synthesized
inside ceÏÏs. Therefore, G$H availability can be increased by supplementation with GSH
amino acids constituents (and especially L-cysteine) or by using GSH esters (e.g. GSH
monoethyl ester, GSH diethyl ester). Indeed, GSH esters are capable of passing through the
plasma membrane. Once inside, intracellular non-specific esterases liberate GSH into the
cytoplasm (225).
Almost 90 % of cellular GSH is contained in the cytosol, 10 % in the mitochondria and a
small percentage in the endoplasmic reticulum (214). The mitochondria cannot synthesize
G$H. Therefore, a GSH transporter on the mitochondrial membrane ensures the uptake of
GSH into the mitochondria. This transporter in specifically inhibited by ethanol thus
explaining the preferential depletion of mitochondrial GSH in alcohol-treated hepatocytes.
(216;226) Cytosolic GSH in the rat liver tums over rapidly with a haif life of 2-3 hours.
However, since mitochondria are normally under high oxidative stress, they avidly retain
their GSH with a haif-life of about 30 hours (197;227).
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GSH serves several vital firnctions including:
1) Detoxification of xenobiotics and their metabolites where GSH S-transferases (phase
II metabolic enzymes) conjugates GSH to liposoluble cornpounds thus rendering them
more hydrosoluble and easily extractable from the celi and, in the case, of hepatocytes
into the bile. However, GSH conjugation irreversibly consumes intracellular GSH (216).
2) Protection of cellular macromolecules against ROS. GSH is used by I) GSH
peroxidases to detoxify peroxides (H202 as well as lipid peroxides). ii) by thiol
transferases to prevent the oxidation of the —$11 moieties of proteins or to reduce the
oxidized disulfide bonds induced by oxidative stress (215;217).
3) Recycling of other anti-oxidants that have become oxidized such as ascorbate and
Œ-tocopherol (196).
To accomplish its anti-oxidant function, thiol-reduced GSH undergoes thiol disulfide
exchange, thus forming GSSG (215). In healthy celis, GSH is present mainly in its reduced
form and GSSG rarely exceeds 10% of total cellular glutathione (GSx). Under normal
conditions, GSSG is eliminated by its recycling to GSH. This reaction is catalyzed by
GSSG reductase, an enzyme that requires NADPH as a source ofelectrons (215;21$;22$).
Therefore, NADPH, coming mainly form the pentose phosphate cycle, is the predominant
source of GSH reducing power. However, under oxidative stress GSSG is also actively
excreted out ofthe celI (214).
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Given the widespread involvement of GSH in several important ftmctions, it is not
surprising that GSH depletion bas been associated with several pathologies, including
Parkinson disease, alcoholic liver disease, cirrhosis, hepatitis and atherosclerosis (197).
The redox state is the result of the balance between generation of ROS and their
elimination by anti-oxidant mechanisrns. Oxidative stress occtirs when ROS and oxidants
in general accumulate in the celi due to overproduction of ROS or exhaustion of anti
oxidant mechanisms. This state varies in severity and therefore lias different consequences
on celi function and fate. Indeed, rnild oxidative stress lias been reported to play an
important role in celi signalling at the receptor level as well as in intracellular transduction
pathways (See Section f.4). Somewhat more severe oxidative stress lias been shown to
inhibit ceil death by apoptosis, although this is stiil subject to much debate (as detailed in
Section f.5). However, it is well documented that extreme oxidative stress disrupts vital
celi functions leading to ceil death by necrosis (see Section f.2). (215;218)
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4. REDOX SIGNALLING
Growing evidence show that cellular redox state plays an important role in ceil signalling
(redox signalling). Indeed, a large number of signalling pathways appear to be regulated by
ROS, although the exact signalling molecules targeted by ROS are not very clear. ROS can
mediate signalling by two mechanisms: 1) Alterations in the intracellular redox state; and
2) oxidative modification ofproteins.
4.1. Atterations in intracetttttar redox state
As mentionned above, thiols (such as GSH and TRX) are important regulators of the
cellular state redox due to their anti-oxidant power. Accumulating evidence suggest that, in
addition to their anti-oxidant flinctions, thiols participate in ceil signalling processes (195).
GSH has been reported to regulate redox signalling by the change in the total level of GSFI
(229;230) as well as in the ratio of the reduced to the oxidized forms (231 ;232). Indeed,
TGf-13-induced growth inhibition of vascular endothelial ceils is accornpanied by GSH
depletion (233). Moreover, GSH:GSSG ratio seems to regulate the DNA binding ofthe sp
1 transcription factor (232). TRX has also been shown to regulate the activity of sorne
proteins by binding them. For example, TRX has been shown to bind to the amino terminal
of ASK-1 and thus to inhibit its activity (234). ROS induce the dissociation of the
TRXIA$K-1 complex thus liberating the kinase, which oligomerizes and becornes activated
(235).
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4.2. Oxidative niodflcatio,ts ofprotebis
ROS can alter protein structure and function by modifying critical arnino acids residues in
or near the active site of enzymes. This oxidative modification of amino acids can occur by
several rnechanisms: j) The best described modification is oxidation of the -SH group of
cysteine residues to sulfenic (-SOH), suffinic (-SO2H) derivative or their S
glutathionylation (-SSG). Such modification may alter the activity of the enzyme if the
cysteine is located in its active site (e.g. protein tyrosine phosphatase lB (236), caspases
(77)) or the transcription factor if it is located within its DNA binding region [e.g. c
Jun(237)]). ll) Two or more cysteine residues within the same protein can be oxidized to
form an intramolecular disulfide bridge, thereby inducing a conformational change of the
protein and altering its activity. This is a well characterized mechanism for oxidant
regulation of the activity of several transcription factors (such as p53 (238), OxyR (239))
.(195)
Protein dimerization is another mechanism mediating oxidant regulation ofprotein activity.
Indeed, intermolecular disulfide bonds formed by the oxidation of cysteine groups of two
identical or different proteins lead to the homodimerization or heterodimerization of
proteins (e.g. GSH $-treansferase-it (240), ASK-l(241)). H202 or peroxidase-induced
cross-linking of tyrosine residues on separate proteins has been shown to participate in the
dimerization and oligomerization of these proteins (e.g. synthesis of thyroxine(242)).
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Lastly, interaction of ROS with metal-ion clusters in metaÏloenzymes (e.g. fe-S) ieads to
their oxidation in a fenton-like reaction thus marking these proteins for ubiquitination and
degradation (243;244). Therefore, modifying the stability of protein by redox-induced
aherations in their levels might be another manner to regulate protein ftmctions by
oxidants.
4.3. Signattingpathways targeted by ROS
Extracellular stimuli transduce signais through a variety of ceiluiar signalling pathways
inciuding signalling molecuies such as protein tyrosine kinases (PTK), serine/threonine
kinases, phospholipases and Ca2. When ceils are stimulated with ROS. signais are
transfened through the same signalling pathways as those triggered by growth factors.
Kinases aitd phosphatases : Several studies have shown that oxidants such as
vanadate and UV-irradiation activate RTK and PTK, protein serine/threonine kinase
(195;198;202). For example, intraperitoneal injection of mice with pervanadate resulted in
the tyrosine phosphorylation of several proteins including receptors for insulin, EGf and
HGF as well as PLCy and insulin receptor substrate-1 tIRS-1). In addition, H202 treatment
was shown to activate MAPK cascades (JNK, p38 and ERK pathways) (198;202), Akt and
PKC. However, evidence for direct activation of these kinases is stiil lacking. In fact.
treatment of some PTK with F1202 did flot show any increase in enzyrnatic activity (202).
On the other hand, protein tyrosine phosphatases (such as protein tyrosine phosphatase-ÏB)
and serine/threonine phosphatases (such as protein phosphatase 1 and 2A (245)) are
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reported to be inhibited by oxidants since ail phosphatases have a reactive cysteine in their
catalytic site (246). This suggests that ROS-induced activation of protein kinases is the
resuit of inhibition of their dephosphorylation by phosphatases (e.g. PDGF receptor, EGf
receptor and fyn) (195;202).
Ca2 sigizatting : Ca2 is widely used as a second messenger that regulates a variety of
biological processes including muscle contraction, neurotransmission, gene transcription
and ccli growth. Oxidants, such as H202 and 02, have been shown to increase
intraceliular Ca2 through inhibition of the Ca2-ATPase of sarcoplasmic reticulum,
increase of membrane permeability as a resuit of peroxidation of membrane lipids; and
increase in the probability of the opening of sarcopiasmic reticulum Ca2-cha;me1s (247).
Transcriptio,zfactors: $everai studies have shown that oxidants are major determinants of
gene expression. Indeed, severai transcription factors contain cysteine residues localized in
their DNA binding domain, which are essentiai for the recognition of the binding site with
DNA bases. The oxidation of these cysteines resuits in the inhibition of the binding of the
transcription factor (such as NFicB, AP-1) to DNA (248). However, F1202 and TNF-Œ have
been shown to induce the activation of the same transcription factors (e.g. NF-icB). This
apparent contradiction was expiained when the phosphorylation and the subsequent
degradation of I-KB, an inhibitory protein that retains NF-KB in the cytopiasm, was
observed following oxidant treatment. This resuits in the release of NF-KB from the
inhibitory complex (Nf-KB / I-KB) foilowed by its transiocation to the nucieus (249).
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Therefore, the activity of Nf-icB seems to be under dual redox regulation, whereby anti
oxidants directly inactivate NF-icB (in the nucleus) while they suppress its upstrearn
inhibition (in the cytoplasm). (202;24$)
4.4. Ligand-indttced ROS production
A variety of cytokines and growth factors have been reported to generate ROS. Indeed,
TNf-Œ and interferon-y (INF-y) were among the first cytokines reported to generate ROS.
For example, TNF-Œ—induced expression of adhesion molecules, IL-8 expression and
production of chemokines have been shown to be mediated through ROS-dependent
mechanisms (195). In addition, growth factors that bind RTK have also been shown to
generate intracellular ROS rapidly afier the activation oftheir receptors for a short period (a
burst) and in a coordinate manner (200). Sundaresan et al. (201) have demonstrated that
PDGf-induced tyrosine phosphorylation, MAPK activation, DNA synthesis and
chemotaxis require transient increase in intracellular J-1202 concentrations. Similarly, EGf
enhanced tumorigenicty, metastatic capacity, and in vitro invasive capacity have been
shown to be partially related to EGF-induced H202 production (250). Other receptors, such
as receptor serine/threonine kinases (e.g. TGf-r3) and G protein-coupled receptors (e.g.
Angiotensin II receptor) have also been reported to generate ROS following binding with
their ligand and to mediate some oftheir biological effect (195).
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5. REDOX REGULATION 0F APOPTOSIS
As mentioned above, accumulation of ROS leads to a state of oxidative stress where severe
intracellular injuries occur and cause to ceil death by necrosis. In similar manner, weak
oxidative stress lias been shown to induce apoptosis or to mediate the apoptotic signal.
However, contradictory findings are emerging regarding this issue. Indeed, accumulating
evidence shows that, on the contrary, oxidants can inhibit apoptosis.
5.1. Oxidatii’e stress sensitizes cetis toward apoptosis
An increase in intracellular ROS levels has been shown in several studies to lead to ceil
death by apoptosis. For example, UV radiation, y-irradiation and TNf-Œ, known for their
ability to stimulate intracellular ROS generation, as well as H202 can induce celi death by
apoptosis in many cell systems (198). In addition, ROS triggered the expression of c-rnyc, a
protein involved in the mediation of the apoptotic signal of several stimuli (251). $imilarly.
anti-oxidant depletion or decrease of anti-oxidant enzymes (e.g. catalases, SOD, GSFT
peroxidase) sensitize cells to apoptosis, while cell replenishrnent with anti-oxidants (GSI-I,
TRX) or overexpression of GSH peroxidase abrogate it. (202;252;253) In fact, extrusion of
anti-oxidant such as GSH was reported to be an early and requisite event in the mediation
of the apoptotic signal. (254-255)
68
However, careful review of the literature reveals that depletion of GSH or ROS exposure
have different effects on apoptosis depending on their intensity, location and timing. for
example, a recent study from Femandez-Checa’s group bas demonstrated that celi exposure
to 3 -hydroxy-4-pentenoate, which specifically depletes mitochondri al GSH, sensitizes
hepatocytes to TNf-Œ- and fas-induced apoptosis (256). In a similar manner, there is
higher sensitivity toward apoptosis in alcoholic liver disease (45), ethanol being known to
preferentially deplete mitochondrial GSH (226).
0f note, the expression of the anti-apoptotic protein BCL-2 was shown to be associated
with relocalization of GSH to the nucleus. (151) $ince BCL-2 is localized to the
mitochondria and the nucleus, it could be postulated that BCL-2 relocates GSH to where it
could effectively protect against the devastating damages of oxidative stress.
5.2. ROSprotect ce!!s agaittst apoptosis
In spite of these findings regarding the role of ROS in apoptotic induction and execution.
several studies have shown that ROS are flot implicated in apoptosis or can even protect
against it. for example, hypoxia should protect against apoptosis, since ROS generation
should be greatly attenuated in a near-anaerobic atmosphere. However, it lias been shown
that, whule hypoxia protectes against oxidant-induced apoptosis (257), it does flot abrogate
staurosporine-, fas- or camptothecin-induced apoptosis. This suggests that sorne apoptotic
signalling occurs independently ofROS generation
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In addition, the groups of Wendel (75;76) and Jaeschke (252) have reported that in vivo
depletion of GSH by phorone or acetaminophen treatment resuits in the abrogation of
apoptosis induced by Fas and TNF-Œ. Furthermore, 02 has been reported to inhibit fas
induced apoptosis (259). These studies have postulated that redox modulation of caspases
is the cause of this loss of apoptotic sensitivity. Indeed, Henzte et al. have shown that
abrogation of the fas signal by GSH depletion was flot due to a decreased recruitrnent of
caspase-$ to the DI$C complex at the Fas-R, but was rather mediated by direct inactivation
of caspase-8.
Hence, the involvement of the redox state in the mediation of the apoptotic signal is not yet
clear. Therefore, further studies are needed to elucidate the involvement of the redox state
in the sensitivity of ceils toward apoptosis.
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CHAPTER 2
OBJECTIVES AND HYPOTHESI$
71
A. RATIONAL
• GSH is a very abundant non-protein intracellular thiol and the liver contains high levels
ofthis thiol.
• Redox state has been involved in the regulation of apoptosis; however whether it
facilitates or abrogates apoptosis is stili a subject for debate.
• In vivo, liver celis are very sensitive toward Fas-induced apoptosis whule hepatocytes in
culture are relatively resistant toward apoptosis.
• Growth factors (Gf) protect against apoptosis; they activate tyrosine-kinase receptors.
which once phosphorylated, recruit and activate several signalling pathways.
• Many biological activities of GF necessitate the tyrosine kinase activity (TK) of their
receptors. However, others were shown to occur independently of the TK activity of
Gf.
• Gf have been shown to induce the generation of ROS rapidly afier the activation of
their receptors.
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B. HYPOTHESES
• Oxidative redox state is a negative regulator of Fas-induced apoptosis in mouse
hepatocytes.
• EGf can modulate intracellular redox state to mediate protection against fas-induced
apoptosis
• EGF anti-apoptotic activity is mediated by the TK activity of its receptor.
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C. OBJECTIVES
• Evaluate the effect of celi isolation and culture procedures on intracellular stocks of
GSH in mouse hepatocytes.
• EstabÏish the relationship between GSH levels and celi sensitivity toward Fas-induced
apoptosis in culture.
• Determine the involvement of the TK activity of the EGF-R in the anti-apoptotic effect
ofEGF in mouse hepatocytes.
• Determine the effect ofEGF on the GSH system and the redox state ofthe cell.
• Examine the relevance of EGF modulation of the redox state to its anti-apoptotic effect
in mouse hepatocytes.
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ABSTRACT
The involvernent of reductionloxidation (redox) state in celi sensitivity to apoptosis has
been suggested by several studies in which induction of apoptosis was shown to require
oxidative stress or 05H extrusion. On the other hand, biochemical studies of caspases
revealed that their activation necessitates a reduced cysteine in their active site : This is
ensured by maintaining intact intracellular glutathione status during apoptotic induction as
reported by in vivo studies. Therefore, we investigated the relationship between
intracellular glutathione levels and the sensitivity of mouse hepatocytes in culture to fas
induced apoptosis as well as potential mechanisms responsible for this sensitivity. We
found that total and reduced glutathione levels are decreased by haïf following ceil
isolation procedure and further decline by 25% during ceil culture for 2h in normal
Williams’ E medium. Ceil culture in medium supplemented with cysteine and methionine
maintains glutathione at a level similar to that measured just afier ceil isolation. Resuits
show that the capacity of fas to activate caspase-$ and to induce apoptosis requires
important intracellular glutathione levels and high GSH/GSx ratio. In conclusion, the
present study shows that intracellular glutathione plays an important role in maintaining the
apoptotic machinery ftinctional and thus capable oftransmitting the apoptotic signal.
Key words : glutathione, redox, Bid, BCL-xL, caspase-$, apoptosis.
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INTRODUCTION
Oxidative stress is defined as the manifestations of ccli or tissue following exposure to
excess oxidants.(20) Reactive oxygen species (ROS)’, such as O2, 0H and H202, are the
principal species of intracellular oxidants. They are generated as by-products of electron
transport through the mitochondrial respiratory chain as well as by y-ray and ultraviolet
light irradiations. (20;27) ROS are highly reactive towards intracellular macrornolecules
(DNA, proteins and lipids) causing severe lesions that can Iead to cdl death by eithet
necrosis or apoptosis, depending on the intensity of the oxidative stimuli. (24;40;41)
Hence, it is necessary for ceils to tightly control their content in ROS. In order to do so.
cells have developed several anti-oxidant (or reductant) mechanisms that maintain the
intracellular redox environment in a highly reduced state. These mechanisms range from
scavengers (e.g. glutathione, vitamins C and E) to enzymes that neutralize ROS
(e.g. superoxide dismutase, catalases and giutathione peroxidase) before they could exert
any damage. (20 ;27) Glutathione, a tripeptide (L-y-glutamyl-L-cysteinyl-glycine)
synthesized in the cytoplasm, is the most abundant intracellular non-protein thiol involved
in anti-oxidant elimination. It is used by different enzymes to reduce not only ROS, but
oxidized macromolecules as well.(20;28) Several oxidative injuries have been associated
with glutathione depletion.(1 ;9;19;20) That is why glutathione replenishment by N
acetylcysteine administration has been proposed as a therapeutic strategy for oxidative
stress injuries.(9)
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Apoptosis can be triggered by different stimuli, including celi surface receptors (e.g. TNF
Œ and fas (10;26;33)), y-irradiation (30), staurosporine (39) and others. These stimuli
converge onto common intracellular effectors such as caspases, endonucleases and pro
apoptotic proteins ofthe BCL-2 family (eg. Bad, Bid, Bax). The fas apoptotic pathway was
recently elucidated. Binding of fas ligand to Fas receptor (fas-R) resuits in receptor
trimerization leading to the recruitment of the adapter protein fADD to the death domain of
Fas-R. (11) The death effector domain of FADD can then interact with a similar dornain of
procaspase-8, which results in the oligomerization of the latter. Activation of caspase-8
through auto-cleavage leads to a series of downstream events, including Bid cleavage,
cytochrome c release from the mitochondria and caspase 3 activation, finally culminating
in ceil death by apoptosis. (43) Ogasawara et al. have reported in 1993 that intraperitoneal
administration of anti-fas antibodies causes severe liver damage by apoptosis within 1-2h
leading to rapid animal dernise within 6h.(36) On the other hand, it is weB documented that
induction of apoptosis in cultured hepatocytes is less successful. (23;34)
As mentioned above, it vas recently reported that apoptosis could be triggered by weak
oxidative stimuli. In these studies, anti-oxidant depletion sensitized ceils to apoptosis while
their replenishment abrogated it.(19;24;41) Moreover, anti-oxidant extrusion (such as
glutathione) was reported as an early and requisite event in the mediation of the apoptotic
signal.(13;42) However, this remains controversial. Recent reports have shown that, on the
contrary, oxidants prevented cell death by apoptosis. for example, caspases, which play a
pivotal role in apoptosis, are themselves redox-sensitive. They require a reduced cysteine in
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their active site in order to function.(25;35) In parallel, Hentze et aï. have reported that
intact intracellular glutathione status is essential for receptor-mediated caspase activation
and apoptosis in vivo.(16;17)
Therefore, in light of the importance of glutathione for Fas-induced apoptosis in vivo, we
investigated the possible relationship between glutathione status and the resistance of
cultured mouse hepatocyte to Fas-induced apoptosis, as well as the potential mechanisms
involved in this resistance. We found glutathione status to be important for the ability of
Fas to induce apoptosis in culture. This resistance in culture appears to resuit front a lower
capability to induce the proteolytic activity of caspase-8.
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EXPERIMENTAL PROCEDURES
Ail animais received humane care according to the guidelines of the Canadian Council on
Animal Care. Experimental protocols were approved by the Comité institutionnel de
protection des animaux ofthe CHUM-Hôpital Saint-Luc.
Hepatocyte isolation and ciiItttre
Hepatocytes were isolated from the liver of fed male BALB/c mice (22-25 g) ttsing the 2-
step collagenase perfusion method described previously (32). Celis were seeded onto
plastic petri dishes (26,000 cells/cm2) in medium supplemented with 10% fetal bovine
serum (GIBCO BRL, Toronto, ON, Canada) and allowed 2h to attach. Cysteine (the
limiting amino acid for glutathione synthesis; Cys) and its precursor methionine (Met) were
used to modulate glutathione intracellular levels. Therefore, we used two different culture
media: 1) normal Williams’ E medium (GIBCO BRL) containing 40 mg/L Cys and
15 rng/L Met (Medium N), and 2) Williams’ E medium supplemented with Cys (90 rng/L)
and Met (55 mg/L; Medium C+M). After attachment, the serum-containing medium was
removed, and ceils were incubated with serum-free medium for the indicated tirnes in each
experimental series. Apoptosis was induced in experimental groups with mouse anti-Fas
Jo2 antibody (Research Diagonistics mc, flanders, NJ, USA) at a concentration of
100 ng/ml, unless stated otherwise, either directly afier attachment in medium N and C+M
or afier 6h of celi incubation in medium C+M.
GSH and resistance to apoptosis MUSALLAM et al./$ I
Determination q[ GSx and GSHtevets
Culture conditions: In order to determine the effect of hepatocyte isolation procedure on
total (GSx) and reduced (GSH) glutathione, we measured G$x and GSH levels at different
stages ofthe isolation procedure. First, to measure glutathione levels in total liver, a section
of the right lobe was homogenized in 0.25 M sucrose solution (20 % w/v). Cells (2xl0)
were also coÏlected afier liver perfusion with Hepes and collagenase solutions as well as
after hepatocyte purification, and washed once in cold phosphate-buffered saline (PBS)
before being resuspended in 300 t1 of 0.25 M sucrose solution. To evaluate glutathione
levels over time in culture, hepatocytes were attached in either medium N or C+M in the
presence of 10% fBS for 2h. Then the semm-containing media was removed and celis
were cultured with medium C+M for 6 h. At the end of the experiment, celis were scraped
off, pelleted by centrifugation and resuspended in 300 pi 0.25 M sucrose solution. Samples
were stored at —80°C until determination of GSx and GSH levels.
GSx and GSH determination: GSx and GSH levels were measured as described
previously (31) with some modifications. Briefly, samples were boiled for 10 min then
centrifuged at 12 000 g for 15 min at room temperature. The pellet was discarded. A
portion of the supematant (100 p.!) was treated with glutathione reductase (1.2 U; Sigma;
Oakville, ON, Canada) and NADPH (1.2 mM; Sigma) for 10 min at room temperature. The
reaction was stopped by precipitating proteins with 4% sulfosalicilic acid (1:1; Sigma).
GSH was measured directly in the supematant afier protein precipitation. Thiol
concentration was determined by adding 5,5’-dithiobis-2-nitrobenzoic acid
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(DNTB; 0.01 M; Sigma) to the sample at a 9:1 dilution and measuring the absorbance at
412 nm. Protein concentration in each sample was determined according to Bradford (5).
Morphotogical cletermination of apoptosis
After attachment, ceils were incubated with medium N or C+M alone or in the presence of
anti-Fas antibodies. Afier 6h, the medium was removed, ceils were fixed with 5%
formaldehyde solution (Anachemia Science, Lachine, Qc, CA) and then stained with
Hoechst 3325$ (250 ng/ml, Sigma) to quantif’ apoptosis as described previously.(32) The
percentage of apoptotic cells is expressed as the ratio of apoptotic nuclei versus the total
number ofnuclei (normal + apoptotic). We evaluated 400 nuclei for each petri dish.
Biochemicat deterrnbtation of cet! death
Cells cultured in medium C+M were induced to undergo apoptosis with anti-fas antibodies
directly after attachment or 6h afler attacbment. To determine celi death, we measured AST
and ALT levels released in the medium afier 24h in culture as detailed elsewhere.(32) AST
or ALT levels for each sample was calculated as the ratio of AST or ALT present in the
medium versus the sum of the levels of A$T or ALT released in the medium and that
present in the homogenate of adherent cells. Results are presented as the ratio of AST or
ALT levels released in fas-treated cultures to those released in untreated cultures.
Measitrement of caspase-8 activity
Culture conditions: In order to determine the effect of medium on fas-induced caspase-$
activity, ceils were treated, afier attachment, with anti-fas antibodies (250 ng/ml) for 3h in
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medium N or C+M. In parallel, the effect of time in culture was evaluated on cultures
incubated with anti-Fas antibodies (for 3h) either directly afler attachment or 6h later in
medium C+M. Celis were then scraped off in P35 and collected by centrifugation. Ceils
were lysed for 15 min on ice in lysis buffer (10 mM Hepes [pH 7.4], 5 mM MgCI2, 42 mM
KCI, 0.1 mM EDTA, 0.1 % 3- [(3-cholamidopropyl) dimethylammonio j - 2 - hydroxy —
1 -propanesulonate (CHAPSO; Calbiochem; San Diego, CA, USA), 0.1 % Triton X-100,
1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 jtg/ml
leupeptin, 10 ig/m1 aprotinin, 10 tg/ml soybean trypsin inhibitor and 100 tM
benzarnidine). Lysates were centrifuged at 13 000g for 10 min and the supernatant stored at
—80°C. Human activated recombinant caspase-$ (Calbiochem) was used to determine the
glutathione-dependent modulation of caspase-$ activity. In order to do so, activated
caspase-$ (30 U/well) was rnixed with assay buffer containing 5mM GSx with different
ratios ofGSWGSx (100 % to O %).
Measurement of the proteolytic activity: The fluorometric Ac-IETD-AMC cleavage
assay was performed in microtiter 96-well plates. Reaction mixture contained 40 tl lysates
(200 jig protein), 50 tl assay buffer 2x (100 mM Hepes [pH 7.2], 200 mM NaC1, 2 mM
EDTA, 20 % sucrose, 0.2 % CHAPSO, 20 mM DTT). Afier an initial 10 min incubation at
37°C, the reaction was started by adding 10 t1 ofcaspase-8 fluorescent substrate Ac-IETD
AMC (100 1.cM; Biosource International, Camarillo, CA, USA). The cleavage activity of
caspase-8 was evaluated over a period of 30 min using 380 nm and 460 nm as excitation
and emission wavelengths respectively in a SPECTRAmax GEMINI microplate
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spectrofluorometer (Molecular Devices, Suunyvale, CA, USA). The maximal substrate
cleavage rate (Vmax!sec) was calculated by 50fTmax® Pro software (Molecular
Devices). The activity of caspase-$, presented in units, was derived from a calibration
curve relating Vmax!sec to increasing units ofhuman activated recombinant caspase-$.
Inzmttnobtotting
Ceil lysis: We determined the expression level of procaspase-$, Bid and BC1-XL proteins
after 0, 0.5, 1 and 3h post-cell attachment. At the end of the experiment, the medium was
removed, celis were then scraped off and pelleted by centrifugation. Celis were
subsequently disrupted by sonication (Sonic & Materials, Danbury, CT, USA) in the
presence oflysis buffer (PBS, pH 7.4; 1 % Igepal CA-630; 0.5 % deoxycholic acid sodium
sait; 0.1 % SDS; 5 mM EDTA; 10 ig/m1 leupeptin, 10 j.ig/ml aprotinin; 10 tg/mi soybean
trypsin inhibitor and 100 tM benzamidine).
Western Blot (3$): Proteins samples (125 fig) of each experirnental condition were
separated by electrophoresis on 15% sodium dodecyl sulfate (SDS)-polyacryÏamide gels.
Equai protein loading was assessed by staining the membranes with Ponceau S (Sigma).
Blots were probed with primaiy antibodies for 2h, then with secondary antibodies for 1h,
both at room temperature with gentie agitation. The expression of procaspase-$ (57 KDa),
Bid (23 KDa), BCL-xL (29 KDa) and actin (42 KDa) proteins were detected respectively
with rabbit anti-human caspase-8 (ljig/ml; R&D Systems; Minneapolis, MN, USA), goat
anti-humanlmouse Bid (1 ig/ml; R&D Systems), mouse monoclonal anti-BCL-x antibodv
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(0.5 tg/ml; Transduction Laboratories, Lexington, KY, USA) and anti-mouse actin
monoclonal IgM ascites (1: 2000; Oncogene Research Products; Cambridge, MA, USA).
Peroxidase-conjugated anti-mouse IgG (1: 10 000; BD Pharmingen; Mississauga, ON,
CA), peroxidase-conjugated anti-rabbit IgG (1: 10 000; BD Pharmingen; Mississauga, ON,
CA), peroxidase-conjugated anti-goat IgG (1:5000; Santa Cruz Bioteclrnology) and
Peroxidase-conjugated anti-mouse IgM (1: 10 000; Oncogene Research Products) activities
were revealed using Western Blot Chemiluminescence Reagent Plus (NENTM Life Science
Products, Boston, MA, USA). Blots were then scanned and bands were quantified by
densitometry.
Statisticat anatysis
Ail data represent the values of at least 5 experiments, each from different ccli isolation.
Differences between groups were analyzed by one-way analysis of variance (ANOVA) for
repeated measures, unless stated otherwise. The difference between treatrnent and time was
analyzed by two-way ANOVA for repeated measures. A p value below 0.05 was
considered significant.
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RESULTS
Jet! isolation and culture decrease tiver G$x tevels
As mentioned above, glutathione is a very abundant intracellular thiol in the liver. GSx
concentration amounted to 2.04+0.33 nmol/ig protein in total liver (figure 1). Levels were
greatly diminished during the celi isolation procedure. Indeed, GSx levels were decreased
by 46% following liver digestion with collagenase (1.11+0.09 nmol Itg protein; p<O.Ol).
but were not significantly reduced by hepatocyte purification (1.01+0.09 nmol /tg protein:
ns). When celis were cultured for 2h in commercial WilÏiams’ E medium (medium N), GSx
levels were fttrther diminished by 46 % (0.55±0.04 nmo1/ig protein; p<O.Ol) as compareci
to just before culture. This signifies that, afier 2h of attachment, cells retained only 27 % of
their original content in GSx (p<O.001).
Cys anci Met stipplernentation stabiizes GSx tevets in ctdtured hepatocytes
In order to modulate GSx synthesis, we added Cys and Met to the culture medium at a final
concentration of 90 mg/L and 55 mg/L respectively (medium C+M). These concentrations
were chosen by performing a dose-response curve where we determined the effect of
different concentrations of these two amino acids on intracellular GSx levels. As shown in
figure 1, cell culture in this enriched medium prevented the loss of GSx that was observed
in medium N during the 2h attachrnent (0.99±0.17 vs 0.55+0.043 nmol/.ig protein for
medium C+M vs N; p<0.Ol).
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0f note, addition of greater concentrations (up to 120 rng/L Cys and 75 rng[L Met) of these
two amino acids to the culture medium during celi attachment resulted in 50 % restoration
of GSx that was lost during liver digestion. However, it was more rapidly evacuated from
the ceils in culture in comparison to medium C+M (resuits flot shown). Thus, our
experimental conditions were optimal in preserving GSx in cultured mouse hepatocytes.
Tue abitity offas to induce apoptosis is greater in cetis cultured in medium C’+M
Our untreated cultures displayed very low rates of apoptosis (<1 %) with no significant
difference between the two media (data not shown). When hepatocytes were incubated with
an agonistic Fas-R antibody, a significant apoptotic response was observed in both media.
0f note, the level of necrosis, as measured by Trypan Blue exclusion, was flot significantly
different between untreated and Fas-treated cultures or between the two media (data not
shown). Interestingly however, the level of apoptotic cells, as determined by condensed
chromatin fluorescence, was more than twice as great in medium C+M (10.0 %+0.9) as in
medium N (4.4 %±0.2; p<O.O5; figure 2A). Similarly, fas-induced AST release was
higher in medium C+M (127.6 % ± 3.1) as compared to medium N (114.6 % + 4.0;
p<O.001; figure 2B). In addition, Fas-induced release of ALT was significantly higher in
medium C+M (209.6 %±9.3) in comparison to medium N (186.0 % ± 10.4; p<O.O5; Figure
2C).
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The expression levets of procaspase-8, Bid anti BC’L-xL protebts are similar in both
media over time in culture
Apoptotic induction depends on the ratio of anti- and pro-apoptotic regulating proteins.
Caspase-8, Bid and BCL-xc are some ofthe key proteins implicated in the regulation offas
pathway in hepatocytes. Therefore, we measured the level of expression of procaspase-8
(57 KDa), Bid (23 KDa) and BCL-xL (29 KDa) in both media for up to 3h post-attac1unent
by western blot analysis. figure 3 shows that protein expression of procaspase-8 (Figure
3A), Bid (figure 3B) and BCL-xL (Figure 3C) in medium N was not significantly different
from that in medium C+M (ns) and this at each time point tested. This suggests that the
difference in the ability of Fas to induced ceil death is flot due to different expression levels
of these key apoptosis-regulating proteins.
fas capacity to activate caspase-8 proteotytic activity is greater in medium C+M
$ince the expression level of procaspase-8 was similar in cultures incubated with either
media N or C+M, we next examined the protease activity of caspase-8 in untreated cultures
or in ceils treated with anti-Fas antibodies for 3h directly after ceil attachment in both
medium N and C+M (figure 4). In untreated cultures, levels of caspase-8 activity in both
medium N (1.16±0.45 U) as well as C+M (1.41±0.25 U; NS) were low. Afier 3h of Fas
receptor stimulation, the activity increased to 8.70±1 .25 U and 13.60±0.79 U in medium N
and C+M respectiveÏy (p<0.00l), with the difference between the two media being
significant (p<0.05).
GSH and resistance to apoptosis MU$ALLAM et al./89
GSH/GSx ratio dectiites over tinte bi culture
Normally, GSWGSx ratio is kept stable in ceils by different mechanisms including GSSG
reduction and GSSG active extmsion. This ratio was at $3.0 %±7.3 in total liver and was
flot significantly modified during liver perfusion, hepatocyte purification or cell attachment
for 2h (results flot shown). However, GSH/GSx ratio was observed to decrease in our
cultures over time. Indeed, hepatocellular content in GSx was decreased by 25 % afier 6h
culture with medium C+M as compared to just afier 2h attachment (p<O.O5; Figure SA).
Nonetheless, GSx levels were 60 % higher in medium C+M than in medium N at 6h
(p<O.O5, data not shown). On the other hand, GSH levels were decreased from
27.65 ± 2.61 nmol / million hepatocytes to 16.95 ± 3.31 nmol / million hepatocytes
(p<O.05), which represents a 39 % reduction (figure 5A). This translates into a significant
decline of GSHIG$x ratio ftom 82.0 % ± 2.6 at 2h attachment to 65.3 % ± 5.9 at 6h
(p<0.05; Figure 5B). While a similar decrease of GSHIGSx ratio was observed in ceils
cultured in medium N (data flot shown), it remained significantly higher in medium C+M
(74.0 % ± 2.1) as compared to medium N (67.0 % ± 2.6; p<0.05) when measured at 3h
post-attachment.
GSH/GSx ratio dectine is associated with a decrease in fas-induced caspase-8 activation
and cet! death
It is weÏl documented that profound GSH Ïoss could promote oxidative stress which
subsequently leads to ceIl death. However, since we observed lower levels of Fas-induceci
apoptosis when GSx levels were depleted, we investigated if the observed decrease in
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GSH/G$x ratio (17 % drop) over time in culture was also able to reduce the transmission of
Fas signal. Therefore, apoptosis was induced afier 6h of culture, and caspase-$ activity as
well as celi death were then assessed. As illustrated in Figure 6A, there was an 18 ¾
decline in the proteolytic activity of caspase-8 from 13.60 U+0.79 (at 2h attachment) to
11.09 U±0.71 (after 6h culture; p<O.05). This decline occurred concomitantly with a
decrease in the capacity of Fas to induce ceil death (Figure 6B and C). Indeed, AST
released from cultures incubated with Fas antibodies after 6h of attachment was 19 ¾ less
(113.3 % ± 4.0; Figure 6B) than those incubated shortly afier attachment (afler 30 mm;
140.0 ¾ ± 6.0; p<0.Ol). Similarly, ALT release was decreased by 23 % in a tirne-dependant
manner as shown in Figure 6C (30 mm: 235.4 %±10.6 vs 6h: 204.5 %±10.2; p<O.Ol).
In order to determine which form of GSx is associated with the observed decrease in the
capacity of Fas to induce ccli death over time in culture, we established a conelation
between the levels of GSH and GSWGSx ratio on one hand and ALT levels on the other.
To do so, we conducted separate sets of experiments where celis were incubated with anti
Fas antibodies afier different periods of culture in medium C+M following attaclu-nent,
while other ceils from the same animal served to measure GSH and GSx levels at the same
time points. There was a significant correlation between ALT levels reieased and
intracellular GSH levels (R2 0.476; p<O.O5). However, the correlation was much more
important between GSH/GSx ratio and ALT levels (R2 0.846; p<O.0001). This suggests
that relative accumulation of GSSG in ceils is associated with a reduction in the capacity of
Fas to induce apoptosis over time in culture.
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Recombinant Caspase-8 activity is decreasett when G$H/GSx ratio is di,ninished bi vitro
We next investigated GSx-dependent modulation of caspase-8 by determining the effect of
varying GSWGSx ratios on the proteolytic activity of the activated recombinant human
form of this enzyme (Figure 7). Caspase-8 activity was flot signiflcantly different between
100% and 75% GSH/GSx ratio (20.61 U±1.55 and 19.72U±0.70 respectively, ns).
Conversely, the activity of the protease significantly decreased when this ratio declined
below 75 % (R= 0.93; p<O.Ol). When 100% GSSG (i.e. 0% GSH/GSx ratio) was attained,
there was no caspase activity detected.
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DISCUSSION
The involvement of oxidative stress in ccli death by necrosis is well established. Indeed,
many studies have demonstrated the devastating effects of oxidants on intracellular
macromoiecules. for example, ROS have been shown to inactivate vital proteins (such as
glutathione peroxidase and adenyl cyclase), cause DNA strand break and membrane lipid
peroxydation.(20;27) As a result, cytosolic Ca2 is increased, ATP is depieted, NADPH and
GSH are oxidized and membrane integrity and signaling are impaired.(37) AlI these lesions
are very harmful if flot repaired. In a prolonged exposure to oxidants, celis exhaust their
anti-oxidant mechanisms and their repair systems are overwhelmed leading to cumulative
lesions and therefore to necrosis. (20;37)
In apoptosis, however, the question is still under debate. On one hand, depletion of
reductant or anti-oxidant reserve was found to sensitize otherwise unresponsive celis to
apoptosis. This was observed in several ccli unes, including Jurkat (42), HepG2 (13) and
cholangiocytes (6). In these studies, depletion of glutathione accentuated the apoptotic
response, while high intracellular glutathione levels abrogated it. In addition, low amounts
of oxidants, such as H202, were found to induce apoptosis in HL-60 celis. (24). On the
other hand, growing evidence demonstrates that oxidants may actualiy prevent apoptosis.
for example, NO-induced apoptosis of macrophages (4), fas-induced apoptosis of T-ceils
(14) and cytokine-mediated apoptosis ofhepatocytes in vivo (1$) were found to depend on
sufficient intracellular glutathione levels. The redox sensitivity of caspases was
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hypothesized to be responsible for the observed protection because of decreased
glutathione levels. In parallel, hepatocyte treatment with °2 was shown to prevent Fas
induced apoptosis.($) Therefore, it stiil remains unclear whether oxidants are pro- or anti
apoptotic. The aim ofthis study was to determine the involvement ofthe major intraceliular
anti-oxidant system, giutathione, in the sensitivity of primary hepatocyte cultures to fas
induced apoptosis.
Since glutathione is known to be very abundant in the liver (9), we wanted to evaluate the
effect of the ccli isolation and culture procedure on GSx levels before determining the
effect of glutathione on apoptosis in culture. Our data show important GSx depletion as a
resuit of ccli isolation and culture. Indeed, isolated hepatocytes cultured in commercial
Williams’ E medium (medium N) for 2h retained only 27 % of their original content of
GSx. Medium supplementation with Cys and Met, while not fully restoring GSx levels to
those in total liver, prevented GSx loss due to ccli culture. In addition, this enriched
medium maintained GSx levels more stable during extended ceil culture as opposed to
medium N since these levels remained twice higher in medium C+M than in medium N
afier 6h of culture in serum-free conditions (data not shown).
GSx represents the sum of cellular content in GSH and GSSG. Since GSH/G$x ratio was
identical in celis cultured in either media (after 2h attachment), the difference in GSx levels
most likely signifies that both GSH and GSSG Jevels diminished. Several studies have
reported that ceils can lose GSH by active extrusion and passive diffusion in addition to its
utilization as a metabolic cofactor. (9;9) In fact, GSH efflux from hepatocytes is the first
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step in the degradation of hepatic glutathione (9). Therefore, glutathione levels can drop
drastically if flot compensated. In parallel, the supply of the three arnino acids that
constitute glutathione is limited in the context of ceil culture. Hence, glutathione synthesis
is expected to decrease over time in culture. Concerning GSSG, ceils convert it to GSH
under normal redox state (over $0 % of GSx being in the form of GSH) and increase its
extrusion under oxidative stress.(9) Therefore, normal culture conditions will result in a net
loss of GSH and GSSG, i.e. G$x. When Cys and Met were added to the culture medium
(medium C+M), Cys supply was increased both directly and indirectly, Met being a
precursor of Cys. This ensures continued glutathione synthesis. In addition, the presence of
Met on the extemal surface of the hepatocyte has been shown to inhibit GSH efflux from
isolated hepatocytes (2;3). Therefore, the stabilization of GSx levels in celi cultures by
medium C+M probably reflects the maintenance of glutathione synthesis and the
attenuation of GSH efflux.
On the other hand, G$HJGSx ratio, which remained stable during ceil isolation and
attachment, declined (17 % drop) over extended period of culture in a similar manner in
medium N and C+M. This drop is indicative of relative GSSG accumulation in the celis.
Therefore, it seems that the processes or mechanisms responsible for GSSG elimination
(reduction to GSH or active GSSG extrusion) lose their efficacy in time. Normally, the
rapid reduction of GSSG to GSH is catalyzed by GSSG reductase, which requires NADPH
as a cofactor (l;28) It could be postulated that alteration ofNADPH availability may affect
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GSH regeneration and consequently promote GSSG accumulation in the celi. Such factors
could participate in the observed decrease of GSHJGSx ratio as a function of culture tirne.
Afier establishing the changes in GSx and G$H/GSx ratio in isolated hepatocytes in
culture, we next evaluated the capacity of Fas to induce apoptosis in mouse hepatocytes
cultured in medium N versus C±M. Our resuits show that ceils cultured in medium C+M
were more sensitive to Fas-induced apoptosis than congeners kept in medium N. Indeed,
following fas receptor stimulation, there was a higher proportion of apoptotic celis and
increased AST and ALT release from ceils cultured in medium C+M in comparison to
those cultured in medium N. This higher sensitivity towards fas-induced apoptosis was not
due to differential expression levels of procaspase-8, Bid or BCL-xL proteins, some of the
key proteins regulating the fas apoptotic pathway. Rather it seems to result from the higher
Fas-induced proteolytic activity of caspase-8 observed in celis cultured in medium C+M as
compared to medium N. In particular, it seems that equivalent proportion of activated
caspases exhibit a more robust catalytic capacity in high G$H/GSx conditions. Indeed, our
in vitro study on fixed amounts of recombinant activated caspase-$ clearly dernonstrates
the negative effect of oxidant (GS$G) on the proteolytic activity of this enzyme. In
parallel, we observed a higher GSH/G$x ratio in medium C+M in comparison to medium
N. This reinforces the hypothesis that lowering celis’ buffering capacity, by GSH depletion
and/or GSSG accumulation, reduces ceil sensitivity towards Fas-induced apoptosis.
As mentioned above, oxidative stress is closely associated with cell death and necrosis.
Consequently, replenishment of anti-oxidants, including glutathione, has been repeatedly
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shown to protect against ceil death. Hence, it seerns contradictory to find that better
preservation of glutathione levels is associated with increased sensitivity towards apoptosis.
However, it is important to point that the liver is naturally sensitive to apoptosis. Indeed,
fas is capable of inducing massive and rapid apoptosis in vivo even in the presence of high
intracellular concentrations of glutathione.(l 7;36) This means that apoptotic signal
transduction and effectors are functional in a reducing environment. In parallel, it is well
documented that hepatocytes in culture acquire resistance against apoptosis.(23;34) Since
there was a drastic decrease of glutathione levels during celi isolation and culture, this
suggests that the decrease in glutathione levels is responsible for the culture-acquired
resistance to apoptosis. This hypothesis is fiirther supported by the strong positive
correlation between GSH/G$x ratio and fas-induced apoptosis. In addition, caspase-8
proteolytic activity, from both human recombinant and ceil lysate sources, directly and
significantly correlated with GSH/GSx ratio. A similar relationship was reported by Hentze
et al. for recombinant activated caspase 3. (17)
Conclusions similar to the present work have been reached in studies conducted by the
groups of Wendel (16;17), Jaeschke (22) and Pessayre (15). These studies showed that in
vivo depletion of glutathione, whether by acetaminophen or phorone administrations,
protected the liver against receptor-induced apoptosis. Collectively, these data therefore
lend support to the concept that GSH depletion and/or relative GSSG accumulation, which
lower the cell’s capacity to buffer against endogenous oxidants, reduce ceil sensitivity
towards receptor-mediated apoptosis. furthermore, resuits from the present study offer
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diminished caspase-8 activity, the apex of Fas/TNFa receptors apoptotic signal, as an
explanation for the acquisition of resistance towards fas-induced apoptosis by hepatocytes
in culture as compared to in vivo conditions.
It is noteworthy that G$H depletion reported in this study occurred very rapidÏy. This lias
an importance at two levels. F irstly, it is well documented that G$H levels play a major
role in mitochondrial fiinction. In fact, mitochondrial GSH/GSSG ratio is a known
modulator of the mega-channel complex, responsible for the mitochondrial transmembrane
potential (1Wm)(7;l2;2l). Therefore, GSH depletion should affect mitochondrial function
and subsequently effectors of the apoptotic pathway. However, mitochondria retain GSH
far more efficiently than the cytoplasm. Indeed, depletion of GSH from the cytoplasrn may
occur very rapidly (t112 = 2h, sec Figure 1 and (29)). On the other hand, it takes more than
30h for the mitochondria to loose haif its GSH content (tj,2 =30h), even conditions of
extreme GSH depletion (29). Therefore, because of the rapid loss of GSH in our
experimental conditions (during isolation procedure and short-terrn culture), there is
potentially flot enough time for the mitochondrial pool of GSH to be affected. This leads us
to postulate that the effect of GSH on Fas-apoptotic pathway is, in fact, exerted on
cytosolic components already present at the time of apoptotic induction. Thus, the rapid
loss of GSH inhibits some of the key eÏements in the apoptotic machinery leading to
protection against apoptosis.
Secondly, Haouzi et al. (15) have recently demonstrated that there is a difference in the
sensitivity of the liver towards apoptosis depending on the length of liver exposure to GSH
GSH and resistance to apoptosis MUSALLAM et al./9$
depletion. Indeed, the authors have reported that long-term GSH depletion accentuated
al)OptOSiS whule acute depletion prevented it. It seems that other mechanisrns enter into
effect in order to compensate for the loss of celi sensitivity towards apoptosis due to the
rapid loss of G$H. Some of these compensatory mechanisms being increased p53 and Bax
protein expression, which are well known pro-apoptotic modulators. Our resuits therefore
provide an explanation for the acute effects of GSH depletion on the sensitivity of
hepatocytes towards apoptosis. The activity of caspase-8 in situations of chronic GSH
depletion would deserve to 5e evaluated.
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CONCLUSION
In conclusion, our resuits clearly demonstrate that glutathione depletion by the isolation
procedure and celi culture is greatly associated with the culture-acquired resistance to
apoptosis. This decrease is related to lower proteolytic activity of caspase-8, which is at the
apex of the fas apoptotic pathway. Therefore, our resuits confirm the importance of
stabilization of intracellular G$x levels for normal cellular function, one of these being the
ability of celis to respond to death signais.
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FIGURE LEGENUS
figttre 1 Effect of ce!! isolation and cttttttre on total gltttatltione (GSx,) levels
G$x levels were measured, as described in Experirnental Procedures, in
total liver (right lobe), afier liver perfusion with collagenase, in purified
hepatocytes and afier 2h attachment in semm-containing medium N
(commercial Williams’ E medium) or medium C+M (Williams’ E medium
supplemented with Cys and Met). The data are presented as nrnol of GSx /
tg of proteins collected afler sample preparation for GSH determination.
Values are depicted as mean + SEM from 5 different experiments.
** p<O.Ol; p<O.001 as compared to total liver; #: p<O.Ol.
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figttre 2 Effect ofmedium N aitd C+M oit fas-induced cet! death
Afier attachment, celis were treated with medium alone (untreated) or
anti-fas antibodies in medium N or C+M. Celi death, as described in
Experimental Procedures, was assessed by morphologie criteria using
Hoechst 3325$ after 6h (panel A; n = 5) or biochemical analysis by
quantitative determination of Fas-induced release of AST and ALT
(presented as % of untreated celis) in the medium afier 24h (panels B and
C respectively; n = 8). Results are presented as mean ± SEM. Differences
between groups (panel B) were analyzed by paired t-test * : p<O.O5;
** :p<O.Ol.
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figttre 3 Effect ofinedium N and C’+Mon tite expression tei’ets ofprocapsase-8,
Bid and B(’L-xL proteuis
Hepatocytes were collected afier 0, 0.5, 1 and 3h post-attachment in either
medium N or C+M. Samples (n = 5) were analyzed on 15 %
polyacrylamide gel. Membranes were then blotted for procaspase-8 (57
KDa; paner A), Bid (23 KDa; panel B) and BCL-xL (29 KDa; panel C)
proteins with the appropriate antibody as described in Experimental
Procedures. Actin (42 KDa) was used as control for equal protein loading.
The data are presented as mean ± SEM. Representative blots are shown.
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figitre 4 Effect of medium N and C+M on fas-induced caspase-8 activation
Afier attachment, ceils were incubated with medium alone (untreated) or
with anti-Fas antibodies [250 ng/mI] in medium N or C+M for 3h. Celis
were then scraped off and caspase-8 proteolytic activity was measured in
these samples (200 jig proteins; n = 6) using a fluorometric-substrate
(IETD-AMC) based assay, as described in Experimental Procedures.
Resuits are presented as mean of activated units of caspase-8 + SEM.
** p<O.Ol.
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figure 5 Effect of extended tirne in culture on G$x, and GSH tevels as wetl as
GSH/GSx ratio in ceils cultured in medium C’+M
The ÏeveÏs of GSx and GSH (panel A) and GSH/GSx ratio (panel B) were
measured either directly afier or 6h afier attachrnent in celis cultured in
medium C+M. Data obtained (mean ± SEM) from 5 experiments are
presented. * p<O.O5.
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figure 6 Effect of tirne in cidttire on fas abitity to i,tdttce caspase-8 activation
autd apoptosis in meditum C+M
(A) Ceils cultured in medium C+M were treated with medium alone
(untreated) or anti-Fas antibodies [250 ng/rnl] either directly afier
attachment or 6h later. 3h post-treatment, samples were collected to
measure caspase-$ activity as described in Experimental Procedures.
Resuits are presented as mean of activated units of caspase-8 ± SEM
(n = 6). Quantitative determination of AST (B) and ALT (C) released
(performed afier 24h of culture) was used to evaluate the capacity of Fas
to induce ceil death in hepatocytes treated with anti-Fas either shortly (30
mm) after attachrnent or 6h later. Resuits (mean ± SEM) from $
experiments are presented. Differences between groups (panel B & C)
were analyzed by paired t-test. ** p<O.Ol.
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figure 7 Modulation oftlte protease activity ofhurnan recombinant activated
caspase-8 by GSH/GSx ratio
Human recombinant activated caspase-8 (30U/well) was mixed with assay
buffer containing 5mM GSx with varying ratios of GSHIGSx. The
protease activity was measured using a fluorometric-substrate (IETD
AMC) based assay. Data (n = 6) are presented as mean of activated units
ofcaspase-$ ± SEM.
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ABSTRACT
The apoptotic fas pathway is potentially involved in the pathogenesis of liver diseases.
Growth factors, such as epidermal growth factor (EGF), can protect ceils against apoptosis
induced by a variety of stimuli, including fas receptor (fas-R) stimulation. However, the
underlying mechanisms of their protection have yet to be determined. We investigated the
involvement of EGF receptor (EGf-R) tyrosine kinase (TK) activity in the anti-apoptotic
effect of EGF on primary mouse hepatocyte cultures. Celis undergoing apoptosis following
treatment with anti-fas antibody were protected by EGf treatment. This protection was
significantly but partially decreased when cells were treated with two specific inhibitors of
the TK activity of EGf-R. Evaluation of the efficacy of these compounds indicated that
they were able to abolish EGF-R autophosphorylation and post-receptor events such as
activation of mitogen-activated protein kinases and the phosphatidylinositol 3-kinase
pathways as well as increases in BCL-xL mRNA and protein levels. This leads us to
postulate that EGF exerts its anti-apoptotic action partially through the TK activity of EGf
R. In addition, our resuits suggest that BCL-xL protein upregulation caused by EGF is
linked to the TK activity of its receptor.
Key words: Apoptosis, fas, BCL-xL, receptor autophosphorylation, inhibitors of receptor
tyrosine kinases.
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underlying mechanisms of this effect remain poorly understood (22;35;44;67). Several
studies have correlated the anti-apoptotic effect of Gf with increased expression of anti
apoptotic BCL-2-like proteins (2;24;35). However, it stili remains unclear whether these
proteins represent the major component of GF protection or whether other mechanisms
exist.
GF signaling is mediated through enzymatic receptors that possess intrinsic tyrosine kinase
(TK) activity. In response to the binding of their ligands, these receptors become
oligomerized and then phosphorylated on specific tyrosine residues by their own catalytic
activity (4;30;54). This phosphorylation leads to the activation of different intracellular
pathways, such as mitogen-activated protein kinases (MAPK) and phosphatidylinositol 3-
kinase (PI 3-K), which mediate the biological effects of GF (17;39). For several Gf, a
number of studies have demonstrated that both the oligornerization (15;25;28;30) and the
autophosphorylation (29;3$;43) oftheir receptors are necessary for the transmission oftheir
signal. On the other hand, it was reported recently that mutation of the TK domain of c-met
(the receptor of HGF) did flot abrogate the anti-apoptotic effect of HGf (5).
Therefore, we investigated the involvement of EGf-R TK activity in the protection against
Fas-induced apoptosis afforded by EGF to primary cultures of mouse hepatocytes. To
achieve this aim, we used specific inhibitors of the TK activity of the EGF receptor (EGF
R), such as PD168393 (1$) and Tyrphostin AG1478 (37). We report that the anti-apoptotic
effect of EGF requires, at least in part, the function of EGF-R catalytic activity. Moreover,
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INTRODUCTION
The phenomenon of ceil death by apoptosis is essential flot only for the proper developrnent
of multiple systems and organs during embryogenesis (for example, through the
elimination of seif-reacting lymphocytes and the formation of digits) but also for the
maintenance of adult tissue homeostasis (34;54;66). Given the widespread involvement of
apoptosis, its potential role in several pathologies, including degenerative and autoimmune
diseases, is not surprising (42;66). The pathogenesis of several liver diseases, such as
hepatocellular carcinoma and alcoholic liver disease, specifically implicates abnorrnal
apoptotic regulation (20;21;27;46;49). In addition, several studies have reported a marked
increase in apoptosis in viral infections like hepatitis C (3) and B (59).
One of the apoptotic-inducing mechanisms that has been especially linked to hurnan liver
diseases is the celi-surface death receptor Fas (Fas-R), since it is constitutively expressed
on hepatocytes (1O;16;21;45). fas-R induces apoptosis by activating intracellular effectors
such as caspases (19;31) and endonucleases (6;12) and by recruiting pro-apoptotic proteins
ofthe BCL-2 farnily (32;47). This family is divided into pro- (e.g. Bax, Bad, Bik) and anti
(e.g. BCL-2, BCL-xL, BAG-l) apoptotic proteins that, respectively, facilitate and inhibit
apoptosis (51 ;65).
It is well established that growth factors (Gf), such as epidermal growth factor (EGf),
nerve growth factor (NGF) and hepatocyte growth factor (HGf), are capable of protecting
various ceil types against apoptosis induced by different apoptotic agents, although the
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this activity is responsible for the upregulation of BCL-xL protein observed following EGf
treatment.
EGF receptor anti-apoptotic signalling MUSALLAM et al./127
MATERIALS AND METHOD$
Ail animais received humane care according to the guidelines of the Canadian Council on
Animal Care. Experimental protocols were approved by the Comité institutionnel de
protection des animaux ofthe CHUM-Hôpital Saint-Lue.
Hepatocyte isolation and culture
Hepatocytes were isolated from the liver of fed male BALB/c mice (22-25 g) using the 2-
step collagenase perfusion method described by Guguen et al. (23) with sorne
modifications. Afier the induction of anesthesia with sodium pentobarbital (400 mg/kg
intraperitoneaïly), the peritoneai cavity was opened, and the liver was perftised in situ via
the portai vein for 4 min at 37°C with calcium-free Hepes buffer and for 7 min with Hepes
buffer containing 45 mg % (wlv) Collagenase D (Boehringer-Mannheim, Lavai, QC.
Canada) and 135 mg % (wlv) CaC12. The perfusion rate was set at 5 ml/min for both
solutions. The ceils were used only if celi viability, as determined by trypan blue exclusion.
was higher than 80%. The ceils were seeded onto plastic petri dishes (26,000 cells/cm2) in
Williams1 E medium (GIBCO BRL, Toronto, ON, Canada) supplemented with 10% fetal
bovine semm (GIBCO BRL) and allowed 90 min to attach. The serum-containing medium
was then removed, and the cells were subjected to different culture conditions in serum-free
media. In control groups, ceils were incubated with medium alone for the indicated tirne of
the experiment. Apoptosis was induced in experimentai groups with mouse anti-Fas Jo2
antibody (250 ng/ml, Pharmingen, Mississauga, CA, USA). The anti-apoptotic effect of
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EGF was studied by simultaneously incubating the celis with 50 ng/rnI of EGF (Sigma.
Oakville, ON, Canada) and the anti-Fas antibody.
Determination ofPD1 68393 and Tyrphostin A G14 78 workbig concentrations
The TK activity ofEGF-R was inactivated by the use of 2 specific inhibitors : a) PD16$393
(10 jiM, Cedarlane Laboratories; Homby, ON, Canada) and b) Tyrphostin AG1478 (25
tM, Sigma). As PD168393 is an irreversible inhibitor {236}, its working concentration
was determined by a dose-response curve where ceils were incubated with EGF alone or in
the presence of different concentrations of this inhibitor for 10 mm, then assayed for EGf
R phosphorylation (see below): total inhibition was obtained at 10 jiM (data flot shown).
On the other hand, Tyrphostin AG1478 is a reversible inhibitor. Consequently its working
concentration must insure complete inhibition over long-term incubation. Therefore, in
addition to the dose-response curve, we conducted time-course experiments in which ceils
were treated with EGf in the presence or the absence of different concentrations of
Tyrphostin AG1478 for 10 mm, 1 h, 4 h and 8 h. The dose-response curve of Tyrphostin
AG147$ indicated that complete inhibition of EGF-R autophosphorylation was obtained at
2.5 jiM (data flot shown). However, time-course experiments revealed that the inhibition
produced by this concentration was not continuous over time (figure 1). Therefore, to
obtain complete and continuous inhibition of the TK activity of EGF-R over long periods
of incubation, it was necessary to use 25 tM Tyrphostin AG1478. No evidence of celi
toxicity was found at this concentration.
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Morphotogicat determination ofapoptosis
Afler 24 h in culture, the medium was removed, and petri dishes were washed once with
phosphate-buffered saline (PBS). The cells were fixed with 3% paraformaldehyde solution
(pH 7.4, Sigma) for 20 min at room temperature, and then washed with P35. To quantify
apoptosis, hepatocyte nuclei were stained with Hoechst 33258 (250 ng/ml, Sigma) for 15
mm, petri dishes were then washed with distilled water and lefi to dry at room temperature
in the dark. Hoechst 33258 fluorescence vas visualized under a microscope (BX5OF,
Olympus Optical Co., Japan) equipped with ultraviolet epifluorescence using excitation and
emission filters of 355 and 465 nm respectively. When stained with this dye, normal
hepatocyte nuclei appear homogenous and intact, as opposed to apoptotic nuclei which are
condensed, fragmented and very bright (63). The percentage of apoptotic ceils is expressed
as the ratio of apoptotic nuclei versus the total number of nuclei (normal + apoptotic). 400
nucÏei were evaluated for each petri dish.
Biochernicat determination of cet! death
Alanine aminotransferase (ALT) is an enzyme normally present in the cytosol of
hepatocytes. In response to celi damage (necrosis or late-stage apoptosis), ALT is released
from the celis. Therefore, to determine ceIl death, we measured ALT levels released in the
medium afier 24 h in culture. In order to do this, the medium was collected to measure
ALT activity. The adherent cells were then scraped off in ice-cold P35. Both solutions
were sonicated then quantitative determination of ALT activity was performed by the
Hôpital Saint-Luc Biochemistry Department with an automatic multi-analyser. ALT levels
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for each sample was calculated as the ratio of ALT present in the medium versus the sum
ofthe levels of ALT released in the medium and that present in the celi homogenate.
h;;rnttnoblotting
Ccli lysis : Based on the resuits of time-course experiments, it was determined that EGF-R
and MAPK phosphorylation assays be performed afier 1-h incubation. AKT
phosphorylation peak, on the other hand, was at 5 min. The expression of BC1-xL protein
was evaluated afier 24 h in culture. At the end ofthe experiment, the medium was rernoved
and the cells were washed once with ice-cold PB$. Celis were then scraped off and pelleted
by centrifugation. Ceils were subsequently disrupted by sonication (Sonic & Materials.
Danbury, CT, USA) in the presence of lysis buffer [25 mM MOPS, pH 7.2; 60 mM f3-
Glycerophosphate; 15 mM 4-Nitrophenylphosphate; 1 mM Phenylphosphate; 1 mM
Sodium Orthovanadate; 2 mM Dithiothreitol (DIT); 1 mM Naf; 15 mM EGTA; 15 mM
MgC12; 10 jig/ml leupeptin, 10 j.ig/ml aprotinin; 10 tg/m1 soybean trypsin inhibitor and 100
tM benzamidineJ. Protein concentration was determined according to Bradford (7).
Western BIot (53): Proteins samples (75 jig) were separated by electrophoresis on 7%
(EGf-R and Akt) or 12% (MAPK and BCL-XL) sodium dodecyl sulfate (SDS)
polyacrylamide gels, then transferred electrophoretically ovemight to HYBOND-ECL
nitrocellulose membranes (Amersham Pharmacia Biotechnology, Baie D’Urfée, QC.
Canada). Afier transfer, equal protein loading was assessed by staining the membranes with
Ponceau S (Sigma). Blots were probed with primary antibodies for 2 h, then with secondary
antibodies for 1 h, both at room temperature with gentie agitation. To determine the levels
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of Akt, of MAPK and of EGF-R phosphorylation, blots were incubated respectively with
rabbit polyclonal anti-phospho $er473 Akt (1:1000; New England Biolabs, Mississauga,
ON, Canada), mouse monoclonal anti-phospho ERK (1 tg/ml; E-4, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and anti-phosphotyrosine (1 ig/ml; PY2O, Santa
Cruz Biotechnology) antibodies. BCL-xL protein expression was detected with mouse
monoclonal anti-BCL-x antibody (Transduction Laboratories, Lexington, KY, USA) used
at a concentration of 1.5 jig/ml. The activity of secondary anti-mouse IgG antibodies
(1:2000) coupled to aikaline phosphatase (Santa Cruz Biotechnology) was revealed by
4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indoyl-phosphate reagents
(Boehringer- Mannheim). Peroxidase-conjugated anti-rabbit IgG (1:5000) activity was
revealed using Western Blot Chemiluminescence Reagent Plus (NENTM Life Science
Products, Boston, MA, USA). Blots were then scanned and bands were quantified by
densitometry.
H3 32P04 incorporation into motise Itepatocytes in ctt!tttre:
Ceils were attached onto 35 mm petri dishes (26,000 cells/cm2) for 90 min as described
above. After cell attachment, the serum-containing medium was removed and ceils were
incubated with phosphate-free Minimal Essential Medium (GIBCO BRL) supplemented
with sodium pyruvate (25 mg/L; Sigma) for 10 min at 37°C then H3 32P04 was added
(30 iCi/petri; ICN Biochemicals, Irvine, CA, USA) for 1h-incubation at 37°C. The
medium was removed and ceils were washed once with Williams’ E medium (37°C). The
celis were incubated with 1 ml lysis buffer on ice for 30 min Cerenkov radiation was
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quantitated in 200 !il of this homogenate using a f3 radiation counter. Proteins were
precipitated from this homogenate by addition of 10% sulfosalicilic acid (1:1) then
resuspended in distilled water before protein concentration was detenTlined according to
Bradford.
Reverse-transcriptase potymerase chain reaction (RT-PCR):
RNA preparation: Samples for RT-PCR were prepared from ceil cultures treated with
medium alone or EGF with or without PD16$393 for 6 h. Total RNA cellular content was
isolated by Trizol® LS reagent (GIBCO BRL) according to manufacturer’s
recommendations. Briefly, ceils (26,000 cells/cm2) were homogenized with 2.25 ml Trizol®
LS reagent. The aqueous phase containing total RNA was obtained by adding chloroform
to the homogenate solution in 1:5 volume then separated by centrifugation at 12 000 g at
4°C. To precipitate RNA present in this phase, isopropanyl alcohol was added (1:1) and the
resulting solution was incubated for 10 min at room temperature then centriftiged at
12 000 g at 4°C. The pellet was washed once in 75 % ethanol then resuspended in diethyl
pyrocarbonate (DEPC)-treated water. RNA was then purified by Rnase-ftee DNase-1
(0.5 UIpJ; Roche Diagnostics, LavaI, Qc) treatment for 1 h at 37°C in a buffer containing
RNase inhibitor (0.1U/pi; Roche diagnostics), 10 mM Tris (pH 8.3), 50 mM KC1 and 1.5
mM MgC12. The purified RNA was extracted by phenol/chloroform treatment and
precipitated with 95 % ethanol and 0.3M sodium acetate. The pellet was washed once in
75 % ethanol then resuspended in DEPC-treated water. RNA yield was determined by
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measuring absorbance of an aliquot of each sample in distilled water at 260 and 280 nrn.
RNA concentration was calculated as follows:
dilution
factori
RT-PCR: PCR primers were made against mouse BCL-xL and 1 $s ribosomal protein
sequences with oligonucleotide primers designed using the PRIMER program (Genetic
Computer Group, Wisconsin) and synthesized by the Sheldon Center (McGill University,
Montréal, Qc). The forward and reverse primers were, respectively: BCL-xL: 5’-
ATGGCAGCAGTGAAGCAAG-3’ and 5’-GCAATCCGACTCACCAATACC
-3’; Y8S:
5’-TACCTGGTTGATCCTGCAGTA
-3’ and 5’-AATGGATCCTCGTTAAAGGATT
-3’.
RNA (1tg) was mixed with lOmM Tris (pH 8.3), 1 mM MgC12, 50 mM KC1, lOOg/ml
BSA, 100 jtM dNTPs, 1 iM primers, 1 OOU/ml RNase inhibitor, 125 U/ml AMV reverse
transcriptase, 20 U/ml Taq polymerase and 20tCi/rnl [Œ-32P] dCTP for a total reaction
volume of 50 j.il. Reverse transcriptase reaction was conducted at 50°C for 15 min followed
by 3 min at 95°C. PCR was conducted at 95°C for 30 sec, 59°C for 45 sec and 72°C for 90
sec. BCL-xL and 18s were amplified, respectively, for 23 and 15 cycles. These
amplification conditions were determined by a kinetic study for each set of primers to
ensure that PCR products remain proportional to initial gene expression template.
following PCR reaction, samples were electrophoresed on 8 % polyacrilamide gels, dried
and Cerenkov radiation in excised band was quantitated using 13 radiation counter.
0.01
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Statisticat anatysis
Ail data represent the values of at least 3 experirnents, each from different ccli isolation.
Differences between groups were anaiyzed by one-way analysis of variance (ANOVA) for
repeated measures (unless stated otherwise). A p value below 0.05 was considered
signifi cant.
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RE$ULTS
EGFprotects primaiy rnottse hepatocyte cttttttres against fas-induced apoptosis
Our control cultures displayed minimal levels of apoptosis (< 1%), even though they
remained without semm for 24 h, as iliustrated in Figure 2. However, hepatocyte
incubation with a monoclonal antibody specific for mouse Fas-R (Jo2 clone) induced a
significant increase in the level of apoptotic celis (21.9%±3.8; p<O.001). The percentage of
apoptotic celis was significantly lower when hepatocytes were simultaneously incubated
with EGF and anti-fas (5 .0%± 1.1; p<O.001) than with anti-Fas alone, confirming that this
GF is capable ofprotecting mouse hepatocytes against Fas-induced apoptosis, as previously
reported by our laboratory (13).
EGR-R catatytic activity ivas effectivety iizhibited by TK inhibitors
As stated above, the TK activity of GF is important for the transmission of their signal in
various ccli types. However, several unes of evidence suggest that the TK activity of GF
receptors (GF-R) may not be essential for ail GF effects. To test the involvement of EGf-R
TK activity in the anti-apoptotic effect of EGf, we assessed the content of EGF-R in
phosphotyrosine in the absence and presence of two specific inhibitors of EGf-R catalytic
activity: PD168393 and Tyrphostin AG1478. We used anti-phosphotyrosine antibodies to
detect the activated EGF-R since GF-R phosphorylates itself on tyrosine residues following
ligand binding. The putative EGf-R was detected at 170 kDa as reported in the literature
{27$}. Its content in phosphotyrosine afier 1 h of EGF addition significantly increased as
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compared to control untreated cultures (23.5±3.8 vs 3.25±0.5 arbitrary units (a.u.)
respectively; p<O.00l; figure 3) indicating increased TK activity. When cell were treated
with EGF in the presence of PD168393, EGf-R displayed similar phosphotyrosine content
(4.0±1.2 a.u.) as that of EGf-R in untreated cells (4.0±1.1 a.u.; ns; figure 3), indicating
effective inhibition ofEGF-R TK activity by PD16$393. Similar resuits were obtained with
Tyrphostin AG1478 (25 iM; data not shown). In addition, to insure the absence ofresidual
EGf-R TK activity, we assessed FI3 32P04 incorporation into mouse hepatocytes after 1h
treatment either with EGf alone or in the presence of both EGf and either inhibitor. As
shown in Table 1, both inhibitors successfuÏly prevented the EGF-induced increase in
FI3 32P04 incorporation (p<0.01).
EGf-R dowitstream signatiitg is btocked by TK btltibitors
Ceils treated with GF display increased activation of several intracellular signaling
pathways (e.g. ERK pathway of MAPK family and PI 3-K pathway) and increased
synthesis of growth and survivai promoting proteins (e.g. BCL-xL). Therefore, in order to
ascertain that EGF-R signal was flot transmitted via the TK activity of EGF-R in the
presence of 1K inhibitors, we used western blot analysis to measure 1) the phosphorylation
(and therefore the activation) of two signal transduction pathways using phospho-specific
antibodies against p42/p44 (ERK) and Akt (PI 3-K) proteins, and 2) the level of expression
of the anti-apoptotic protein BCL-xL. Ail these experiments were perforrned in untreated
celis and in cells treated either with or without EGf in the presence of the inhibitors.
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1) Signal transduction pathways: Celi treatment with EGF increased basal
phosphorylation levels of p42 (p<O.O5; figure 4A), and of p44 (p<O.O5; data flot
shown) by 2 fold and induced the phosphorylation of Akt on $er473 (p<0.00l; Figure
4D). Ceil treatment with PD16$393 (Figure 4A+D) or Tyrphostin AG147$ (data flot
shown) abolished EGF-induced increase in p42144 and Akt phosphorylation (p<0.0l)
strongly suggesting that EGF-R signal was flot transmitted into the celi neither tlwough
the ERK nor the PI 3-K pathways in the presence ofthese inhibitors.
2) BCL-xL rnRNA and protein expressions: BCL-xL protein, a known homologue of the
BCL-2 anti-apoptotic protein, is constitutively expressed in hepatocytes. As already
observed in our laboratory (14), the level of BCL-XL mRNA expression in untreated
mouse hepatocytes (57.75±5.4 a.u.) increased by 30 % in EGf-treated ceils
(74.5±7.6 a.u.; p<O.Ol; figure 4B). As a consequence, BCL-xL protein expression level
was doubled following EGF treatment (17.1±0.2 vs 33.7±5.9 a.u. for untreated vs
EGF-treated cultures respectively; p<O.O5; Figure 4C). PD16$393 slightly increased
basal BCL-xL protein cellular content in untreated celis, but this effect was flot
significant (22.4±1.4 vs 17.1±0.2 a.u. for PD168393-treated vs control celis
respectively; ns). Cell treatment with EGF in the presence of 10 tM PD168393 totally
blocked EGF-induced elevation in BCL-xL mRNA in comparison to control conditions
(57.75±4.9 vs 74.5±7.6 a.u. respectively; p<O.Ol; figure 4B). This was confirmed by
protein expression (19.4±2.6 vs 3 3.7±5.9 a.u. respectively; p<O.05; Figure 4C). f inally.
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treatment with this inhibitor prevented celi spreading, a characteristic morphofogical
change ofEGf-treated celis (figure 5).
Taken altogether, these resuits establish the efficacy of PD 162393 and Tyrphostin AG147$
as inhibitors of EGF-R TK activity and its downstream signaling events. Therefore, these
compounds represent adequate tools to study the implication of the catalytic activity of
EGf-R in the anti-apoptotic effect of EGf.
Inhibition ofEGf-R TK activity diminishes the anti-apoptotic efftct ofEGf
The level of apoptosis in anti-f as+EGf-treated cultures was significantly increased by
PD16$393 addition as illustrated in Figure 6A (13.4%±3.4 vs 44.$%±1.O for control vs
PDÎ 62393 respectively; p<O.OS). Interestingly, however, addition of this inhibitor did flot
fully abolish EGf protective capacity against fas-induced apoptosis (p<O.O 1). This
phenomenon was also observed when we measured the level of ALT released in the
medium. Indeed, PD168393 addition significantly increased ALT levels in the medium of
anti-Fas+EGf-treated cultures (84.2%±5.2) as compared to control anti-fas+EGf cultures
(52.1 %±9.3; p<O.Ol; figure 6B). Nonetheless, medium ALT levels of cultures treated with
anti-fas and EGf in the presence of PD168393 remained significantly lower than in
cultures treated with anti-fas alone (p<O.05). Similarly, EGf provided partial protection to
mouse hepatocytes against fas-induced apoptosis in the presence of Tyrphostin AG1478
(figure 6C). It is important to point out that treatment of primary mouse hepatocyte
cultures with PD168393 or Tyrphostin AG1478 did not significantly affect the level of
apoptosis in untreated or anti-fas-treated cultures (data not shown).
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Taken altogether, these observations strongly suggest that, in spite of the potency and
efficacy of the inhibitors that we established above, the presence of either inhibitor caused
only a partial decrease in the ability of EGF to protect mouse hepatocytes against Fas
induced apoptosis.
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DISCUSSION
Growth Factors (such as EGf, HGF and NGf) are essential for several celi flinctions,
including proliferation, differentiation, and survival (1). Therefore, several investigators
have focused their studies on the identification and characterization of the intracellular
effectors involved in the execution of GF biological responses in various celi types. Hence,
a general model regarding the mode of action of Gf was elaborated (26;6$) $ the interaction
of Gf with their receptors induces the oligomerization of the latter and, consequently,
activates the 1K domain of the same receptor. This domain was shown to be responsible
for the phosphorylation of the receptor itself on specific tyrosine residues, which then serve
as docking sites for $H2-containing molecules such as Grb2 and PI 3-K. These molecules
lead to the activation of several intracellular pathways (such as MAPK, PLCy and PI 3-K)
which consequently mediate the diverse biological responses ofGf (l7;39;40;50;62). Thus,
according to this hypothesis, the 1K activity of GF-R plays a central role in the
transmission ofthe GF signal.
Nevertheless, there have been some conflicting reports regarding the importance of this
activity and of the subsequent receptor autophosphorylation in the mediation of some of the
biological functions of GF. $everal studies have indeed reported that the 1K activity of Gf
R is required for the transmission of biological responses such as proliferation and gene
transcription (29;3$;43;68). On the other hand, evidence has accumulated to show that
some GF effects may occur independently of the 1K activity of their receptors. for
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instance, Schreiber et al. have reported that cross-linking of celi-bound monoc’onal EGF-R
antibodies resulted in the clustering of the receptor and the stimulation of DNA synthesis
without activation ofthe TK domain ofthis receptor (55). Therefore, the aim ofthe present
study was to determine the importance of the EGf-R TK activity in the anti-apoptotic
effect ofEGf.
We first examined the effect of EGF on normal and fas-stimulated mouse hepatocytes in
primary cultures. EGF addition to fas-treated cultures protected more than 70 % of mouse
hepatocytes susceptible to fas-induced apoptosis. This protection occurred in parallel with
increased EGf-R phosphotyrosine content as well as MAPK and Akt phosphorylation. In
addition, EGF treatment increased the cellular content of BCL-xL mRNA and protein
suggesting the implication of this protein in the anti-apoptotic effect ofEGF.
It is important to point out that Fas-R stimulation had no influence on either baseline levels
or EGF-induced levels of EGF-R, p42/p44 and Akt phosphorylation (data not shown). In
addition, fas-induced apoptosis in primary mouse hepatocytes cultures was shown by our
laboratory to occur without any modulation of BCL-xL protein expression since fas-R
stimulation had no significant effect on BCL-XL mRNA and protein levels (14).
The involvement of the TK activity of EGF-R in the anti-apoptotic effect of EGF was then
tested using two inhibitors of this activity : PD168393 and Tyrphostin AG147$. As
previously reported (1 $;52), these compounds selectively inhibit the TK activity of the
EGf-R by competing for its substrate subsite. Consistent with this fact, the findings of the
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present study demonstrate that these inhibitors did flot affect the basal state of any of our
tested parameters. Indeed, PD168393 and Tyrphostin AG1478 addition to the culture media
of untreated cultures had no significant effect on either overali H3 32P04 incorporation into
the ceils (see Table 1) nor on basal MAPK and Akt phosphorylation levels (figure 4A and
D respectively). In addition, the level of apoptosis in untreated and fas-treated cultures was
flot significantly affected when these inhibitors were present (data not shown). Therefore,
these resuits clearly indicate that PD16$393 and Tyrphostin AG1472 have no direct effect
on other kinase activities in mouse hepatocytes. Consequently, these compotinds represent
adequate tools to selectively inhibit the TK activity of EGf-R. In addition, their use
permitted us to utilize normal mouse hepatocytes instead of celi unes transfected with
mutated receptors, and thus alÏowed us to test conditions close to physiological settings.
In addition to being selective, these inhibitors are efficient. Indeed, ccli treatment with
either compound completely abolished EGF-induced 1) EGf-R autophosphorylation, 2)
p42/p44 (ERK) phosphorylation 3) Akt (PI 3-K) phosphorylation, 4) BCL-xL protein
expression, and 5) FI3 32P04 incorporation into ceils. Their effect was observed irrespective
of the presence of pro-apoptotic fas-R stimulation (data not shown). Therefore, these data
strongly demonstrate that, in our experimental conditions, no residual TK activity (and
consequently no TK-dependent EGF-R signal) could be detected in the presence of these
inhibitors.
However, in spite of these observations, we were surprised to find that EGf-induced anti
apoptotic effect, even though significantly reduced by both TK inhibitors, was not
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completely abolished. Indeed, we found that the level of apoptotic celis was higher in anti
fas+EGf-treated cultures in the presence of PD168393 (by at least 35 %) and Tyrphostin
AG1478 (by 50 %) as compared to control fas+EGf-treated cultures. This level, however,
neyer reached that observed in fas-treated cultures, indicating that some of EGF protective
signal stili passes through into the cell in the presence of these inhibitors. Therefore, our
results strongly suggest that part of this protection is not related to the 1K activity of EGf
R.
Several studies have shown that the TK activity is important for the anti-apoptotic effect of
Gf. for instance, it was demonstrated that an IGF-1 receptor lacking a ftinctional ATP
binding site provided no protection from apoptosis (4$). In addition, it was reported that
Tyrphostin AG1478 was able to negate the anti-apoptotic action of EGf in a human
bladder carcinoma ceil une: transformed ceils that express high levels of EGf-R (8). Here
we report that EGf anti-apoptotic signal requires, at least in part, the catalytic activity of
EGf-R to be able to modulate certain celi death pathways. This modulation would probably
be mediated through the well established TK-dependent signaling cascades such as MAPK
and P13-K, which either induce the activation of survival-promoting proteins (i.e. BCL-x1
protein), the down-regulation of pro-apoptotic proteins (i.e. Bid and Blk (14)) or simply
their inactivation (i.e. P13-K—mediated suppression of caspase-9 activation (33;64) or Bad
protein inactivation by phosphorylation following Gf treatment (9;69)).
However, contrary to the above-cited studies, we found that part of EGF anti-apoptotic
response persisted independently of the 1K activity of the receptor. As mentioned earlier,
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there are precedents to anti-apoptotic signal transduction being independent from the
catalytic activity of Gf-R. Indeed, Bardelli et al. have reported that mutation of HGf-R in
its catalytic domain did flot affect HGf protective effect (5). More interestingly, partial
involvement of the TK domain in the anti-apoptotic effect of a Gf was previously
reported: Dews et al. have demonstrated that mutation of IGF-1 receptor in its TK domain
resulted in reduction of the anti-apoptotic action of IGf- 1, without completely abolishing it
(11). Here we report similar observations for EGf-R in primary mouse hepatocyte cultures.
To date, these TK-independent pathways have flot been identified. However, in an attempt
to understand these processes, it is important to remember that following Gf binding to
their receptors, another important initial event occurs; that is, receptor oligornerization.
This phenomenon of receptor association and subsequent conformational changes may
favor interactions between certain intracellular proteins in a manner that would link the
oligomerized receptor to certain effectors of the anti-apoptotic machinery. Bardelli et al. (5)
have indeed proposed that the anti-apoptotic protein BAG-1, a cytoplasmic protein ofthe
BCL-2 family expressed in many celi types including hepatocytes (5;14;60), may play a
role in these interactions. This group lias shown that BAG-1 is capable of interacting with
the cytoplasmic domain of 0F-R through its C-terminus (5) independently of the 0F-R
phosphorylation state. At the same time, the BAG-1 N-terminus (which contains a
ubiquitin-like domain) lias been implicated in the mediation of protein-protein interactions
(61). It is known that only full BAG-1 protein is capable oftransmitting the anti-apoptotic
signal of certain GF (61). Hence, with such functional and structural properties, BAG-1
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(and other BAG- 1 -like proteins) may link Gf-R with intracellular anti-apoptotic effectors
without the need for Gf-R autophosphorylation.
Another interesting point is raised by our observations. We showed that BCL-xL protein is
upreguÏated by EGf treatment only when TK activity of its receptor is functional and that
this increase was also observed in fas+EGF-treated cells (14). Expression of BCL-2-like
proteins by gene manipulation (overexpression) lias been shown by many to 5e sufficient to
protect ceils against apoptosis induced by different stimuli (2;56;57). For instance, it was
reported recently that overexpression of the B CL-2 transgene was able to protect mouse
hepatocytes against apoptosis induced by fas-R stimulation (36). However, our
observations suggest that it might ;iot be the sole anti-apoptotic pathway activated by the
EGf signal. Indeed, BCL-xL levels did flot increase when hepatocytes were treated with
EGf-R TK inhibitors, yet part of EGF protection persisted. Some investigators have also
observed that overexpression of BCL-2 and BCL-xL proteins did not abrogate Fas/Tumor
necrosis factor Œ (TNFŒ)-induced apoptosis, but protected the sarne celi types against
radiation- (5$) or glucocorticoid- (41) induced apoptosis. Therefore, protection against
apoptosis can occur without the invoïvement of BCL-2-like proteins. In the present study,
we focused on the protective effect of EGf against fas-induced apoptosis in primary
mouse hepatocytes cultures. Therefore, our resuits lead us to postulate that when BCL-x1
protein is increased in physiological settings in mouse hepatocytes, it represents one of
several key constituents of the intracellular anti-apoptotic machinery.
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CONCLUSION
In conclusion, our studies clearly showed that the protection afforded by EGf against
Fas-induced apoptosis is mediated, at least in part, through intracellular mechanisrns that
depend on the TK activity of EGf-R (receptor autophosphorylation, MAPK and PI 3-K
activation, as well as BCL-xL protein increase). Nevertheless, our resuits strongly suggest
that part of EGf-R signal might be transrnitted into the ceil independently of these
mechanisms.
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FIGURE LEGENDS
figure 1 Effect Kinetics ofEGf-R phosphoiytation in mouise hepatocytes treated
with EGf in tite absence andpresence of Tyrphostin AG1478
Primary mouse hepatocyte cultures were incubated with EGf [50 ng/mlj
alone or in the simultaneous presence of 2.5 iiM or 25 iiM Tyrphostin
AG1478 for 10 mm, 1 h, 4 h and 8 h. The ceils were then scraped off,
lysed and assayed for EGf-R phosphorylation, as described in Materials
and Methods.
++
+
+
EGF receptor anti-apoptotic signalling MU$ALLAM et al./161
00 +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
Ir
Li
E-.
‘-4
E
C
EGf receptor anti-apoptotic signalling MU$ALLAM et al./1 62
figttre 2 Anti-apoptotic effect oJEGF on primaiy mouse hepatocyte cultures
subjected to Fas receptor stimulation
Afier attacliment, mouse hepatocytes were treated with medium alone
(untreated ceils), with anti-Fas [250 ng/ml], with EGf [50 ng/ml] or with
anti-fas and EGF simultaneously. Afier 24 h in culture, apoptosis was
assessed by microscopy, as described in Materials and Methods, using
Hoechst 3325$. Data obtained (means ± SEM) from 7 experiments are
presented. p<O.00l.
EGF receptor anti-apoptotic signaïling MUSALLAM et al./163
I
35
30
25
20.
15.
10.
n
Untreated EGF anti-Fas anti-Fas
+EGF
EGf receptor anti-apoptotic signalling MUSALLAM et al./1 64
figure 3 Effect PD168393 oit EGf-R phosphorytation in rnottse hepatocytes
treated with EGf
Hepatocytes were incubated for 1 h in medium alone or with EGF
[50 ng/ml] in the absence or presence PD168393 [10 tM]. They were then
lysed and anaÏyzed by western blotting (7% polyacrylamide gel) using
anti-phosphotyrosine antibodies. Resuits were obtained from 5
experiments and are presented as means ± SEM. A representative bÏot is
shown.*** p<O.001; ns : flot significant.
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figttre 4 Effect ofPD168393 on post-receptor events in inotise hepatocytes
treated with EGf
Untreated and EGf-treated ceils were incubated in the absence and
presence of PD168393 [10 iM] (A) Samples (n = 3) were incubated for
1 h with each condition then analyzed on 12 ¾ polyacrylamide gel.
Membranes were then blotted with anti-phospho MAPK antibodies. (B)
Samples (n = 4), afier 6 h incubation, were analyzed by RT-PCR for
BCL-xL gene using the ribosomal protein 1 8s as a control gene. Results
are represented as a ratio of BCL-xL I 1 $s. (C) Samples (n 4) were
incubated for 24 h with each condition then analyzed on 12 %
polyacrylamide gel. Membranes were then blotted with anti-mouse
BCL-xL antibodies. D) Samples (n = 3) were incubated for 5 min with
each condition then analyzed on 7 % polyacrylamide gel. Membranes
were then blotted with anti-phospho Ser473 Akt antibodies. The data are
presented as means ± SEM. Representative blots are shown. * : p<O.O5;
** p<O.Ol; ns non significant.
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figure S Morphotogy ofEGf-treated mouse hepatocytes in the preseitce and
abseitce ofPDl 68393
Primary mouse hepatocyte cultures were incubated with medium (untreated)
or EGf [50 ng/ml] in the presence or absence of 10 jiM PD168393. Afler
24 h in culture, EGf-treated hepatocytes were spread and their ceil surface
increased, compared to untreated ceils. Hepatocytes treated with EGf in the
presence of PD168393 were spheroid and resembÏed control ceils with or
without PD168393. [Magnification, x100]
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figure 6 Effect ofPD168393 and Tyrphostin AG1478 011 tlte aliti-apoptotic
respoi;se ofEGf in mottse hepatocytes
Hepatocytes were incubated with anti-fas [250 ng/rnl] alone or with EGF
[50 ng/ml] in the absence or presence PD168393 [10 iM; panels A and B;
n=3] or Tyrphostin AG1478 [25 jiM; panel C; n=7] for 24 h. Results are
presented as ratio
apoptotic ceils [anti-Fas+EGF1 * 1 0
% apoptotic celis [anti-Fas]
At the end of the experiment, ceil death was assessed by morphologie
criteria, using Hoechst 33258 (panels A and C) or by biochemical analysis
by quantitative determination of ALT activity released in the medium
(panel B). Differences between groups were analyzed by paired t-test.
* p<O.0S; ** : p<O.Ol; ‘‘ : p<O.00l.
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Table 1 Effect of PD168393 and Tyrphostin A G14 78 on H3 32P04 incorporation into
inouse hepatocytes treated with EGf
CPM I tg protein (x103) ± SEM
Control PD16$393 Tyrphostin AG147$
30.7 ±1.0 31.5 ±1.1
Untreated 32.4 ±2.2
EGF 40.2 ±1.3 * 31.3 ±0.3 t 32.3 ±1.6 t
* p<O.Ol as compared to control untreated cultures.
p<0.0 Ï as compared to control EGf-treated cultures.
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ABSTRACT
Several pieces of evidence have demonstrated the importance of reduction/oxidation
(redox) signalling in biological processes, including sensitivity toward apoptosis. In
parallel, it was recently reported that growth factors induce the generation of ROS.
Therefore, we tested the hypothesis that the effect of EGf was mediated by changes in the
redox state of hepatocytes through changes in GSH stocks. Isolated mouse hepatocytes
were cultured and exposed to anti-fas stimulation in order to induce apoptosis. Ceil death
by apoptosis was assessed by Hoechst 33258 staining and by measuring caspase-3
proteolysis activity. Celi treatment with EGf signfficantly decreased total (GSx) anci
reduced (GSH) glutathione levels in the presence and the absence of anti-Fas. Furtherrnore,
glutathione reductase activity was lower in EGf-treated cultures (by 28%) as compared to
untreated cultures which lead to a significant decline in GSH/GSx ratio. These effects were
found to be EGf-specific. Co-stimulation of celis with anti-fas and EGF attenuated
caspase-3 activation and celi death by apoptosis by 70%. GSH monoethylester (GSHmee)
significantÏy attenuated the effect of EGf on GSH and GSH/GSx ratio. It caused an
increase in caspase-3 activation and in the percentage of apoptotic celis in anti-fas+EGf
treated cells, thus resulting in a 53% decline in the protective effect of EGF. In conclusion,
EGf induces a significant and specific depletion and oxidization of intracellular GSH,
paralleled by a protection against fas-induced apoptosis. GSH replenishment partly
counteracted these effects suggesting that GSH depletion contributed to the protective
effect ofEGf against caspase-3 activation and ceil death by apoptosis.
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INTRODUCTION
The apoptotic process is tightly regulated considering the disastrous consequences that may
ensue from excess or lack of apoptosis. That is why the apoptotic intracellular pathways are
under intensive investigation. Protection against apoptosis is of special interest in cases of
excess apoptosis such as in viral hepatitis and alcoholic liver disease (Galle 1997; Galle anci
Krammer 1998; Pinkoski et al. 2000). Growth Factors (GF) are well known protectors
against apoptosis induced by a variety of stimuli. Some of the anti-apoptotic mechanisms
activated by GF have recently been elucidated: 1) increases in the expression of the anti
apoptotic proteins ofthe BCL-2 family such as BCL-2, BCL-xL and BAG-1 (Allsopp et al.
1993; Bardelli et al. 1996); 2) inactivation of Bad (a pro-apoptotic protein of the BCL-2
family(del Peso et al. 1997; Zha et al. 1996)) and procaspase-9 (Webster and Anwer 1999)
through phosphorylation by protein kinase B (PKB/Akt). However, whether these
mechanisms are the only ones employed by GF is not yet known.
Reactive oxygen species (ROS), generated from the mitochondria and other sources, have
been traditionally regarded as toxic by-products of metabolism with potential to cause
serious damage to intracellular macromolecules (such as lipids, DNA and
proteins)(Kaplowitz and Tsukamoto 1996; Orrenius 1993). Therefore, celis employ
different anti-oxidant mechanisms to protect the intracellular macromolecules and
organelles and therefore to prevent cellular injury. The glutathione system, the most
abundant soluble cellular thiol, acts as a homeostatic redox buffer(Meister 198$; Kamata
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and Hirata 1999; Kaplowitz and Tsukamoto 1996). This is an important cellular parameter,
since the intracellular redox state monitors the relative amounts of the oxidized and reduced
species of each redox system within the celi. Oxidative stress occurs when intracellular
redox homeostasis is altered. The imbalance may be due to either an overproduction of
ROS or a deficiency in anti-oxidants. (Kamata and Hirata 1999; Kaplowitz and Tsukamoto
1996)
Several unes of evidence demonstrate that intracellular redox state affects cellular
signalling (both at the receptor level and in intracellular pathways; reviewed in (Kamata
and Hirata 1999; McCord 2000; Thannickal and Fanburg 2000b)). for example, the
reversible oxidation of cysteine residues can significantly modify the cellular response to a
given stimulus. Therefore, proteins (e.g. transcription factors, phosphatases and caspases)
rich in reduced cysteine residues in their active site are susceptible to the intracellular redox
state. Given the nature of these redox- sensitive proteins, variation of the redox state has
very important consequences on a wide variety of cellular functions (celi signalling.
enzyme activation, DNA synthesis, selective gene expression) and even on ceil viability
(Reviewed in (Powis et al. 1997; Gamaley and Klyubin 1999)).
ROS and oxidative stress have long been implicated in ceil death by necrosis and recently
by apoptosis as well (Orrenius 1993; Kaplowitz and Tsukamoto 1996). Although their role
in necrosis is well established, their role in apoptosis is stili under debate. Several studies
ascribe ROS as inducers or at least mediators ofapoptosis. (Zamzami et al. 1997; Sarafian
and Bredesen 1994) Others, on the other hand, have demonstrated that they may in fact
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function as anti-apoptotic agents (Clement and Stamenkovic 1996). This discrepancy might
be explained by the intensity and localization of ROS production as well as the cellular
context in which ROS production occurs. Indeed, depending on the level of F1202
treatment, cellular response shifis from proliferation to apoptosis to necrosis (Kaplowitz
and Tsukamoto 1996). 0f note, recent findings showing that GF induce specific bursts of
ROS (Thaimickal et al. 2000a) might tip the balance even more toward protection since GF
are known protectors against apoptosis.
Our laboratory has recently demonstrated the importance of intact glutathione status and
especially the ratio of reduced (GSH)/total (GSx) glutathione on Fas-induced caspase-$
activation and consequently celi death by apoptosis (Musallam et al. 2002). Indeed, lower
rates of caspase-8 activity and apoptotic bodies were found in ceils containing low levels of
GSH and GSH/G$x ratio. Based on these findings and the data mentioned above from the
literature, we tested the hypothesis that the anti-apoptotic effect of EGf was mediated, at
least in part, by changes in GSH stocks.
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MATERIALS AND METHODS
Ail animais received humane care according to the guidelines of the Canadian Council on
Animal Care. Experimental protocols were approved by the Comité institutionnel de
protection des animaux ofthe CHUM-Hôpital Saint-Lue.
Hepatocyte isolation aiul cttttttre
Hepatocytes were isolated from the liver of fed male BALBIc mice (22-25 g) using the 2-
step collagenase perfusion method described previously (Musallam et ai. 2001). Cells were
seeded onto plastic petri dishes (26,000 cells/cm2) in enriched Williams’ E medium
(cysteine : 90 mg/L and methionine 55 mg/L) supplemented with 10% foetal bovine
serum (GIBCO BRL, Toronto, ON, Canada) and allowed 2h to attach. Afler attachment,
the serum-containing medium was removed, and cells were incubated with serurn-free
medium for the indicated times in each experimental series. Apoptosis was induced in
experimental groups with mouse anti-fas Jo2 antibody (Research Diagonistics Inc.
Flanders, NI, USA) at a concentration of 250 ng/ml. The anti-apoptotic effect of epidermal
growth factor (EGF) was studied by simultaneously incubating celis with 50 ng/ml of EGf
(Sigma, Oakville, ON, Canada) and the anti-Fas antibody. PD16$393 (Cedarlane
Laboratories; Homby, ON, Canada), a specific inhibitor of the tyrosine kinase activity of
EGF receptor, was used at 10 jiM, a concentration previously shown to be effective in
blocking EGf-R autophosphorylation (Musallam et al. 2002). Glutathione monoethylester
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(GSHmee; Sigma) was used at 2.5 mM to increase the intracellular content of GSH on the
basis ofpreliminary dose-response experiments.
Determination of GSx and GSH tevels
Culture conditions: Celis were treated according to the different experimental conditions.
At the end of the experiment, celis were scraped off, pelleted by centrifugation and
resuspended in 300 tl 0.25 M sucrose solution. Samples were stored at —80°C until
determination of GSx and GSH levels. GSx and GSH determination: GSx and GSH
levels were measured by a colorimetric assay using DTNB as described previously
(Musallam et al. 2002).
Morphologicat determination of apoptosis
Afier attachment, celis were incubated with medium alone, anti-Fas, EGF or the
combination of both EGF and anti-Fas for 1h. The medium was replaced with medium
alone (Control conditions) or with one containing GSHmee [2.5 mM; GSHmee conditions].
After 5h, celis were fixed with 5% formaldehyde solution (Anachemia Science, Lachine,
Qc, CA) and then stained with Hoechst 3325$ (250 ng/ml, Sigma) to quantify apoptosis as
described previously (Musallam et al. 2001).
Measiirement of Gtutathione rediictase (GR)
Culture conditions : Celis were treated with medium alone, anti-fas antibodies, EGF and
anti-Fas+EGF for 3h. Celis were collected and were subsequently disrupted by sonication
(Sonic & Materials, Danbury, CT, USA) in the presence of Tris 5OmM [pH 7.5] and 5 mM
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EDTA buffer. Lysates were centrifuged at 13 000g for 10 min and the supernatant stored at
—80°C. Measurement of GR activity : GR is responsible for the reduction of one molecule
of oxidized glutathione (GSSG) into two molecules of G$H, using NADPH as source of
protons. The measurement of GR activity is based on the decrease in the auto-fluorescence
of NADPH at 340 nm as a resuit of its oxidation. Samples (250 jig proteins) were diluted in
200 pi (final volume) Sample Diluent Buffer (125 mM KH2PO4 [pH 7.5]; 1 mM EDTA, 1
mg/ml BSA) and warmed to room temperature. One min before the start of the reaction,
400 tl of Assay Buffer (125 mM KH2PO4 [pH 7.5]; 2.5 mM EDTA) containing 2.5 mM
GSSG was added. G$SG was flot added in the blank. The reaction was started by the
addition of 400p1 of 0.45mg/ml NADPH. D.O. were recorded every 60 sec for 5 min at
340 nm. The slope of the regression curve for each sample was used to calculate GR
activity using the following equation:
1 mU = 1 nmol NADPH/ min = (A340/min)/0.00622
Measurernent of caspase-3 activity
Culture conditions: In order to determine the effect of GSHmee on the anti-apoptotic
effect of EGF on caspase-3 activity, the medium of untreated, fas-treated, EGF-treated and
Fas+EGF —treated cultures was changed afier 1-h incubation and replaced with medium
alone or with one containing 2.5 mM GSHmee for 3h. Samples were prepared as described
previously and stored at —80°C.
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Measurement of the proteoiytïc activity: The fluorometric Ac-DEVD-AMC (100 tM;
Biosource International, Camarillo, CA, USA) cleavage assay was used to measure
caspases-3 activity (Musallam et al. 2002). The reaction was evaÏuated over a period of 30
min using 380 nm and 460 nm as excitation and emission wavelengths respectively and the
maximal substrate cleavage rate (Vmax!sec) was calculated. The activity of caspase-3,
presented in units, was derived from a calibration curve relating Vmax/sec to increasing
units ofhuman activated recombinant caspase-3.
Irninrinoblotting
Ccli lysis : We determined the effect of G$Hmee treatrnent on the level of procaspase-3
protein expression and EGf receptor (EGF-R) autophosphorylation. Afier ce!! incubation
with medium alone or EGf for 1h, the culture medium was removed and ceils were
cu!tured in medium alone or with medium + GSHmee for 1h30 (for EGF-R
phosphorylation) or 3h (for procaspase-3 protein expression). At the end of the experirnent,
celis were col!ected and prepared for SDS-PAGE as detailed elsewhere (Musallam et al.
2001).
Western Biot (Sambrook et al. 1989) : Proteins samples (125 jtg) of each experimental
condition were separated by electrophoresis on 10% (EGF-R) or 12% (procaspase-3) SDS
PAGE. Equal protein loading was assessed by staining the membranes with Ponceau S
(Sigma). The expression of procaspase-3 (34 KDa), and actin (42 KDa) proteins were
detected respectively with rabbit anti-human caspase-3 (21g/m1; Santa Cruz
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Biotecimologies; Santa Cruz, CA, USA) and anti-mouse actin monoclonal IgM (1: 2000;
Oncogene Research Products; Cambridge, MA, USA). The level of EGF-R
autophosphorylation was detected by mouse anti-mouse anti-phosphotyrosine (1 ig/m1:
PY99, Santa Cruz Biotechnology). Peroxidase-conjugated anti-mouse and anti-rabbit IgG
(1: 10 000; BD Pharmingen; Mississauga, ON, CA) as well as peroxidase-conjugated anti
mouse IgM (1: 20 000; Oncogene Research Products) activities were revealed as described
previously (Musallam et al. 2001).
Statistica! ait atysis
Ail data represent the values of at least 3 experiments, each from different celi isolation.
Differences between groups were analyzed by one-way analysis cf variance (ANOVA) for
repeated measures, unless stated otherwise. The difference between treatment and time was
analyzed by two-way ANOVA for repeated measures. A p value below 0.05 vas
considered significant.
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RESULTS
EGf decreases GSx intracettutar levets aitd GSH/G$x ratio lit a tinte- and dose
dependent niaimer
Given the importance of glutathione for hepatocyte sensitivity toward apoptosis, we first
evaluated the effect of ceil treatment with anti-fas and/or EGf on GSx intracellular stocks
afier 3h incubation. In untreated cultures, GSx levels were at 26.2 ± 2.4 nmol/106
hepatocytes. When anti-fas antibodies were added, GSx levels were not significantly
affected (24.6 ± 3.2 nmol/106 hepatocytes; figure 1; not significant [NS]). However, GSx
levels decreased following exposure to EGf alone (13.8 + 2.4 nmol /106 hepatocytes:
p<O.00l) as well as in combination with anti-fas (15.0 + 2.6 nmol /106 hepatocytes;
p<O.Ol). $imilarly, GSH levels were decreased following EGf treatment in the presence
(p<O.00l) and in the absence offas (j<O.OOl; figure 1). The drop is more pronounced in
the case of GSH levels in comparison to GSx. This resulted in a decrease in GSH/GSx ratio
(by 1$ %) in EGF-treated cultures as compared to untreated ones (Figure lB; p<O.05). This
lower ratio is indicative of relative accumulation G$SG in ceils.
EGf decreases tite activity of GSSG redttctase (GR)
Cells convert 055G to GSH under normal redox state (over 80 % of GSx being in the form
of GSH) and increase its extrusion under oxidative stress (Deleve and Kaplowitz 1990).
Normally, the rapid reduction of 055G to GSH is catalyzed by OR, which requires
NADPH as a cofactor (Meister 1988; Anderson 1998). Therefore, since EGF decreased
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GSH/G$x ratio, we analyzed the activity of GR following 3-h EGF treatment. The activity
of this enzyme in untreated cultures was 35.8 + 0.5 JiU/1g protein (Figure 2). However, it
declined by 28 % in EGF-treated cultures (25.6 +0.2 jiU/jig protein; p<O.Ol). Stimulation
of Fas receptor did flot significantly affect baseline or EGF-depressed GR activity. This
relative inhibition of GR activity probably accounts for the obseiwed lower GSH/GSx ratio
in EGF-treated cultures.
Based on the resuits mentioned above, as weIl as on those from our previous work
(Musallam et aI. 2002), this suggests that EGF may transmit its anti-apoptotic effect in part
by lowering GSH intracellular stocks. In order to demonstrate this, we had to first explore
whether EGF-induced depletion ami oxidization of intracellular GSx stocks is specific.
EGf decreases GSx intraceltutar levels and GSH/GSx ratio in a tinie- and dose
clependent nrnnner
First, we evaluated the time course of GSx decrease following EGF treatment. As shown in
Figure 3A, GSx levels in untreated cultures slightly decreased over time. We had
previously observed this process and suggested that it was responsible for the relative
resistance of hepatocytes in culture toward apoptosis as compared to in vivo (Musallam et
al. 2002). However, when celis were treated with EGf, GSx levels decreased more steeply
to reach 13.5 ± 2.1 nmol /106 hepatocytes 3-h post-EGF treatment. Thus, afier 3h in culture.
GSx is 54 % lower is EGF-treated cultures in comparison to untreated ones (p< 0.0 1). In
parallel, increasing concentrations of EGF (0.5 — 50 ng/mI) resulted in a dose-dependent
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decrease of GSx levels ((EC5O = 3.0 ng/ml; Figure 3C) which suggests that EGf cari
specifically affect GSH intracellular levels.
$imilar to GSx, GSH levels decreased, but more sharply than G$x, in a tirne- and dose
dependent maiiner (data flot shown). This difference led to lower GSH/GSx ratio. Indeed,
Figure 3B showed that G$H/GSx ratio is significantly lower in EGF-treated cultures as
compared to untreated ones, at each time point tested (p<0.05). GSH/GSx ratio diminished
in a dose-dependent manner as well (EC5O = 2.8ng/ml; Figure 3D).
PD168393 inhibits EGf-indttced GSH deptetion amI oxidation
In order to assess the specificity of EGF’s effect on GSx and GSH stocks, GSH/GSx ratio
and GR activity, we used PD168393, a specific inhibitor ofthe tyrosine kinase activity of
the EGF receptor. We have previously tested the efficacy of this inhibitor and showed that
it effectively inhibited the autophosphorylation of the EGF-R as well the downstream
phosphorylation cascades (330). As illustrated in Figure 4, the use of this inhibitor
abolished the observed depletion of GSx (j<O.Ol; Figure 4A) and GSH (p<O.Ol; Figure
4B) following EGF addition. furthermore, ceÏl treatment with PD168393 in combination
with EGF reversed the decline in GR activity reported in EGF-treated cultures
(35.6 ± 0.8 tU/.ig protein vs 25.6 ± 0.2 iU/j.ig protein respectively; p<O.Ol; Figure 4C).
This resulted in a retum ofthe GSH/GSx ratio ofEGF + PD168393 cultures (71.0 %± 5.5)
to a similar value as that of untreated cultures in the presence (73.0 % ± 6.1) or in the
absence (74.0 % ± 3.2) ofPD168393.
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GSH monoethytester treatment partiatty reversed EGf-indttced decrease of GSx levels
and GSH/GSx ratio
Since EGf seems to specifically lower GSH intracellular content and create a weak
oxidative stress, the next step was to explore the involvement of this phenomenon in the
anti-apoptotic effect of EGF against fas-induced apoptosis by G$H replenishment.
Normally, GSH can flot enter into the celi (Anderson and Meister 1989). On the other hand,
the ester form of GSH (called GSHmee) can cross the plasma membrane. Intracellular non
specific esterases then liberate GSH into the cytoplasm (Anderson and Meister 1989).
Therefore, we used GSHmee to increase intracellular GSH levels. Ceil treatrnent with
GSHrnee atone increased GSH intracellular content (data not shown). However, when
GSHmee was added in the presence of EGF, there was no significant increase in GSH
levels as compared to cultures treated with EGF alone (data not shown). This suggested
that the effect of EGf is powerful enough to mask the observed increase in GSH in
untreated cultures. Hence, we had to find another treatment protocol to counteract the
strength of EGF effect. We have previousïy verified that brief exposure of ceils to EGF
(1h) followed by its retrieval produced similar EGF-R and MAPK phosphorylations as well
as comparable protection against Fas—induced apoptosis as compared to continuous
exposure to EGF for the sarne time period (Musallam et al., unpublished data). Therefore,
afier lh-treatment, the EGF-containing medium was replaced with medium alone (EGF
treated control cultures) or one containing GSHmee (2.5 mM; EGf GSHmee-treated
cultures) for 3h. These conditions were compared to cultures treated with (GSHmee
untreated cultures) or without (untreated control cultures) G$Hmee in the absence ofEGF.
EGF anti-apoptotic effect and G$Hdepletion MUSALLAM et al./1 8$
EGf in control conditions (added for 1h then removed) was able to decrease the levels of
GSx and GSH as well as GSH/GSx ratio in a similar manner to conditions where it was
present dtiring the whole time of treatment (sec Table 1). GSHmee addition slightly
increased the levels of GSx in the absence of EGF, albeit not significantly (Table 1).
However, the EGf-induced decrease of G$x levels was less prominent in the presence of
GSHmee since higher levels of GSx were observed in G$Hrnee + EGF—treated cultures
(18.4 ± 1.7 nmol/106 celis) as compared to control EGf—treated cultures
(12.6 ± 1.0 nmol/106 hepatocytes; p<O.05). This signifies that there was a decline of GSx
levels by 44 % following EGf treatment in control conditions but this decrease was only by
28% when GSHmee was added to the medium. In parallel, EGf-induced decline in GSI-l
levels was 56% in the absence of GSHmee (p<O.Ol; Table 1) as compared to 37% decline
in its presence NS; Table 1). However, according to our previous work, the rnost important
factor determining hepatocytes sensitivity toward apoptosis is the intracellular ratio of
GSH/GSx. Therefore, we determined the effect of GSHmee addition on this parameter.
EGf addition induced a significant decrease in GSHIGSx ratio from 78.2 + 7.8 % in
control untreated culmred to 57.3 ± 7.5 % in control EGF-treated cultures (p<O.Ol; Table
1). This represents a 27 % decline. When GSHmee was added, EGF only induced a 10 %
decline in this ratio which was not significantly different from baseline (NS; Table 1). This
means that GSHmee addition diminished by 63 % the effect of EGf on GSH/GSx ratio.
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GSHmee treatmentpartiatty iithibited tue EGf anti-apoptotic effect
Since GSHmee treatment significantly attenuated EGf-induced decrease of GSx and GSI-1
levels as well as GSH/G$x ratio, we tested the effect of replenishing GSH on the anti
apoptotic effect of EGF. first, untreated cultures displayed negligible levels of apoptotic
bodies (<1%; Figure 5A) and caspase-3 activity (0.33 ± 0.0$ U; Figure 55) in both media.
The apoptotic response to anti-fas as weÏl as the protective effect of EGf could be
identified in control conditions even though anti-fas and/or EGF were removed from the
medium afier 1-h exposure. Indeed, celi stimulation with anti-Fas antibodies induced a
significant increase in the rate of apoptotic bodies (11.0 + 0.4 %; p<O.001) and caspase-3
activity (46.0 ± 2.9 U; p<0.001). The simultaneous addition ofEGF with anti-Fas protected
70 % of mouse hepatocytes against celi death (3.3 ± 0.5 %; p<O.001) and attenuated
caspase-3 activation by 70 % as well (13.8 + 2.3 U; p<O.05). When GSHmee was added,
the level of apoptotic bodies significantly increased to 18.3 ± 1.2 % (p<O.001; Figure 5A)
accompanied with a similar increase in caspase-3 activity (7 1.1 + 10.1 U; p<O.O5; Figure
55). However, when anti-Fas+EGF-treated ceils were exposed to GSHrnee, the protective
effect of EGF was significantly impaired. Indeed, the level of caspase-3 activity
(47.2 + 8.5 U) and apoptotic bodies (12.1 ± 1.1 %) were higher in GSHmee Fas+EGF
treated cultures in comparison to control Fas+EGF —treated cultures (p<0.001). This
signifies that EGf protection was halved in the presence of GSHmee (34 %) as compared
to its absence (70 %; p<O.OS). 0f note, EGF-R autophosphorylation (figure 6A) and
procaspase-3 protein expression (Figure 6B) were not significantly affected by GSHmee
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addition in the presence or in the absence of EGf. Therefore these resuits suggest that the
decrease in GSH levels is important for the EGf-mediated protection against fas-induced
apoptosis in mouse hepatocytes.
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DISCUSSION
Gf signalling is mediated through enzymatic receptors that possess intrinsic tyrosine kinase
activity. In response to the binding of their ligands, these receptors become oligomerized
and then phosphorylated on specific tyrosine residues by their own catalytic activity
(Schiessinger 1990; Ballotti et al. 1992; Hurwitz et al. 1991). This activates different
intracellular phosphorylation pathways to transmit the biological signal of Gf. The
classical intracellular cascades activated by GF are phospholipase C (PLCy), mitogen
activated protein kinases (MAPK) and phosphatidylinositol 3-kinase (PI 3-K), which have
been implicated in the mediation of several of the biological effects of GF (Force and
Bonventre 199$; Margolis and $kolnik 1994).
Recent experimental data demonstrate that Gf might use a new and previously unsuspected
pathway to mediate their signal: ROS. Several studies have reported that Gf generate ROS
in a specific and coordinate manner suggesting that ROS might be used as mediators of Gf
signalling. For example, some GF such as EGF and PDGF, induce the rapid production of
superoxide anion (02fl andJor hydrogen peroxide (H202) (Thannickal et al. 2000a).
Moreover, oxidants can also stimulate receptor tyrosine kinases even in the absence oftheir
ligands as well as the downstream effectors in signal transduction pathways including Ras,
PKC, MAPK and c-Jun N-terminal kinase (JNK) (Kamata and Hirata 1999). In addition,
low concentrations of H202 and O{ are known to stimulate growth of several celi types in
vitro (Martin and Barrett 2002; Heffetz et al. 1990; Monteiro and Stem 1996; Burdon
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1995). Taken together, this suggests that GF can modulate ;-edox components to transmit
their signal. Thus, the aim ofthis study was to determine if modulation ofintracellular
redox state participated in the anti-apoptotic effect of EGF against Fas-induced apoptosis
on mouse hepatocytes.
first, we observed that ceil exposure to EGF resulted in a time- and dose-dependent
decrease in the levels of GSx and GSH. This occurred concomitantly with an attenuation of
the activity of GR leading to lower GSH/GSx ratio in EGf-treated cultures in comparison
to untreated control. These effects were abolished by PD16$393 strongly suggesting that
they are specific to EGF-R activation. The decline in GSH and GSH/GSx ratio may be due
to the glutathionation of redox-sensitive proteins. Indeed, these reversible glutathionation
events have been detected at the peak ofROS generation in response to Gf such as EGF
(Barrett et al. 1999). This may protect cellular proteins from irreversible oxidation damage
by ROS. On the other hand, the EGf-induced inhibition of GR activity maintains celis in a
mild oxidized redox state. Such a state was shown necessary for the full expression ofthe
proliferate action of GF. In fact, inhibition of de novo synthesis of GSH bas been shown to
stimulate proliferation by Gf and, in general, to potentiate the sensitivity ofcells to
extracellular stimuli acting via MAPK activation (Kamata et al. 1996; Bhunia et al. 1997).
In parallel, redox state has also been implicated in the control of apoptosis. Some studies
have reported that fas-induced apoptosis requires extnision of GSH (van den Dobbelsteen
et al. 1996; Ghibelli et al. 199$). Others have reported that ROS production is necessary for
the induction ofapoptosis. (Kamata and Hirata 1999; $later et al. 1995; Lennon et aÏ. 1991)
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However, this is stili a controversial subject. Indeed, accumulating evidence suggests that,
on the contrary, oxidative stress can abrogate apoptosis (Lawson et al. 1999; Haouzi et al.
2001; Musallam et al. 2002; Clement and Stamenkovic 1996). Therefore, it was important
to assess the effect of Fas on GSH levels in our cultures. Fas treatment did flot significantly
modify the levels of GSx and GSH, GR activity or GSHIGSx ratio. This confirms our
previous finding (Musallam et al. 2002) as well as that of others (Hentze et al. 1999;
Hentze et al. 2000) showing that intact GSH status and high redox state were essential for
the transmission ofthe Fas apoptotic signal.
We next investigated the relevance of EGF-induced oxidative state to the anti-apoptotic
effect of EGF against fas-induced apoptosis. Ceil treatment with GSHmee effectively
increased GSx and G$H levels by 46% and 59% in cultures co-treated with EGF. This
represents a 36% and 34% attenuation of the EGf-induced decrease of GSx and GSH
levels. In addition, the effect of EGf on GSH/GSx ratio was 67% less in the presence of
GSHmee in comparison to control conditions. This partial normalization of the reduced
intracellular redox state in EGF-treated cultures was paralleled by a decrease in the
protective effect of EGF against Fas-induced ceil death by apoptosis. Indeed, the anti
apoptotic effect of EGF declined by 53% following GSHmee addition. This occurred
concomitantly with the loss of 53% of the ability of EGF to inhibit caspase-3 activity
without, however, modification of the expression of procaspase-3. Since redox state has
been shown to modulate the activity of protein tyrosine kinase cascades, we confirmed that
no significant alteration of EGF-R autophosphorylation was observed following GSHmee
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treatrnent in comparison to cultures flot treated with it. Therefore, GSHmee addition seems
to exert its effect through modulation of G$H intracellular stocks and intracellular redox
state and not by interfering with the activation of the EGF-R.
Taken together, these resuits confirm the negative regulation of apoptosis by oxidative
stress. Indeed, the findings of this study are in accordance with our previous work as weII
as that of others in which depletion of GSH by various treatments resulted in the abrogation
of the transmission of the apoptotic signal. Such protection is thought to proceed through
redox inhibition of caspases activity (due to their need of a reduced cysteine in their active
site). In fact, Hentze et al. have recently shown that GSH depletion resulted in the
inhibition of the activity of caspase-$ without alteration in the recruitment of DISC
complex to the Fas receptor (Hentze et al. 2002). Similarly, we have shown that increase in
GSH intracellular content lead to higher activation of caspase-8 activity and cell death by
apoptosis without affecting the expression of procaspase-8, Bid or BCL-xL proteins
(Musallam et al. 2002).
Other studies have reported that GSH depletion and ROS production are necessary for
higher sensitivity toward apoptosis. However, careful review of the literature reveals that
depletion of GSH or ROS exposure has different effects on apoptosis depending on its
intensity, location and timing. For example, a recent study from Femandez-Checa’s group
has demonstrated that cdl exposure to 3-hydroxy-4-pentenoate, which specifically depletes
mitochondrial GSH, sensitizes hepatocytes to TNFa— and fas-induced apoptosis (Mari et
al. 2002). In a similar manner, there is higher sensitivity toward apoptosis in alcoholic liver
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disease, ethanol being known to preferentially deplete mitochondrial GSH (Fernandez
Checa et al. 1997). On the other hand, cytoplasmic depletion ofGSH resuits in inhibition of
apoptosis as shown by the groups of Wendel (Hentze et aI. 1999; Hentze et al. 2000),
Jaeschke (Lawson et al. 1999) and Pessayre (Haouzi et al. 2001) as well as our own. 0f
note, rapid depletion of GSH, should principally deplete the cytoplasmic pool rnainly since
mitochondria retain GSH far more efficiently than the cytoplasm. Therefore, it appears that
if the GSH mitochondrial pool is flot affected, GSH depletion inhibits apoptotic signal.
Thus such G$H depletion may be used by GF to mediate their anti-apoptotic effect.
Indeed, the data of the present study strongly suggest that EGF specifically induces rnild
oxidative stress to mediate its biological signal of protection against apoptosis. Thus, anti
oxidants should abrogate this signal. Such findings were reported in isolated digestive
gland celis where EGf-induced stimulation of glycolic enzymes was abolished by ceil
treatment with antioxidant N-acetyl-cysteine (NAC)(Canesi et al. 2000). In addition, NAC
treatment in PC-12 celis resulted in lower NGF-induced MAPK activation while
Buthionine Sulfoximine (a specific GSH synthesis inhibitor) had the opposite effect
(Kamata et al. 1996). This suggests the concept that oxidationlreduction of the cysteine
residues in the active site of proteins can be used as regulatory mechanism by external
stimuli to modulate their activity under pathological as well as physiological conditions.
The involvement of ROS production!redox state in a multitude of normal biological process
defines a new role for ROS production in normal ceil homeostasis as opposed to classical
toxic damage to cellular macromolecules. This also adds a new perspective to the use of
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anti-oxidants. Indeed, depending on the circumstance they can be beneficial by protecting
against high levels of ROS but harmful by inhibiting GF signalling.
Finally, there appear to be multiple check points in the control of the apoptotic rnachinery
by Gf. Indeed, their pro-survival signal is divided between the activation of anti-apoptotic
processes and the inhibition of pro-apoptotic ones. In the later category, redox modulation
of the activity of caspases appears to be another step in the negative regulation of pro
apoptotic mechanisms by Gf which acts in conjunction to the phosphorylation of Bad and
procaspase-9.
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CONCLUSION
In conclusion, our resuits clearly demonstrate that EGf specifically induces glutathione
depletion, which is important for the full anti-apoptotic activity of EGF. Ibis depletion is
associated with a lower proteolytic activity of caspase-3. Therefore, our resuits conflrrn the
importance of stabilization of intracellular GSx levels for the sensitivity of hepatocytes to
apoptosis and show that EGF employs redox signalling to protect against fas-induced.
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Table 1 Effect of GSHinee oit tite intraceltutar levets of GSx, GSH and GSH/GSx
ratio in mouse hepatocytes treated with EGf
nmol / x106 hepatocytes ± SEM
GSx GSH GSHIGSx ratio
17.1 + 2.4 78.2 ± 7.8
Untreated 21.5 ± 1.4
Control(s)
7.3 ± 1.3 ** 57•3 ± 7.5 **
EGF 12.6±1.0*
18.2±2.3 71.2±5.8
Untreated 25.6 ± 2.3
GSHmee
EGF 18.4± 1.7 * t 11.6±0.5NS 63.8±4.2NS
NS: flot significant; * : p<O.O5; **: p<O.Ol as compared to the respective untreated cultures
(ANOVA).
p<O.05 as compared to control EGf-treated cultures (t-paired test).
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FIGURE LEGEND$
figure 1 Effect ofautti-fas aitd/or EGf on intracelludar gtutatltione tevels and
GSH/GSx ratio
Afier attacliment, hepatocytes were incubated with medium alone, anti-Fas
{250ng/ml] and/or EGF [5Ong/ml] for 3h. Ceils were then collected to
measure total (GSx) and reduced (GSH) glutathione levels (panel A) as well
as GSH/GSx ratio (panel B), as described in Materials and Methods. Values
are depicted as mean ± SEM from 5 different experiments. * p<O.O5:
** : p<O.O1; p<O.001 as compared to untreated culture; #: p<O.001;
1: p<O.Ol as cornpared to anti-Fas alone.
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figure 2 Effect ofanti-fus and/or EGf on tite activity ofgtutathioite reductase
(GR)
Afier 3h with anti-Fas and/or EGF, ceils were collected, lysed and 250 jig
proteins were used to monitor the decrease in NADPH absorbance at 340nm
(which is indicative of NADPH oxidation and GSSG reduction), the siope
being used to calculate the activity of GR. Resuits (n=3) are presented as
mean ± SEM. NS: flot significant; * p<O.O5; ** p<O.Ol as compared to
untreated cultures.
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figure 3 Tirne-course and dose-response cttrves ofbitraceittilar GSx tevels and
GSH/GSx ratiofollowing exposttre to EGf
Time-course: untreated or EGF-treated cultures were collected afier 30 min.
1h 3h and 6h of incubation (n = 5; Panels A and B). Dose-response curves:
hepatocytes were treated with increasing concentrations of EGf (0.5-50
ng/rnl) then collected afier 3h (n=5; Panels C and D). GSx and GSH/GSx
ratio were measured as detailed in Materials and Methods. The data are
presented as mean + SEM.*: p<0.O5; **: p<0.O1.
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figttre 4 Effect ofPD168393 oit EGf-btdttced decrease of GSx, GSHlevets as
ive!! as GSH/GSx ratio and GR activity
Ceils were treated with medium alone (untreated) or with EGF (50 ng/ml)
in the presence of PD16$393 [lOjiM] or in its absence (control
conditions). Afler 3h, celis were collected as described in Materials and
Methodsto measure G$x (panel A) and GSH (Panel B) levels as well as
G$H/GSx ratio (Panel C) and GR activity (Panel D) using colorimetric
assays. Resuits are presented as mean ± SEM. *: p< 0.05; ** : p<O.Ol for
the indicated comparisons.
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figttre 5 Effect ofglutathione monotheyl ester (GSHmee) on protective effect of
EGF agailtst Fas-induced caspase-3 activation and ceit death by
apoptosis
Afler attachment, hepatocytes were treated with medium alone, anti-fas
[250 ng/rnl} and/or EGf [50 ng/mlJ for 1h, followed by medium alone or
one containing GSHmee [2.5mM]. A: Ceil death by apoptosis was
measured afier 5h where celis were fixed then stained with Hoechst 33252
as described in Materials and Methods. Data are presented as mean
± SEM. (n = 4). B: afier 3h, samples were collected to measure caspase-3
activity as described in Materials and Methods. Resuits are presented as
mean of activated units of caspase-3 + SEM. (n = 4). NS not significant;
* p<O.O5; ***: p<O.00l for the indicated comparisons.
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figure 6 Effect of G$Hrnee oit EGf receptor (EGf-R) autophosphorytation and
procaspase-3 proteiit expression ht EGf treated cttttttres
Cells were cultured in medium (Untreated) or EGf for 1h then with
medium alone (Control) or one containing GSHmee [2.5mM] for 1h30 for
detection of EGf-R autophosphorylation (Panel A) and afier 3h for
detection of procaspase-3 protein expression (Panel B). Samples were
collected and analyzed by Western blot as detailed in Materials and
Methods. Resuits (mean ± SEM) from 4 experiments are presented. NS:
not significant p<O.00l as compared to untreated counterparts.
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CHAPTER 4
DISCUSSION & CONCLUSION
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In the present work, the mechanisms implicated in the regulation of apoptosis and
especially those involved in the protection against Fas-induced apoptosis in prirnary mouse
hepatocyte cultures were studied. We focused on the redox control of apoptosis and its
relevance in the protection afforded to these celis by epidermal growth factor (EGf) as well
as the involvement of the tyrosine kinase (TK) activity ofthe EGf receptor (EGF-R).
Redox signalling is a new concept which implies control of intracellular signalling pathway
by the redox state of the ceil. The primary consequence of redox signalling is a change in
the oxidative state of cysteine residues localized in the catalytic domain of several key
proteins. Some of these proteins are transcription factors, phosphatases, receptors(195;198)
and caspases (77;260-263) . Redox signalling has been implicated in several cellular
functions including host protection, celi proliferation and gene expression. (19$;264)
First, we determined the involvement of the GSH system, the most abundant intracellular
non-protein thiol, in the sensitivity of mouse hepatocytes in primary culture toward Fas
induced apoptosis. We found that the isolation procedure and culture resulted in significant
loss of intracellular total glutathione (GSx) content. In fact, afier only 2h of culture in
commercial Williams’ E medium (medium N), celis retained only 27% of their original
stocks of GSx (total liver). Celi culture in a cysteine- and methionine- enriched medium
(medium C+M) maintained G$x levels twice higher as compared to culture in N medium,
and this even over an extended culture time. GSH/GSx ratio, which reftects the redox state
of the cell, was unaffected by the isolation procedure. On the other hand, this ratio
decreased significantly over time in culture in medium C+M as well as medium N,
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although it remained significantly higher in the former (74%) as compared to the latter
(67%).
Since the liver is very sensitive to apoptosis in vivo (where GSH levels are very high) as
compared to in culture (where GSH levels are significantly diminished), this suggested that
GSH depletion might play a role in hepatocyte sensitivity toward fas-induced apoptosis.
Indeed, cells cultured in medium C+M displayed higher caspase-8 activation and ceÏl death
by apoptosis following fas-treatment in comparison to medium N cultures ceils. There was.
however, no effect on the expression of apoptosis-regulating proteins (pro-caspase-8, Bid
and BCL-xij. In addition, in vitro evaluation of recombinant active caspase-$ activity
revealed that pro-oxidant states (i.e. decrease in GSH/GSx ratio) significantly and gradually
attenuated the proteolytic activity of the caspase, finally leading to its complete inactivation
when G$H/GSx ratio reached 0%. Our results thus favour the interpretation that redox
modulation of the sensitivity of mouse hepatocytes to Fas-induced apoptosis is attributable
principally to alteration ofthe activity ofcaspases.
0f note, stimulation of the Fas receptor did not significantly alter the redox state of mouse
hepatocytes since GSx and G$H levels, GSH/GSx ratio and G$SG reductase activity were
flot affected by cell treatment with anti-Fas antibodies (see article 3). Moreover, one
expects the apoptotic machinery to be fiinctional in a highly reduced state, particularly in
the liver where high levels of GSH are present. Taken together, these facts do not support
the concept that fas-induced apoptosis may require GSH depletion or the generation of an
intracellular oxidative state to transmit its apoptotic signal in hepatocytes.
9
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In support of this, Henzte et ai have reported that in vivo GSH depletion using phorone
abrogated fas-induced liver apoptosis (75;76). This depletion was flot due to a decrease in
caspase-8 recruitment to the DISC complex, but rather by redox modulation of the
proteolytic activity of the caspase (261). Biochemicai studies have confirmed the redox
control of ail caspases. They possess a redox-sensitive cysteine in their active site, which
must be reduced for the caspase to function (262;263). Indeed, Disulfiram, a potent
inhibitor of caspases, acts by oxidizing the cysteine residues in the active site of the
enzymes (77). furthermore, O{ was shown to abrogate fas-induced apoptosis.(259)
Similar resuits were also reported by the Pessayre’s group who observed that a rapid
depletion of GSH resulted in the protection against Fas-induced apoptosis in vivo (265).
However, prolonged depletion resulted in the upregulation of compensatory mechanisms
(such as increase in Bax expression) to regain sensitivity toward apoptosis. On the other
hand, several studies have reported that treatment with oxidants or anti-oxidant depletion
can accentuate apoptosis (202;252;253). In fact, it was reported that GSH extrusion was a
necessary step for the induction of apoptosis (254;255). These findings seem to contradict
our own findings as well as those just mentioned.
The findings of the Passaeyre’s group (265) might shed light on the mechanisms
responsible for the discordance conceming the involvement of oxidative stress in the
control of apoptosis. As mentioned above, there are two important intracellular pools of
GSH located in the cytosol and in mitochondria respectively. The latter retain GSH far
more efficiently than the former (227). Studies that reported higher sensitivity toward
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apoptosis involved either mitochondrial G$H depletion (by ethanol, 3-hydroxy-4-
pentenoate (226) or prolonged general G$H depletion (265)) or generation of
mitochondrial ROS (e.g. TNf-Œ-induced apoptosis (266)). It must be noted that the
mitochondrial mega-cliannel is controlled by redox status and GSH levels. Oxidation of the
mitochondrial interior space induces the opening of the mega-channel (267). This
culminates in the loss of the mitochondrial transmembrane potential, which lias been
repeatedÏy shown to cause apoptosis (149;26$-270). Hence, in conditions where
mitochondrial G$H is depleted, apoptosis may be enhanced.
On the other hand, when the mitochondrial G$H pool is spared (for example when there is
rapid and transient GSH depletion), this leads to protection against apoptosis since sorne of
the key cytosolic effectors of the apoptotic machinery (notably caspases) are inhibited by
the ensuing oxidative stress. Indeed, carefiul review of the literature suggests that mild
oxidative stress can protect against apoptosis, as long as the mitochondria and the nucleus
are spared (151;271-273). In fact BCL-2, a known anti-apoptotic protein present on the
mitochondrial and nuclear membranes, has been shown to relocate GSH from the cytosol to
the nucleus (151) lending support to this observation. Hence, cytosolic GSH depletion leads
rather to a reduction ofthe sensitivity toward apoptosis.
The recent discovery that growth factors (GF), known anti-apoptotic agents, induce a
coordinate generation of ROS that is required for some of their biological effects
(200;274;275), led us to hypothesize that Gf can negatively control apoptosis by inducing a
mild intracellular oxidative stress.
/225
Therefore, we examined the effect of EGF on the GSH system in mouse hepatocyte
primary cultures. EGf was able to effectively decrease intracellular GSx and GSH levels in
a time- and dose-dependent manner. However, since the decline in GSH levels was steeper
than that of GSx levels, this resulted in a decrease of the GSH/GSx ratio, hence a shift
toward a more oxidized redox state. Attenuation of G$SG reductase (GR) activity was
detected in EGf-treated cultures as compared to untreated ones, which might explain the
decline in G$H/GSx ratio. This EGF-induced mildly oxidized redox state was shown by
others to be necessary for the full expression of the proliferative action of Gf. In fact,
inhibition of de novo synthesis of GSH has been shown to potentiate the sensitivity of ceils
to extracellular stimuli acting via MAPK activation (275;276).
In order to verify the specificity of the effect of EGF on GSH stocks, we used an inhibitor
of the tyrosine kinase activity of the EGf-R called PD163893. We have shown that this
compound is capable of completely abolishing the autophosphorylation of the EGF-R, the
phosphorylation and activation of the MAPK and Akt pathways, the incorporation of
H332P04 into ceils as well as the increase in BCL-xL mRNA and protein expression
observed following EGf treatment. Therefore, these findings showed that PD1 68393 is a
specific and potent inhibitor of the TK activity of EGf-R.
Celi treatment with PD168393 completely abolished the EGf-induced decrease in GSx and
GSH levels, G$WGSx ratio as well as the attenuation of GR enzymatic activity. This
suggests that EGf-induced GSH depletion and oxidation was mediated by the tyrosine
kinase (TK) activity of the EGF receptor. Therefore, these results strongly indicate that
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EGf specifically induces an oxidative state in primary hepatocyte cultures due to depletion
of GSH stocks and by favouring GSH oxidation.
EGF has been shown by many investigators, including our group, to be able to protect
against apoptosis induced by various stimuli (136;277-279). from our resuits, this
protection against apoptosis occurs in conjunction with the establishment of a milU
oxidative stress. Thus, it was necessary to investigate the relevance of the observed GSH
depletion and oxidation to the anti-apoptotic effect of EGf. Ceil G$H replenishment with
glutathione monoethylester (GSHmee) resulted in a partial nonualization of intracellular
redox state in EGF-treated cultures by diminishing EGf-induced decrease in GSx and GSH
levels as well as G$H/GSx ratio. This partial normalization also partly attenuated (53%
decline) the protective effect of EGF against fas-induced caspase-3 activation and celi
death by apoptosis. These findings are in accordance with the concept that depletion of
GSH by various treatments (e.g. ceil isolation, acetaminophen, phorone) results in the
abrogation of the transmission of the apoptotic signal. Such a protection is thought to
proceed tbrough redox inhibition of caspases activity (due to their need of a reduced
cysteine in their active site) as reported by the Wendel group (261) and our own (280).
Therefore, this suggests that the anti-apoptotic effect of EGf is mediated, at least in part,
through redox modulation of key components of the apoptotic machinery.
Gf have been shown to use mild oxidative stress to mediate sorne of their biological
signais. Indeed, PDGF induces F1202 generation that has been shown to be required for
PDGf-induced tyrosine phosphorylation, DNA synthesis and MAPK activation (201).
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Furthermore, the anti-oxidant N-acetyi-cysteine (NAC) has been reported to inhibit EGF
induced stimulation of glycolic enzymes in isoiated digestive gland celis (274). Hence, the
involvement of ROS production!altered redox state in a multitude of normal biological
processes defines a new role for ROS production in normal ceil homeostasis in addition to
their classical toxic damage to cellular macromoiecules. This also adds a new perspective
to the use of anti-oxidants. Indeed, depending on the circurnstance, they can be beneficial
by protecting against high leveis ofRO$ but harmful by inhibiting Gf signalling (264).
Summarizing the rnechanisms used by GF to protect against apoptosis, their pro-survival
signal is divided between the activation of anti-apoptotic processes (such as the anti
apoptotic proteins of the BCL-2 family) and the inhibition of pro-apoptotic ones (e.g. Bad.
caspase-9). In the latter category, redox modulation of the activity of caspases appears to be
another step in the negative regulation of pro-apoptotic mechanisms by GF, which acts in
conjunction with the phosphorylation of Bad and procaspase-9 by Akt. 0f note, these
rnechanisms have ail been shown to depend on the TK activity of GF receptors. Indeed, the
increase in BCL-xL levels, the activation of Akt kinase and the depletion and oxidation of
GSH were all blocked by EGF-R TK inhibitors (PD16$393 and Tyrphostin AU 147$).
However, some data show that flot ail of the biological effects of GF can be mediated
through TK-dependent mechanisms.
As mentioned eariier, when EGf binds to its receptor, it induces the oligomerization of the
latter. The subsequent conformationai change activates the TK activity ofthe EGF-R. This
model of activation is similar to most Gf that bind TK receptors. A number of studies have
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demonstrated that both the oligomerization (2$ 1-284) and the autophosphorylation (285-
287) of these receptors are necessary for the transmission of the signal of GF. On the other
hand, evidence has accumulated to show that some GF effects may occur independently of
the TK activity of their receptors. For instance, Schreiber et al. have reported that cross
linking of ceil-bound monoclonal EGf-R antibodies resulted in the clustering of the
receptor and the stimulation of DNA synthesis without activation of the TK domain of this
receptor (288). Therefore, we investigated the involvement of the TK activity ofthe EGF-R
in the anti-apoptotic effect of EGF. We used two inhibitors of TK activity: PDÎ 68393 and
Tyrphostin AG1478. Their efficacy was confirmed by measuring EGF-R
autophosphorylation, MAPK and PI 3-K activation, 32P incorporation into cefls, as well as
of BCL-xL mRNA and protein expression.
As mentioned above, EGf co-stimulation with anti-Fas decreased the levels of apoptotic
ceils as cornpared to cultures treated with anti-fas only. Ceil treatment with TK inhibitors
resulted in the significant increase of the level of apoptotic celis in anti-fas+EGF—treated
cultures as compared to their control counterparts. However, we were surprised to find that
this level (anti-Fas+EGF+TK inhibitors) neyer reached that observed in Fas-treated
cultures (anti-Fas+TK inhibitors). This suggested that some of the EGf protective signal
was stili transmitted into the ceil in the presence of these inhibitors. Therefore, our resuits
strongly suggest that part ofthe EGf-induced protection is flot related to the TK activity of
EGF-R. Similar findings were reported by Dews et al. who have demonstrated that the
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mutation of IGf-1 receptor in its TK domain resulted in a reduction of the anti-apoptotic
action of IGf- 1, without completely abolishing it (289).
To date, these TK-independent pathways have flot been identified. However, in an atternpt
to understand these processes, it is important to remember that following Gf binding to
their receptors, another important initial event occurs; namely, receptor oligornerization.
This phenomenon of receptor association and subsequent conformational change may
favour interactions with certain intracellular proteins. for instance, oligomerization may
create a link between the receptor and certain effectors of the anti-apoptotic machinery
through protein-protein interactions. BAG-1, an anti-apoptotic protein ofthe BCL-2 family,
has been shown to associate with the cytoplasmic domain of GF-R through its C-terminus
(138) independently of Gf-R phosphorylation state. In addition, BAG-1 has the ability to
bind to heat-shock proteins and other chaperones molecules, which play an important role
in protein stability. Hence, with such functional properties, BAG-1 (and other BAG-1-like
proteins) may link Gf-R with intracellular anti-apoptotic effectors without the need for Gf
R autophosphorylation.
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CONCLUSION
In conclusion, the work presented here shed some light on the involvement of the
intracellular redox state in the control 0f apoptosis, which is stili subject for much debate.
Indeed, the resuits of these studies demonstrate that oxidative stress protects against fas
induced apoptosis and that this may represent a novel mechanism used by growth factors to
protect hepatocytes in primary cultures. These findings are in accordance with an ernerging
concept, which postulates that flot ail oxidative stress is harmful to celis. In fact, several
recent unes of evidence indicate that mild oxidative stress is important for the mitogenic
effect of growth factors and host defence.
However, the reievance of these findings to in vivo models is worth further investigating.
especially since thiol depletion is a known pathogenic factor in several diseases. Indeed, the
effect of growth factors on in vivo GSH stocks is interesting to study especiaily in models
of acetarninophen hepatotoxicity where important question need to be answered: Does
growth factors potentiate this kind of pathologies? Or again, the over ah cellular context of
GSH depletion plays a role in defining the end resuit? In addition, what is the potential
effect of oxidative stress on the immune response during hepatic, or other organ, virus
infection or cancer defence since the Fas system is particularly important in these immune
responses?
Therefore, much work remains to be done in the quest for the understanding of the
modulation of apoptosis for therapeutic purposes.
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